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ABSTRACT 
 
Malaria, which is caused by Plasmodium parasites, is responsible for the death of 
millions of humans every year in the tropical and subtropical regions of the world. 
Specifically P. falciparum, one of four malaria species infecting humans, is 
responsible for the greatest morbidity and mortality burden in African populations. 
The Anopheles mosquito transmits the parasite to the human host, where it infects 
and destroys human erythrocytes. The erythrocyte membrane therefore plays a 
vital role in all aspects of the pathogenic phase of the P. falciparum life cycle and 
protein-protein interactions between host and parasite are thus a key focus of 
research. The human erythrocyte maintains its shape with a structural network of 
proteins underneath the plasma membrane and the main protein component of this 
erythrocyte membrane skeleton is spectrin. To investigate host-parasite protein 
interactions, a novel application of phage display technology was developed, 
whereby purified human erythrocyte spectrin was biopanned against a P. 
falciparum phage-display library. The P. falciparum DNA inserts of interacting 
phage were compared to the PlasmoDB database and five interacting proteins 
were identified: a putative aminopeptidase (PfM18AAP); a putative Ebl-1 like 
protein, which is proposed to participate in erythrocyte invasion; and three 
hypothetical proteins. The interaction of the hypothetical proteins with spectrin is 
the first information available on the function of these proteins. The five gene 
sequences were cloned into the pET-15b or pGEX-4T-2 expression vectors for 
purification of the recombinant proteins from Escherichia coli. Only the 6His-
PfM18AAP fusion protein was expressed in soluble form and purified by affinity 
selection. PfM18AAP migrated as a 67 kDa peptide on SDS-PAGE and native gel 
analysis revealed multiple subunits of the enzyme, predominantly a tetramer and 
higher oligomers. Cleavage of the 6His-tag and subsequent IEF SDS-PAGE 
revealed three 65 kDa entities with pI ~6.6, ~6.7 and ~6.9. An in vitro coupled 
enzyme assay showed that PfM18AAP cleaved an N-terminal aspartate from a 
peptide substrate with a maximum activity at pH 7.5 and 37 ºC. Inhibitor studies 
confirmed that the enzyme is a metalloprotease. Blot overlay assays with 
PfM18AAP against spectrin and erythrocyte membrane proteins verified that 
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PfM18AAP binds strongly to β-spectrin, as well as protein 4.1, protein 4.2, actin 
and glyceraldehyde-3-phosphate dehydrogenase. Comparison of the PfM18AAP 
protein sequence to ten other M18 aminopeptidase sequences, including human 
and three other Plasmodium species, revealed that all the critical amino acids 
responsible for the binding of two catalytic metal ions, enzymatic catalysis and 
quaternary structure stabilisation are conserved. The peptide fragment, which 
initially bound to spectrin during phage display, is not found in other M18 
aminopeptidases, suggesting that the presence of this fragment is an evolutionary 
development of P. falciparum that allows the protease to bind to human spectrin. 
Analysis of four M18 aminopeptidase crystal structures revealed that the spectrin-
binding region forms an external loop on the protein and would thus be accessible 
to spectrin. Results from this study suggest that, apart from haemoglobin digestion, 
PfM18AAP performs additional functions in the parasite and infected erythrocyte 
by cleaving spectrin and other erythrocyte membrane proteins. This would 
destabilise and disrupt the erythrocyte membrane skeleton to facilitate entry or 
exit from the host cell, or the insertion of parasite proteins into the host cell 
membrane. Further analysis and characterisation of PfM18AAP and its 
interactions with the erythrocyte membrane proteins will shed more light on the 
multifunctional role of this parasite enzyme. Studies of this enzyme and the 
hypothetical proteins may also aid in the quest to discover new therapeutics to 
combat this killer disease. 
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The men of experiment are like the ant, they only collect and use; the 
reasoners resemble spiders, who make cobwebs out of their own substance. 
But the bee takes the middle course: it gathers its materials from the flowers 
of the garden and field, but transforms and digests it by a power of its own. 
Not unlike this is the true business of philosophy (science); for it neither 
relies solely or chiefly on the powers of the mind, nor does it take the matter 
which it gathers from natural history and mechanical experiments and lay 
upon its memory of whole, as it finds it, but lays it up in the understanding 
altered and digested. Therefore, from a closer and purer league between 
these two faculties, the experimental and the rational (such as has ever been 
made), much may be hoped.  
 
Francis Bacon (1561-1626) 
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Chapter 1: Introduction 
1.1 Malaria 
 
Malaria, caused by an Apicomplexan of the genus Plasmodium, is a disease 
affecting humans in most tropical and subtropical regions of the world (Figure 1). 
Yearly 300-660 million people are diagnosed with clinical malaria and two thirds 
of the global incidence occurs in Africa (Snow et al., 2005). The World Health 
Organisation estimates that annually 2.7 million deaths can be attributed to the 
disease (WHO, 2006). P. vivax, P. ovale, P. malariae, and P. falciparum are the 
four Plasmodium species infecting humans. P. falciparum causes the most severe 
and majority of malaria cases in Africa (Snow et al., 2005) and often manifests 
itself as cerebral malaria in infected people. The disease can also induce anaemia 
and this results in the death of 10-20 % of infected children (WHO, 2006). 
 
 
Figure 1: The global malaria distribution. 
Map showing the endemicity of malaria. The severity of malaria throughout the 
tropical and subtropical regions of the world is indicated in green. The endemicity 
increases with increasing colour intensity (Roll Back Malaria, 2005). 
 
The Plasmodia that cause malaria in humans, alternate their life cycle between the 
human and a mosquito host (reviewed in Miller et al., 2002). The parasites use the 
mosquito as their primary host, where they complete their sexual replication and 
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undergo asexual replication, termed sporogony. The secondary human host is used 
for asexual replication, classified as schizogony. This phase includes the initial 
development in the liver known as pre-erythrocytic or exo-erythrocytic 
schizogony and the main asexual replication cycle that occurs in the human red 
cells, known as erythrocytic schizogony. It is during erythrocytic schizogony that 
the pathological and clinical symptoms of malaria occur, which include repeated 
attacks of fever, headache, vomiting and other flu-like symptoms. If the disease is 
not treated, or the parasites build up a resistance to the treatment, the parasite can 
kill its human host by infecting and destroying erythrocytes and by obstructing the 
capillaries that carry blood to the brain or other vital organs. 
 
1.1.1 The P. falciparum life cycle 
 
The intricate P. falciparum life cycle (Figure 2) (reviewed in Tuteja, 2007) 
commences in the human host when a female Anopheles mosquito injects a small 
amount of anticoagulant-containing saliva with approximately 20 haploid 
sporozoites into human subcutaneous tissue, or less commonly directly into the 
bloodstream. Once parasites have entered the bloodstream they travel to the liver, 
where they traverse several host cells before a single sporozoite comes to rest in a 
hepatocyte and develops asexually to produce 30,000-50,000 merozoites in about 
5 to 7 days. Upon maturation the merozoites are released from the liver cells into 
the bloodstream, where they attach themselves to erythrocytes, which they 
subsequently invade. 
 
Inside the erythrocyte, the parasite begins to enlarge as a uninucleate ring form, 
and continues to develop into a young feeding stage, known as the ring or early 
trophozoite. Trophozoites continue to divide asexually to produce a schizont that 
has approximately 16-32 nuclei. Further parasite maturation results in 
mononucleated merozoites that rupture the erythrocytes, thereby releasing 
themselves into the bloodstream. Merozoites reinvade healthy erythrocytes, 
resulting in a replication cycle that repeats itself approximately every 48 hours 
during a P. falciparum infection. 
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Figure 2: The P. falciparum life cycle. 
Diagram showing the three distinct stages and the different parasite forms during 
the P. falciparum life cycle. The mosquito stage is labelled in purple; the exo-
erythrocytic liver stage is labelled in green; and the asexual erythrocytic stage is 
labelled in red (Bannister and Mitchell, 2003). 
 
Not all merozoites commit themselves to erythrocytic schizogony. Instead, 
parasites differentiate into macrogametocytes and microgametocytes (Fujioka and 
Aikawa, 1999) that are ingested by an Anopheles mosquito when it bites an 
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infected human host. The gametocytes develop into female (macro) and male 
(micro) gametes (Fujioka and Aikawa, 1999), which escape from the erythrocytes 
once they have entered the mosquito’s gut and fuse to form a diploid zygote called 
the ookinete. The ookinete penetrates the gut wall and forms an oocyst on its outer 
surface. The diploid oocyst undergoes meiosis and eventually ~8,000 haploid 
sporozoites erupt from the oocyst and migrate to the salivary glands of the 
mosquito (Sinden and Gilles, 2002). The sporozoites remain in the salivary glands 
until the mosquito bites a new human host and thereby releases the parasites into 
the human bloodstream. 
 
1.2 The human erythrocyte 
 
The human erythrocyte functions as the main oxygen carrier in the body. Varying 
from 7.5 to 7.8 µm in diameter, the cells contain no nucleus and lack intracellular 
organelles (Bull and Breton-Gorius, 1995). Haemoglobin makes up 90 % of the 
cellular composition and it is the haem moiety contained within the haemoglobin 
that binds oxygen. Due to a lack of mitochondria the cell generates its energy 
through direct glycolysis of glucose and the hexose monophosphate shunt.  
 
1.2.1 The erythrocyte membrane 
 
Erythrocytes need to be supple and at the same time robust to allow them to 
withstand large deformations during their passage through the capillaries and 
spleen. These characteristics are provided by the erythrocyte membrane which 
contains two structural elements made up of lipids and proteins (Figure 3). 
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Figure 3: The erythrocyte membrane. 
Diagram showing the structure of the erythrocyte membrane. The erythrocyte 
membrane consists of two structural components, the phospholipid bilayer and the 
membrane skeleton. The skeleton is attached to the integral proteins (band 3 and 
GPC) in the lipid bilayer via ankyrin and protein 4.1. GPA = glycophorin A; GPC 
= glycophorin C; 3 = band 3; 4.1 = protein 4.1; 4.2 = protein 4.2 (Walensky et al., 
2003). 
 
The first structural element is the lipid bilayer that forms the permeability barrier 
between the internal and external environment of the erythrocyte. It is composed 
of two phospholipid layers that are arranged in such a way, that the hydrophobic 
fatty acid chains form the core of the membrane and the polar heads face outwards 
towards the blood plasma (outer leaflet) and the erythrocyte cytoplasm (inner 
leaflet). The outer leaflet contains phosphatidylcholine and sphingomyelin and the 
inner leaflet consists of phosphatidylserine and phosphatidylethanolamine, thus 
showing an asymmetry in the phospholipid arrangement. The phospholipid bilayer 
is very rich in nonesterified cholesterol, the majority of which is associated with 
sphingolipids in structures called rafts. These rafts form detergent-resistant plasma 
membrane microdomains and function in sorting and signalling processes of the 
cell (Brown and London, 1998). Embedded within the erythrocyte lipid bilayer are 
the integral membrane proteins, the anion exchanger (band 3) and the 
glycophorins (reviewed in Walensky et al., 2003). 
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The second structural element is the membrane skeleton consisting of a protein 
scaffold that lies about 10 nm below the inner side of the lipid bilayer and it is this 
membrane skeleton that gives the erythrocyte its structural integrity. The 
erythrocyte membrane skeleton is anchored to the integral membrane proteins by 
linker proteins such as ankyrin and protein 4.1 (reviewed in Walensky et al., 
2003). 
 
1.2.2 Spectrin 
 
Making up 50-75 % of the total skeletal protein mass (Yu et al., 1973), spectrin is 
the predominant protein in the membrane skeleton. Spectrin occurs as an αβ-
heterodimer consisting of a 240 kDa alpha and 220 kDa beta chain (Marchesi, 
1979).  
 
Each chain is composed of multiple homologous 106 amino acid residue motifs 
(termed repeats) which fold into triple α-helical bundles with the first and third 
helices in parallel and the intervening second helix in an antiparallel arrangement 
(Speicher and Marchesi, 1984) (Figure 4). The amino acids in each α-helical 
bundle are arranged as a heptad motif with a seven-residue symmetry (Figure 5), 
where the first and fourth positions (a & d) are filled by hydrophobic and the fifth 
and seventh positions (e & g) are occupied by charged amino acids. The charged 
amino acids link the three bundles together and embed the hydrophobic amino 
acids in the repeat (Yan et al., 1993). Formation of the repeat leaves the outer 
polar uncharged, positively and negatively charged amino acids (b, c & f) of each 
α-helical bundle available for hydrogen and electrostatic bond formation with 
other molecules. 
 
The spectrin α and β chains self-associate in an antiparallel fashion starting at the 
dimer nucleation site, which forms at the amino terminus of β-spectrin and the 
carboxyl terminus of α-spectrin (Figure 6) (Ursitti et al., 1996). The rest of the αβ-
heterodimer then proceeds to associate side-by-side in a zipper-like fashion 
(Speicher et al., 1992), forming a supercoiled rope-like structure. 
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repeats 
Figure 4: Triple helical repeats. 
Diagram showing two spectrin repeats. Three α-helical bundles, containing 106 
amino acids, fold with the first and third helices (A and C) in parallel and the 
intervening second helix (B) in an antiparallel arrangement to form a single 
spectrin repeat. Two repeats are stabilised by the interaction of the second helix of 
the first repeat (B4 and B5) with the third helix of the first repeat (C29) and the 
first helix of the second repeat (A2) (Walensky et al., 2003). 
 
 
Figure 5: The amino acid distribution of a spectrin repeat. 
Cross-section of a Drosophila α-spectrin repeat. Three heptad motif containing α-
helical bundles align in a parallel (A & C) and anti-parallel (B) fashion to form the 
repeat. Hydrophobic (a & d) and charged (e & g) amino acids stabilise repeat 
formation by ionic interactions. The remaining polar uncharged, negatively and 
positively charged (b, c & f) amino acids are available for interactions with the 
spectrin-binding peptides, via hydrogen bonds and ionic interactions. Ionic 
interactions are represented as dashed lines and amino acids are coloured 
according to class: blue = polar uncharged; black = nonpolar aliphatic and 
aromatic; red = positively charged; green = negatively charged (adapted from Yan 
et al., 1993). 
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The spectrin tetramer is the predominant form of spectrin found in the erythrocyte 
membrane skeleton (Ungewickell and Gratzer, 1978). A tetramer is formed when 
two dimers self-associate at the tetramerisation site (self-association site), which is 
at the opposite end to the dimer nucleation site in the spectrin molecule (Figure 6). 
At this tetramerisation site one N-terminal α-helix from the α-chain and two C-
terminal α-helices from the β-chain link together to form a complete triple helix 
repeat (Tse et al., 1990). Thus, spectrin tetramers are long flexible molecules 
arranged in a lattice framework, which lends stability and flexibility to the 
membrane skeleton.  
 
 
Self-association site 
4.1; 
Actin; 
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Figure 6: The spectrin tetramer. 
Diagram showing the association of α- and β-spectrin triple helical repeats into 
dimers and a tetramer. The spectrin dimer, consisting of an α- and β-spectrin 
monomer, forms at the nucleation site. The tetramer is created when two spectrin 
dimers join at the self-association sites (inset). One N-terminal α-helix from α-
spectrin (C) and two C-terminal α-helices from β-spectrin (A and B) link together 
to form a complete repeat. Features of the α- and β-spectrin monomers are 
marked: Alpha-spectrin contains a src homology domain (SH3) and EF hands. 
Beta-spectrin contains 4.1, actin, adducin and ankyrin binding sites and the 
phosphorylation sites. Repeats involved in phosphatidylserine binding are labelled 
as ‘Lipids’ and the five α- and four β-spectrin tryptic digest domains are labelled 
‘αI-V’ and  ‘βI-IV’ respectively  (adapted from Walensky et al., 2003). 
 
Each spectrin monomer has additional functional domains (Figure 6). Alpha 
spectrin contains a src homology (SH3) domain in the 10th repeat, and two or 
three calcium-binding EF hands at the C-terminal end of the molecule. The SH3 
domain functions as a protein attachment site and it has been shown that tyrosine 
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kinases interact with this domain (Ziemnicka-Kotula et al., 1998). The N-terminus 
of β-spectrin contains a region of 272 amino acids that binds protein 4.1, actin and 
adducin (Li and Bennett, 1996) and the 15th repeat binds ankyrin, which is part of 
the band 3 complex (Kennedy et al., 1991). The C-terminus of β-spectrin has an 
additional stretch of 52 amino acids that contains phosphorylated serines and 
threonines (Harris and Lux, 1980). Beta-spectrin also binds calmodulin, which, in 
the presence of calcium, regulates the interactions between spectrin, protein 4.1 
and actin (Anderson and Morrow, 1987). In addition, both spectrin molecules 
contain repeats that interact with the lipid bilayer (An et al., 2004). Finally, a 
limited tryptic digest of the αβ-heterodimer liberates five α-spectrin (αI = 80 kDa, 
αII = 46 kDa, αIII = 52 kDa, αIV = 41 kDa and αV = 41 kDa) and four β-spectrin 
(β I = 17 kDa, βII = 65 kDa, βIII = 33 kDa and βIV = 74 kDa) peptide domains 
(Speicher et al., 1992). 
 
1.2.3 The erythrocyte membrane skeleton 
 
The lattice framework of the membrane skeleton consists of a two-dimensional 
network of spectrin tetramers and junctional complexes (Figure 7A). The 
junctional complexes are found at the distal end of the spectrin tetramer. The N-
termini of six β-spectrin chains (Byers and Branton, 1985, Liu et al., 1987) link to 
two actin protofilaments (Brenner and Korn, 1979) via protein 4.1 (Ungewickell 
et al., 1979) and dematin (protein 4.9) (Siegel and Branton, 1985) (Figure 7b). 
The two actin filaments are stabilised and their length regulated by two 
tropomyosin molecules, that each bind six actin monomers (Fowler, 1996). The 
barbed ends of the actin filaments are capped by adducin and the tropomyosin 
molecules are capped at the opposite end by tropomodulin (Fowler, 1996). 
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  Figure 7: The two-dimensional network of the red cell membrane skeleton. 
Electron micrograph and diagram (a) depicting the two-dimensional network of 
the membrane skeleton and diagram (b) showing the junctional complex. 
Junctional complexes are found at the ends of the spectrin tetramer and band 3 
complexes are located along the spectrin tetramer. The spectrin tetramers are 
attached to actin protofilaments via protein 4.1 and dematin. The actin filaments 
are stabilised by tropomyosin molecules and capped by adducin. The tropomyosin 
molecules are capped by tropomodulin ((a) Liu et al., 1987, (b) adapted from 
Walensky et al., 2003). 
 
1.2.4 Integral membrane proteins 
 
The erythrocyte integral membrane proteins, namely band 3 and the glycophorins, 
penetrate or traverse the erythrocyte membrane by interacting with the 
hydrophobic lipid core of the phospholipid bilayer (Figure 3). 
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Band 3 is the major integral membrane protein of the red cell. It forms a 52 kDa 
transmembrane channel, which functions in the exchange of HCO3- and Cl- and 
therefore actively participates in the exchange of CO2. The 43 kDa N-terminal 
cytoplasmic domain serves as an anchor point for the membrane skeleton by 
interacting with ankyrin, protein 4.1, and protein 4.2 (Bennett and Stenbuck, 
1980). Two complexes associate with band 3. The first is the Rh complex, which 
is linked to ankyrin and protein 4.2 via the Rh polypeptide and CD47 respectively 
(Bruce et al., 2003). The second is a glycolytic enzyme complex containing 
glyceraldehyde-3-phosphate dehydrogenase (Kant and Steck, 1973), 
phosphofructokinase and aldolase (Jenkins et al., 1984), haemoglobin (Walder et 
al., 1984), lactate dehydrogenase and pyruvate kinase (Campanella et al., 2005). 
This complex interacts with the cytoplasmic domain of band 3. 
 
The glycophorins have sialic acid moieties bound to domains that are exposed on 
the erythrocyte surface. These sialic acid chains code for blood group variants and 
also give the erythrocyte surface a net negative charge, which prevents the 
erythrocytes from adhering to each other and the vessel walls (reviewed in Chasis 
and Mohandas, 1992).  
 
1.2.5 Membrane skeleton linkage to the lipid bilayer 
 
The membrane skeleton is linked to the integral proteins of the lipid bilayer via 
primary and secondary attachment sites. Primary attachment occurs through the 
band 3 complex, where band 3 binds to the C-terminal end of β-spectrin via 
ankyrin (Bennett and Stenbuck, 1979, Byers and Branton, 1985). Protein 4.2 
further strengthens this membrane interaction by linking ankyrin and band 3 
(Korsgren and Cohen, 1988). In the secondary attachment site, protein 4.1 links 
the actin filaments in the junctional complex to glycophorin C (Anderson and 
Lovrien, 1984) and this interaction is stabilised by p55 (Figure 3) (Alloisio et al., 
1993).  
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The membrane skeleton linkage to the lipid bilayer is also strengthened by the 
direct interaction of the skeleton proteins with the phospholipids of the 
erythrocyte membrane. Alpha- and beta-spectrin have specific repeats (Figure 6) 
that bind phosphatidylserines (An et al., 2004) and the 30 kDa basic domain of 
protein 4.1 also interacts with phosphatidylserines (Cohen et al., 1988, Rybicki et 
al., 1988). 
 
1.3 The erythrocytic phase of the P. falciparum life cycle 
 
The malaria parasite spends the main part of its asexual life cycle in the human 
erythrocyte. To ensure its survival, the parasite has to enter an erythrocyte by 
disrupting the organisation of the erythrocyte membrane, and once inside, the site 
of invasion has to be repaired. During development and maturation the parasite 
depletes the nutrient resources available in the erythrocyte and therefore the 
parasite has to modify the host cell and host cell membrane to obtain additional 
nutrients and eliminate waste products. The parasite also needs to remain 
undetected by the host’s immune system and this is achieved by further 
modifications to the host cell and membrane. Finally, the parasite has to disrupt 
the erythrocyte membrane to ensure its release from the erythrocyte. 
 
1.3.1 Erythrocyte invasion 
 
The host cell invasion model suggests that the parasite merozoite goes through 
three phases to enter the erythrocyte (Figure 8) (reviewed in Topolska et al., 2004). 
These phases are: 1) an initial low-affinity interaction between any part of the 
merozoite and the host cell surface, followed by the reorientation of the merozoite 
to allow its apical prominence to contact the host cell; 2) irreversible attachment 
and formation of an electron-dense junction between the apical prominence and 
the host cell and finally; 3) invasion, in which the parasite propels itself forward 
into a membrane enclosed compartment called the parasitophorous vacuole, which 
eventually seals behind the parasite (Dvorak et al., 1975). 
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Figure 8: Erythrocyte invasion by P. falciparum. 
Diagram showing the three phases of invasion. The merozoite undergoes initial 
attachment and reorientation; followed by irreversible attachment and junction 
formation; and parasitophorous vacuole formation and invasion (Kats et al., 2006, 
originally adapted from Chitnis and Blackman, 2000). 
 
During each phase a specific set of proteins located either on the surface of, or in 
specific organelles and compartments of the merozoite, are used to recognise and 
disrupt the erythrocyte (Figure 9). The organelles involved in invasion are the 
rhoptries, which are made up of two, large, tear-shaped organelles terminating at 
the apex of the parasite, and the micronemes, which are small tube-shaped 
structures associated with the rhoptries. Additional proteins are released from the 
dense granules, which are intermediate in size, spherical, and denser than the 
micronemes and rhoptries (Langreth et al., 1978). 
 
The first phase of invasion occurs when the merozoite comes into contact with an 
uninfected erythrocyte. This contact is accidental in nature and results from the 
recognition of red cell receptors by the coat filaments of the merozoite. These 
filaments are made up of parasite proteins such as the merozoite surface proteins 
(MSP-1-10), serine-rich antigen (SERA/SERP) and S antigen. This initial 
interaction between parasite and host is weak, non-specific and reversible, and 
merozoites are often seen to dissociate from erythrocytes. 
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Figure 9: The P. falciparum merozoite. 
Diagram showing the structure and organelles of the P. falciparum merozoite. The 
merozoite contains secretory organelles involved in invasion, namely the 
micronemes, rhoptries and dense granules (Bannister et al., 2000). 
 
Invasion continues with the parasite reorientating itself so that its apical end 
comes into contact with the erythrocyte surface. This reorientation strengthens the 
interaction between the merozoite surface and the red cell surface and eventually 
becomes irreversible, and the parasite commits itself to erythrocyte invasion. 
After contact, intracellular stores of Ca2+ are released within the parasite (Lovett 
and Sibley, 2003) and this activates the discharge of parasite proteins, such as the 
erythrocyte binding antigens (EBA-175, EBA-140/BAEBL, EBA-181/JESEBL) 
and the apical membrane antigen 1 (AMA-1) from the micronemes. The 
erythrocyte binding antigens form a junction with the erythrocyte membrane 
receptors, such as Glycophorin A, B, and C/D (Hadley et al., 1987) and these 
interactions are to some degree redundant and interchangeable (Mayer et al., 
2002). The tight junction remains during invasion and is seen as a ring that moves 
backwards over the parasite surface as the parasite actively invades the 
erythrocyte (Aikawa et al., 1978). Shortly after junction formation the rhoptries 
release their parasite proteins, namely the rhoptry associated proteins (RAP-1, 
RAP-2, RAP-3), high molecular weight rhoptry proteins (RhopH-1, RhopH-2, 
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RhopH-3), and proteases (gp76), which aid in the invasion process. The rhoptries 
also discharge parasite lipids (Etzion et al., 1991). These rhoptry proteins and 
lipids, together with proteins and lipids from the host cell membrane, are used to 
form the parasitophorous vacuole membrane (Stewart et al., 1986). This 
membrane surrounds the parasitophorous vacuole which is a sack-like structure 
that provides a secure environment for the parasite to reside and grow in. The 
dense granules are the last organelles to discharge their protein content, such as 
the ring-infected erythrocyte surface antigen (RESA), ring membrane antigen 
(RIMA), and the subtilisin-like proteases (PfSUB-1, PfSUB-2). These proteins 
either integrate themselves into the parasitophorous vacuole or cross the 
parasitophorous vacuole membrane to interact with the erythrocyte membrane 
lipid bilayer and erythrocyte membrane skeleton proteins. PfSUB-2 has been 
implicated in the shedding of MSP-1 and AMA-1 from the parasite surface as it 
invades the erythrocyte (Howell et al., 2003). Another set of proteases, the 
rhomboids (PfROM-1 and PfROM-4), cleave AMA-1, thrombospondin-related 
anonymous protein (TRAP), circumsporozoite protein (CSP) and TRAP-related 
protein (CTRP), merozoite TRAP homologue (MTRAP), PFF0800c, EBA-175, 
EBA-140/BAEBL, EBA-181/JESEBL, MAEBL, and the reticulocyte-binding 
homologues (RH-1, RH-2a, RH-2b, and RH-4), and could therefore be involved 
in the shedding process (Baker et al., 2006). 
 
Invasion requires the use of an actin/myosin motor complex termed the 
glideosome (Figure 10) (Keeley and Soldati, 2004, reviewed in Cowman and 
Crabb, 2006). This complex is located in the parasite’s pellicle, between the 
parasite plasma membrane and the inner membrane complex (IMC). The IMC is 
constructed from a single large flattened vesicle that is joined at a single suture 
line running the length of the long axis of the parasite (Morrissette and Sibley, 
2002). The IMC is not found at the apical prominence (Bannister et al., 2000), 
thereby allowing the micronemes, rhoptries and dense granules to discharge their 
contents to the external environment. Within the glideosome, Plasmodium myosin 
(MyoA) (Pinder et al., 1998) attaches to the Myosin Tail Interacting Protein 
(MTIP) via its light chain and the other end of myosin interacts with actin (Webb 
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et al., 1996). MTIP in turn interacts with glideosome-associated protein 45 
(GAP45) and glideosome-associated protein 50 (GAP50) to link the glideosome 
to the IMC (Jones et al., 2006). The glideosome is also present in other invasive 
stages of Plasmodium, and in sporozoites it has been shown that the glideosome 
connects to the parasite plasma membrane via aldolase and the adhesin TRAP 
(Buscaglia et al., 2003). It is therefore thought that the link to the merozoite 
plasma membrane is formed by the secreted microneme or rhoptry ligands and 
possibly aldolase. The parasite gains entry into the host cell using the force that is 
generated by the actin-myosin motor. Because the motor is anchored to the IMC, 
the generated movement is highly directional and causes the parasite to be 
propelled forwards into the host cell. During invasion the adhesin-aldolase-actin 
complex moves towards the posterior end of the parasite and this complex is 
released from the host cell by proteases such as the subtilisin-like proteases and 
rhomboids mentioned previously. 
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Figure 10: The actin-myosin motor of P. falciparum. 
Diagram showing the actin-myosin motor found in the P. falciparum glideosome. 
The glideosome consists of glideosome-associated protein 50 (Gap50), Myosin 
Tail Interacting Protein (MTIP), glideosome-associated protein 45 (GAP45) and 
Plasmodium myosin (MyoA). It attaches to the inner membrane complex (IMC) 
via GAP50 and interacts with the actin filaments via MyoA. Aldolase and 
erythrocyte binding antigen-175 (EBA-175) could form the link between actin and 
the parasite plasma membrane. Myosin moves along the actin filaments and 
thereby moves the parasite into the host cell (adapted from Jones et al., 2006). 
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1.3.2 Erythrocyte remodelling 
Enhancing the permeability of the erythrocyte membrane 
 
Once the parasite has invaded the erythrocyte the ring stage parasite seems to be 
‘dormant’ within the parasitophorous vacuole until approximately 12-16 hours 
later when it develops into the trophozoite stage. This maturation is concomitant 
with a rapid increase in metabolic and biosynthetic activity, requiring an energy 
source for glycolysis (Roth, 1990) and other molecules for protein, RNA and 
DNA synthesis. The parasite’s main source of amino acids for protein synthesis 
comes from the degradation of haemoglobin in the food vacuole (Sherman, 1977), 
but the acquisition of the other essential components required for survival poses a 
problem for the parasite, because it resides in a host cell that is devoid of and 
lacks the ability to synthesise macromolecules. In addition to acquiring nutrients 
from the plasma external to the erythrocyte, the parasite needs to eliminate the 
excess amino acids from the digestion of haemoglobin (Krugliak et al., 2002), 
lactate from glycolysis (Kanaani and Ginsburg, 1991) and other toxic waste 
products produced during parasite growth. The parasite also needs to regulate the 
influx and efflux of ions and water as it matures within the erythrocyte. The 
parasite overcomes these obstacles by upregulating and activating transporters and 
channels within the erythrocyte plasma membrane via phosphorylation (Decherf 
et al., 2004). The parasite also incorporates its own transporters and channels into 
the erythrocyte membrane to obtain essential nutrients, such as the vitamin 
pantothenic acid (Saliba et al., 1998). All these transporters and channels have 
been collectively termed New Permeability Pathways (NPP) (Kirk, 2001). 
 
Modifying the erythrocyte to accommodate cellular trafficking 
 
As the parasite progresses to the late trophozoite stage it further modifies the 
erythrocyte to satisfy its own survival and growth requirements. The parasite 
shuttles parasite proteins, required for cytoadherence and rosetting, to the 
erythrocyte surface and incorporates them into structures termed ‘knobs’ 
(Atkinson and Aikawa, 1990). However, the transport of proteins to the 
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erythrocyte surface is not a straightforward procedure because the parasite resides 
within the parasitophorous vacuole that is surrounded by a membrane. This 
membrane does not contain any transporters or channels and is often referred to as 
a molecular sieve that allows the free exchange of nutrients and metabolites, but 
prevents the movement of proteins to and from the erythrocyte cytosol (Desai and 
Rosenberg, 1997). Underlying the transport of proteins from the parasite through 
the parasitophorous vacuole to the erythrocyte membrane and the transport of 
lipids from the erythrocyte membrane to the parasitophorous vacuole membrane 
are several transport mechanisms. 
 
Protein transport in eukaryotic cells is normally initiated through the classical 
secretory pathway and this is also the case in the parasite (Das et al., 1994). In this 
pathway proteins that contain a hydrophobic N-terminal signal sequence are 
transported into the endoplasmic reticulum (ER) after leaving the ribosome. From 
the ER the proteins move into the Golgi complex where they are sorted and 
subsequently transported in vesicles to the cellular organelles or to the plasma 
membrane of the cell. A classical Golgi complex containing cisternae has 
however not been visualised in the parasite (Aikawa, 1971), but components of 
the Golgi apparatus have been found and it has therefore been suggested that the 
parasite contains a highly modified ‘unstacked’ Golgi form, where the Golgi 
compartments are not located adjacent to one another (Van Wye et al., 1996). It 
should also be noted that not all exported parasite proteins contain an N-terminal 
signal sequence that determines transport via the ER and thus it seems that the 
parasite also relies on an ER-Golgi-independent secretory pathway (Mattei et al., 
1999) that has yet to be defined. 
 
Once the parasite proteins have been processed via the ER they have to traverse 
the parasitophorous vacuole. Parasite proteins can be either soluble or membrane-
bound and this defines if the protein is transported freely through the 
parasitophorous vacuole and erythrocyte cytosol, or if the protein has to be 
transported via vesicles either in a soluble form or attached to the membrane of 
the transport vesicles (Lingelbach and Przyborski, 2006). Vesicle transport is 
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thought to occur via a one-step or a two-step process (Figure 11) for membrane-
bound proteins. 
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Figure 11: P. falciparum protein transport to the erythrocyte cytosol. 
Diagram showing the transport of membrane-bound proteins across the 
parasitophorous vacuole via the two-step (a) or one-step (b) process. In the two-
step process the secretory vesicle containing the exported protein (grey dot) 
releases its contents into the parasitophorous vacuole via the parasite plasma 
membrane (1). The protein is transported in another vesicle across the 
parasitophorous vacuole (2) and released into the erythrocyte cytosol via the 
parasitophorous vacuole membrane (3). In the one-step process the secretory 
vesicle containing the exported protein joins to the parasite plasma membrane 
where it is in close contact with the parasitophorous vacuole membrane and 
releases the protein directly into the erythrocyte cytosol (4) (Lingelbach and 
Przyborski, 2006). 
 
In the one-step process secretory vesicles within the parasite join the parasite 
plasma membrane where it is in close contact with the parasitophorous vacuole 
membrane. The contents of these vesicles are thus released directly into the 
erythrocyte cytosol (Elmendorf and Haldar, 1993). The two-step process entails 
parasite secretory vesicles releasing their contents into the parasitophorous 
vacuole. The proteins are then transported across the vacuolar space in another 
secretory vesicle and are finally released into the erythrocyte cytosol through the 
parasitophorous vacuole membrane either by protein translocation complexes or 
by vesicle budding (Ansorge et al., 1996, Lingelbach and Przyborski, 2006). The 
two-step process seems to be the predominant form of trafficking utilised by the 
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parasite (Ansorge et al., 1996) and transport across the parasitophorous vacuolar 
membrane requires the presence of transport signal. A vacuolar transport signal 
(VTS) (Hiller et al., 2004) and a Plasmodium export element (PEXEL motif) 
(Marti et al., 2004) have been characterised to date, and are located downstream 
from the hydrophobic N-terminal signal sequence recognised by the endoplasmic 
reticulum. 
 
After the parasite proteins have reached the erythrocyte cytosol, they need to be 
transported to the erythrocyte membrane. This transport occurs via two proposed 
transport models (Figure 12). The first is the vesicular transport model (Taraschi 
et al., 2001), in which parasite proteins are transported in vesicles across the 
erythrocyte cytosol to the Maurer’s clefts. Maurer’s clefts are ‘secretory 
organelles’ (reviewed in Przyborski et al., 2003) that consist of stacks of flattened 
lamellae and are located just below the erythrocyte plasma membrane (Langreth et 
al., 1978). In the second model, termed the lateral diffusion model, the 
tubovesicular membrane network (TVN) is utilised to transport proteins to the 
Maurer’s clefts (Elmendorf and Haldar, 1994, Wickert et al., 2004). The TVN 
extends from the parasitophorous vacuolar membrane into the erythrocyte cytosol 
and consists of a collection of membranous structures. It is interesting to note that 
the P. falciparum Golgi proteins that have been identified to date, have been 
found to be associated with the TVN (Elmendorf and Haldar, 1994, Van Wye et 
al., 1996). 
 
The final transportation step in both models is the release of the parasite proteins 
from the Maurer’s clefts into the erythrocyte membrane and the incorporation of 
these proteins into the knobs, which are often seen to be closely associated with 
the Maurer’s clefts (Aikawa et al., 1986). 
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Figure 12: P. falciparum protein trafficking to the erythrocyte surface. 
Diagram showing the vesicular transport (a) and the lateral diffusion model (b). In 
the vesicular transport model parasite proteins are transported in vesicles across 
the erythrocyte cytosol to the Maurer’s clefts. In the lateral diffusion model 
proteins are transported via the tubovesicular membrane network (TVN) to the 
Maurer’s clefts. In both models the proteins are eventually transported in vesicles 
to the erythrocyte membrane and surface (adapted from Przyborski et al., 2003). 
 
1.3.3 Haemoglobin digestion 
 
Several P. falciparum proteases are involved in the degradation of haemoglobin 
inside the food vacuole (Figure 13). Digestion of haemoglobin commences at the 
hinge region of the α-globin chain and is mediated by the aspartic proteases 
plasmepsins-I, -II, and -IV (Gluzman et al., 1994, Banerjee et al., 2002, Wyatt and 
Berry, 2002). Further degradation of the globin chains is facilitated by the same 
enzymes, as well the histo-aspartic protease (HAP) (Banerjee et al., 2002), and 
three cysteine proteases, falcipain-2, -2’, and -3 (Shenai et al., 2000, Sijwali and 
Rosenthal, 2004, Sijwali et al., 2001). The M16 metalloprotease falcilysin 
converts short globin polypeptides into oligopeptides consisting of 2-10 amino 
acids (Eggleson et al., 1999). Finally, the calpain-like dipeptidyl peptidase I 
(DPAP1) hydrolyses the oligopeptides into 2-10 amino acid residues (Klemba et 
al., 2004) which are exported to the cytoplasm where they are cleaved into single 
amino acid units by the cytosolic neutral aminopeptidases (Curley et al., 1994). 
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Figure 13: Haemoglobin digestion. 
Haemoglobin digestion in the food vacuole is initiated by the aspartic proteases, 
plasmepsin -I, -II, and -IV. Further processing into dipeptides is performed by the 
cysteine proteases falcipain-2, -2’, and -3, followed by the metalloprotease 
falcilysin and finally the dipeptidyl peptidase DPAP1. Dipeptides are transported 
into the cytosol where they are digested by neutral aminopeptidases (adapted from 
Klemba et al., 2004). 
 
1.3.4 Parasite escape 
 
Approximately 40 hours after invasion the trophozoite develops into a schizont 
containing several daughter nuclei. These mature into merozoites which escape 
the host cell at approximately 48 hours after the parasite entered the erythrocyte. 
The two-step parasite exit process is initiated at the schizont stage when the 
parasite secretes proteases, probably a cysteine protease (Salmon et al., 2001), 
into the parasitophorous vacuole. Micrographs of P. falciparum schizont-infected 
erythrocytes have shown that the material on each side of the parasitophorous 
vacuole membrane has an equal density and structure, indicating that the 
parasitophorous vacuole membrane has become permeable to host cell proteins 
(Langreth et al., 1978). The proteases implicated in the second step of the two-
step parasite exit process are an aspartic protease and a cysteine or serine protease 
that degrade the membrane skeleton of the erythrocyte (Wickham et al., 2003).  
 
The degradation of the membranes and the conversion of the schizont into 
merozoites, give rise to the irregular schizont (Figure 14). Just before escape the 
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parasites rearrange themselves into a short-lived distinctive ‘flower’ shape (Trager, 
1956, Glushakova et al., 2005). This rearrangement is concomitant with an influx 
of fluid into the erythrocyte due to the excess colloid-osmotic pressure of 
intracellular proteins since most of the haemoglobin has been digested by the 
parasite (Lew, 2005). The build-up of osmotic pressure causes the parasitophorous 
vacuole membrane and the erythrocyte plasma membrane to blow apart, thereby 
scattering the merozoites (Trager, 1956, Glushakova et al., 2005). The force of the 
merozoite release is strong enough to bring the merozoites into contact with new 
erythrocytes even in places where the parasites have been sequestered. The 
parasite therefore does not need to be motile and only becomes motile when a host 
cell is encountered and the parasite has committed itself to invasion. 
 
 
(1) (2) (3) (4) (5) 
Figure 14: P. falciparum escape from the erythrocyte. 
Diagram showing the morphological changes parasite and erythrocyte undergo 
during P. falciparum escape. The irregular schizont surrounding the food vacuole 
(black), initiates the two-step escape process by first weakening the 
parasitophorous vacuole membrane (pink) and then the erythrocyte membrane 
(green) by enzymatic proteolysis (1). The schizont continues to develop into 
merozoites (orange) (2) and the influx of fluid through the damaged erythrocyte 
membrane results in the distinctive ‘flower’ shape (3). The build-up of osmotic 
pressure causes the parasitophorous vacuole membrane and erythrocyte 
membrane to rupture, ‘blowing’ the cell apart and scattering the mature 
merozoites (4). Vesiculation of the erythrocyte and parasitophorous vacuole 
membranes results from the violent and sudden rupture of the erythrocyte (5) 
(Glushakova et al., 2005). 
 
1.4 Parasite and erythrocyte membrane interactions 
 
Malaria proteins interact with the erythrocyte surface and the membrane skeleton 
proteins at several points during the erythrocytic life cycle. A summary of these 
interactions is listed in Table 1. 
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Table 1: P. falciparum proteins interacting with the erythrocyte membrane. 
Parasite protein EM protein Stage Possible function 
MSP-1 band 3; spectrin invasion initial erythrocyte contact and contact during active invasion 
MSP-9/ABRA band 3 invasion cleavage of band 3 
EBA-175 glycophorin A invasion contact during active invasion 
BAEBL/    
EBA-140 glycophorin C/D invasion contact during active invasion 
RH-1 receptor Y invasion contact during active invasion 
RH-2b receptor Z invasion contact during active invasion 
JESEBL/    
EBA-181 receptor E invasion contact during active invasion 
SERA erythrocyte and PVM phospholipids  
invasion; 
escape disrupts phospholipids 
RhopH complex erythrocyte phospholipids invasion disrupts phospholipids 
gp76 band 3, glycophorin A invasion 
membrane skeleton destabilisation by 
band 3 and glycophorin A cleavage;    
PV formation 
RESA β-spectrin invasion; growth 
chaperone in membrane skeleton 
repair; thermal stability; inhibits 
subsequent parasite invasion 
FEST EM skeleton growth possible role in phosphorylating protein 4.1 and spectrin 
MESA/   
PfEMP-2 protein 4.1 growth 
anchors knobs; membrane skeleton 
destabilisation by binding to protein 
4.1 where glycophorin C and p55 bind 
PfEMP-1 spectrin-actin junction growth anchors knobs 
PfEMP-3 EM skeleton growth transports PfEMP-1 from Maurer’s clefts to the erythrocyte surface 
Pf332 EM skeleton growth - 
KAHRP/ HRP-I 
α-spectrin; 
ankyrin 
growth anchors knobs by interacting with spectrin and PfEMP-1 
Pfsbp1 EM skeleton growth attaches Maurer’s clefts to membrane skeleton network 
RIFINs erythrocyte phospholipids growth rosetting and antigenic variation 
STEVOR erythrocyte phospholipids growth rosetting and antigenic variation 
plasmepsin-II α-spectrin; protein 4.1; actin escape  disrupts membrane skeleton 
plasmepsin-IV spectrin escape disrupts membrane skeleton 
37 kDa acidic 
protease β-spectrin; protein 4.1 escape disrupts membrane skeleton 
falcipain-2 ankyrin; protein 4.1 escape disrupts membrane skeleton 
Abbreviations: ABRA = acidic-basic repeat antigen; EBA= erythrocyte binding antigen; EM = erythrocyte membrane; 
FEST = falciparum-exported serine/threonine kinase;  HRP = histidine-rich protein; KAHRP = knob-associated histidine-
rich protein; MESA = mature parasite-infected surface antigen; MSP = merozoite surface protein; PfEMP = P. falciparum 
erythrocyte membrane protein; Pfsbp1 = P. falciparum skeleton binding protein-1; PV = parasitophorous vacuole; PVM = 
parasitophorous vacuole membrane; RESA = ring-infected erythrocyte surface antigen; RH = reticulocyte-binding 
homologues; RhopH = high molecular weight rhoptry protein; RIFINs = repetitive interspersed family; SERA = serine-rich 
antigen; STEVOR = subtelomeric variant open reading frame family. 
References for each protein-protein interaction are given in the text. 
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1.4.1 Protein interactions involved in erythrocyte invasion 
 
To initiate and commit to invasion several parasite ligands interact with the 
glycophorin moieties and band 3 on the erythrocyte surface. MSP-1 and MSP-
9/ABRA interact with band 3 (Goel et al., 2003, Kushwaha et al., 2002) and 
MSP-1 also interacts with spectrin (Herrera et al., 1993). EBA-175 binds to 
glycophorin A (Sim et al., 1994) and BAEBL/EBA-140 associates with 
glycophorin C/D (Mayer et al., 2001). Receptors Y, Z, and E are utilized by RH-1, 
RH-2b and JESEBL/EBA-181 respectively (Rayner et al., 2001, Duraisingh et al., 
2003, Gilberger et al., 2003) and the ligands of glycophorin B and receptor X 
have yet to be identified (Dolan et al., 1994). During invasion several proteases 
and phospholipases are released by the micronemes and rhoptries. These enzymes 
induce structural changes in the erythrocyte membrane, such as the stripping of 
the underlying erythrocyte membrane skeleton proteins from the area where the 
merozoite has attached itself to the erythrocyte surface. Interestingly Dluzewski et 
al. (1983) showed that immunological and chemical crosslinking of spectrin 
inhibited parasite invasion in resealed erythrocytes. The cysteine protease SERA 
and the rhoptry proteins of the RhopH complex associate with the phospholipids 
of the inner leaflet of the erythrocyte membrane and could thus facilitate the entry 
of the parasites into the host cell (Perkins and Ziefer, 1994). The protease, gp76, 
has been suggested to be involved in invasion by degrading band 3 and 
glycophorin A (Roggwiller et al., 1996). In addition, an erythrocyte cyclic 
adenosine monophosphate-independent kinase that phosphorylates spectrin is 
necessary for invasion (Rangachari et al., 1986) because phosphorylation of β-
spectrin decreases the rigidity and stability of the erythrocyte membrane (Manno 
et al., 1995). Finally RESA, which interacts with spectrin, is thought to act as a 
chaperone during the repair of the membrane skeleton after invasion has been 
completed (Foley and Tilley, 1995). The protein binds to β-spectrin, close to the 
self-association site where it stabilises the spectrin tetramer, thereby increasing the 
thermostability of the erythrocyte and preventing further invasion by other malaria 
parasites (Pei et al., 2007). 
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1.4.2 Protein interactions facilitating parasite growth 
 
As the parasite proliferates within the erythrocyte it causes striking structural and 
morphological changes to its host cell. These include the loss of the typical 
erythrocyte shape, alterations in the mechanical properties of the cell, and 
modifications in the phosphorylation state of erythrocyte membrane skeleton 
proteins. Phosphorylation of ankyrin in uninfected erythrocytes destabilises the 
interaction between ankyrin and spectrin tetramers (Lu et al., 1985) and the 
phosphorylation of protein 4.1 disrupts the interaction between protein 4.1, 
spectrin and actin (Ling et al., 1988), and destabilises the interaction between 
band 3 and the erythrocyte membrane skeleton (Manno et al., 2005). Thus an 
increased phosphorylation of protein 4.1 which is observed in P. falciparum 
infected erythrocytes (Chishti et al., 1994) could reduce the mechanical stability 
of the membrane skeleton and contribute significantly to the morphological 
changes observed in infected erythrocytes. To date the enzyme responsible for the 
phosphorylation of protein 4.1 has not been identified, but a falciparum-exported 
serine/threonine kinase (FEST) (Kun et al., 1997) could be one such candidate. 
 
Another striking change in the malaria-infected erythrocyte is the appearance of 
knobs on the host cell surface (Langreth et al., 1978). Parasite proteins cluster 
amongst host proteins in these knobs (Figure 15) and are responsible for altering 
the adhesive properties of the erythrocyte. Several of the parasite proteins, for 
example P. falciparum erythrocyte membrane protein 3 (PfEMP-3), RESA, 
mature parasite-infected surface antigen (MESA/PfEMP-2), FEST, and 
falciparum interspersed repeat antigen (FIRA), are distributed throughout the 
membrane skeleton, while others, such as the knob-associated histidine-rich 
protein (KAHRP/HRP-I) and PfEMP-1, are found with erythrocyte membrane 
skeleton proteins associated with the membrane knobs. Studies have shown that 
MESA/PfEMP-2 binds to protein 4.1 (Waller et al., 2003) and RESA interacts 
with spectrin (Foley et al., 1991). KAHRP/HRP-I interacts with repeat 4 on α-
spectrin (Pei et al., 2005), a phosphorylated region of ankyrin (Magowan et al., 
2000), and the cytoplasmic tail of PfEMP-1 (Waller et al., 1999). The cytoplasmic 
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domain of PfEMP-1 has also been shown to bind to the spectrin-actin junction of 
the membrane skeleton (Oh et al., 2000). The Maurer’s clefts are connected to the 
erythrocyte membrane skeleton network via P. falciparum skeleton binding 
protein 1 (Pfsbp1) (Blisnick et al., 2000). 
 
 
Figure 15: P. falciparum and erythrocyte membrane protein interactions. 
Diagram showing the P. falciparum proteins that interact with the erythrocyte 
plasma membrane and membrane skeleton proteins. Interactions between parasite 
proteins and membrane skeleton proteins disrupt the host protein interactions that 
stabilise the membrane skeleton. These interactions also facilitate the display of 
malaria proteins on the cell surface in structures called knobs. MESA: mature 
parasite-infected surface antigen; PfEMP: Plasmodium falciparum erythrocyte 
membrane protein; KAHRP: knob-associated histidine-rich protein; FEST: 
falciparum-exported serine/threonine kinase; RIFINs: products of the repetitive 
interspersed family; STEVOR: products of the subtelomeric variant open reading 
frame family (Cooke et al., 2004). 
 
Although the binding of malaria proteins to the membrane skeleton ensures and 
strengthens the display of malaria proteins on the cell surface, the binding also 
disrupts the host protein interactions that stabilise the membrane skeleton network. 
For example, the binding site of KAHRP/HRP-I on ankyrin coincides with the 
binding domains of band 3 and spectrin and the parasite therefore disrupts the 
connections in the band 3 complex (Magowan et al., 2000). MESA/PfEMP-2 
binds to protein 4.1 at the same domain as glycophorin C and p55. This could 
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influence the binding capacity of p55 (Waller et al., 2003), which would again 
destabilise the integrity of the membrane skeleton network. The precise function 
of MESA/PfEMP-2 in the erythrocyte skeleton is still unknown, but accumulation 
of MESA/PfEMP-2 in the cytosol of erythrocytes deficient in protein 4.1 leads to 
intracellular death of the parasite (Magowan et al., 1995). 
 
Parasite growth has also been shown to decrease the mobility of band 3 and 
glycophorin (Parker et al., 2004), as well as causing band 3 to cluster in the 
erythrocyte membrane (Winograd and Sherman, 2004). These alterations 
contribute to the decreased deformability of the erythrocyte membrane and have 
been observed during the ring stage of growth, before the parasite introduces the 
knobs into the erythrocyte surface. 
 
1.4.3 Protein interactions mediating parasite escape 
 
Sodium dodecylsulphate (SDS) polyacrylamide gel electrophoresis (PAGE) 
analysis and microscopic analysis of erythrocyte membranes revealed a decrease 
of α- and β-spectrin, as well as band 3 in Plasmodium-infected erythrocytes 
(Weidekamm et al., 1973, Konigk and Mirtsch, 1977, Sherman and Jones, 1979, 
Garcia et al., 1997) indicating that the parasite degrades the erythrocyte skeleton 
proteins during growth within the erythrocyte. The decrease of membrane 
skeleton proteins was seen at the end of the erythrocytic life cycle when late 
trophozoites and schizonts were present in the host cell. The parasite could 
therefore be weakening the erythrocyte membrane to enable it to escape. 
Wickham et al. (2003) showed that the use of protease inhibitors prevented the 
release of parasites from their erythrocyte host and proposed that parasite exit 
involved two stages of membrane lysis. In the first stage, the parasitophorous 
vacuole membrane is lysed and in the second stage the red cell membrane 
skeleton proteins are broken down. The first lysis stage is prevented by addition of 
E64 (Wickham et al., 2003), a cysteine protease inhibitor and the second lysis 
stage is inhibited by the addition of leupeptin and pepstatin (Lyon and Haynes, 
1986), which are cysteine/serine and aspartic protease inhibitors respectively. A 
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set of related papain-like proteases (papain is a cysteine protease), namely the 
SERAs and the serine stretch protein homologue (SERPH) have been implicated 
in the breakdown of the parasitophorous vacuole membrane, because inhibition of 
SERA prevented the release of schizonts from their erythrocyte host (Li et al., 
2002). Several parasite enzymes have been suggested to play role in the 
breakdown of the membrane skeleton. A 37 kDa acidic protease cleaves β-
spectrin and protein 4.1 (Deguercy et al., 1990). Although the primary function of 
the aspartic protease plasmepsin-II is to digest haemoglobin in the acidic parasite 
food vacuole, it is also the main enzyme found in a parasitic extract that cleaves 
spectrin, specifically the SH3 domain of α-spectrin, at a neutral pH. Plasmepsin-II 
also interacts with actin and protein 4.1 (Le Bonniec et al., 1999) and another 
aspartic protease, plasmepsin-IV, has been shown to degrade spectrin (Wyatt and 
Berry, 2002). Another food vacuole enzyme, the cysteine protease falcipain-2, 
cleaves ankyrin and protein 4.1 within the spectrin-actin-binding domain (Dua et 
al., 2001) and has been implicated in parasite release (Dhawan et al., 2003). 
 
1.5 Erythrocyte protein abnormalities that protect against 
malaria infections 
 
Several erythrocyte mutations and polymorphisms, that have arisen due to 
selective pressure of the malaria parasite (reviewed in Williams, 2006), protect 
against infection by either preventing invasion or hampering the growth of the 
parasite within the erythrocyte.  
 
The haemoglobinopathies, which are caused by a decrease in or incorrect folding 
of globin, were the first erythrocyte abnormalities to be implicated in malaria 
protection. They include the structural variants of haemoglobin (haemoglobins S, 
C or E) and the thalassaemias (α- and β-thalassaemia). Mutations in these globin 
coding genes are often homozygous lethal and tolerable only in the heterozygous 
state, when they protect against malaria (reviewed in Min-Oo and Gros, 2005). 
The haemoglobin S mutation has arisen several times in Africa (Chebloune et al., 
1988), indicating that the mutation was caused by the same selective pressure.  
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The enzymopathies, namely glucose-6-phosphate dehydrogenase (G6PD) and 
pyruvate kinase deficiency, are caused by mutations in the genes that code for 
these erythrocyte enzymes. The protective mechanisms of the enzyme deficiencies 
against malaria have not been well characterised, but it is thought that G6PD-
deficient erythrocytes are more susceptible to haemolysis due to the oxidative 
stress caused by the parasite (reviewed in Weatherall, 2008). Protection against 
malaria due to pyruvate kinase deficiency has been shown in the mouse model 
(Min-Oo et al., 2003) and recently also in humans in an in vitro study (Durand 
and Coetzer, 2008, Ayi et al., 2008). 
 
Mutations in the erythrocyte membrane skeleton proteins are responsible for 
hereditary spherocytosis (HS) and the spectrum of hereditary elliptocytosis (HE) 
disorders. In HS the attachment of the membrane skeleton to the phospholipid 
bilayer is disrupted due to mutations in spectrin, or band 3, or in the linker 
proteins, namely ankyrin and protein 4.2. HS cells with a decreased spectrin 
content inhibit malaria parasite growth in vitro, and the extent of growth 
inhibition is related to the extent of spectrin deficiency (Schulman et al., 1990). 
 
Hereditary pyropoikilocytosis (HPP) and some cases of HE are caused by spectrin 
mutations that prevent the self association of spectrin dimers into tetramers 
(Coetzer et al., 1990). In vitro studies demonstrated that these abnormal 
erythrocytes inhibited invasion by P. falciparum (Facer, 1989). Other cases of HE 
are caused by protein 4.1 or glycophorin C deficiency and these  erythrocytes also 
reduce parasite invasion, as well as retard the growth of parasites in vitro (Chishti 
et al., 1996, Schulman et al., 1990). 
 
Southeast Asian Ovalocytosis (SAO) is the only red cell membrane disorder that 
has been shown to have developed due to the malaria burden (Foo et al., 1992). It 
protects against the disease by preventing the development of cerebral malaria 
(Allen et al., 1999), as well as decreasing the parasitaemia by preventing 
erythrocyte invasion by the parasite (Cortes et al., 2004). SAO is caused by an in-
frame 27 nucleotide deletion in the band 3 gene (Jarolim et al., 1991). The mutant 
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protein loses its anion exchange function and binds more tightly to ankyrin, 
resulting in a rigid membrane (Mohandas et al., 1992), that presumably prevents 
the parasite from invading the red cell in vitro (Kidson et al., 1981). A rapid 
decline of adenosine triphosphate (ATP) levels within SAO erythrocytes has also 
been shown to prevent invasion by the parasite in vitro (Dluzewski et al., 1992). 
 
Finally, the polymorphic red cell receptors displayed on the erythrocyte surface 
have also been implicated in malaria resistance. P. falciparum uses several 
erythrocyte receptors during invasion and the lack of one receptor, such as 
Glycophorin A or B (Hadley et al., 1987) or the Gerbich blood group system 
(Maier et al., 2003), does therefore not provide complete protection against P. 
falciparum invasion. In contrast, P. vivax only uses the Duffy antigen as a 
receptor and the absence of this antigen in some West African populations has 
resulted in protection against P. vivax infections (Miller et al., 1976). 
 
1.6 P. falciparum proteins 
1.6.1 The P. falciparum genome and proteome 
 
The complete P. falciparum 3D7 nuclear genome sequence was published in 2002 
(Gardner et al., 2002) and contains 14 chromosomes, ranging in size from 0.643 
Mb (chromosome 1) to 3.290 Mb (chromosome 14). Two non-nuclear genomes, 
consisting of the 6 kb mitochondrial genome and the 35 kb apicoplast genome, are 
also present. The 22,853,764 bp nuclear genome encodes 5,268 predicted genes, 
implying an average frequency of one gene every 4,338 bp. Of these protein-
coding genes, 3,208 (60.9 %) have no assigned function or homology to genes of 
other organisms with known genome sequence and have been designated as 
‘hypothetical proteins’. Introns are found in 53.9 % of the genes and their AT- 
composition rises to 90 % when compared to the overall AT-content of the whole 
genome, which is 80.6 %. P. falciparum has the highest AT-content of all the 
organisms sequenced to date. The Homo sapiens genome, for example, only has a 
59 % AT-content (Lander et al., 2001).  
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The central chromosome regions encode ‘housekeeping’ genes and the highly 
variable end regions encode polymorphic antigens and surface-related molecules. 
The genome of this intracellular parasite encodes fewer enzymes and transporters 
when compared to the genomes of free-living eukaryotic microbes. Additionally, 
a large subset of the genes is responsible for immune evasion and host-parasite 
interactions (Gardner et al., 2002). 
 
The mean length of P. falciparum coding genes (excluding introns) is 2.28 kb. 
This is larger than in other organisms, for example the 1.34 kb mean length of the 
H. sapiens coding genes (Lander et al., 2001), and this can be attributed to the 
presence of numerous codons encoding low complexity regions found in 
Plasmodium proteins. These low complexity regions may be over several hundred 
amino acids in length and contain stretches of one or a few amino acids, 
particularly asparagine and lysine (Pizzi and Frontali, 2001). Low complexity 
regions generally occur between domains of a protein, but in P. falciparum 
proteins they are also found within the domains. They tend to be located on the 
outer surface of the folded protein, where they form unstructured soluble stretches 
that do not interfere with the functions of the domains or the rest of the protein 
(Aravind et al., 2003). No physical function has thus far been assigned to low 
complexity regions, but it has been thought that they may be employed as decoys 
for the human immune system (Anders, 1986). 
 
1.6.2 P. falciparum protein identification 
 
Before the 1970s, P. falciparum proteins were isolated directly from malaria 
infected patients. This research however had limited success and thus the 
establishment of parasites in continuous culture by Trager and Jensen (1976) 
provided a new source of parasite proteins in the laboratory. Purification of 
proteins directly from the parasite by conventional methods was difficult due to 
the presence of erythrocyte protein contaminants and insufficient quantities of 
parasite protein being isolated. Combinations of other methods were however 
successfully employed to isolate and identify parasite proteins. 
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Several parasite surface proteins, for example MSP-1 (Holder and Freeman, 1982), 
were isolated by immunoprecipitation from parasite culture supernatants with 
human sera containing parasite-specific antibodies. Hybridoma technology was 
also applied to produce antibodies that recognise specific parasite antigens, for 
example CSP (Nardin et al., 1982). The antibodies were subsequently used to 
purify parasite proteins by affinity chromatography and for immunolocalisation 
experiments to determine the exact location of the proteins, such as AMA-1 
(Peterson et al., 1989), in the parasite. 
 
Standard methods, such as SDS-PAGE, chromatography and centrifugation, were 
also applied to isolate P. falciparum proteins. For example, Kilejian (1979) 
compared the erythrocyte membrane protein composition of cultured parasitised 
and non-parasitised erythrocytes by SDS-PAGE and isolated KHARP/HRP-I, and 
Perkins (1984) used immobilised erythrocyte glycophorins to isolate RESA and 
glycophorin-binding protein from lysed parasites. Goldberg et al. (1990) isolated 
P. falciparum food vacuoles by applying a combination of saponin lysis and 
Percoll gradient centrifugation and this group subsequently used anion exchange 
chromatography and gel filtration to isolate plasmepsin-I and -II, falcipain-I and 
falcilysin from these food vacuoles (Gluzman et al., 1994, Eggleson et al., 1999). 
Sanders et al. (2005) used sucrose density centrifugation to isolate erythrocyte 
detergent-resistant membranes from cells that were infected with parasites. The 
amino acid sequence of the N-termini of some isolated proteins, for example 
falcipain-2 (Shenai et al., 2000) and MSP-6 (Trucco et al., 2001) were determined 
by Edman sequencing and the amino acid sequence of peptide fragments of other 
proteins, such as RhopH1 (Kaneko et al., 2001), were determined by tandem mass 
spectroscopy. 
 
The genes coding for several isolated malaria proteins, for example MSP-2 and 
the rhoptry associated membrane antigen (RAMA) (Smythe et al., 1988), were 
identified by screening a P. falciparum bacteriophage λ cDNA library with MSP-
2 and RAMA-specific antibodies. Some parasite genes, for example  MAEBL 
(Blair et al., 2002) and TRAP (Robson et al., 1988), were isolated by 
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hybridisation and polymerase chain reaction (PCR) experiments using specific or 
degenerate oligonucleotide primers designed from the DNA and amino acid 
sequences of previously identified related malaria proteins or other conserved 
protein motifs. Primers were also used to screen mRNA, genomic DNA, 
expressed sequence tag (EST) libraries and cDNA libraries to ultimately obtain 
the complete DNA sequences coding for malaria proteins. 
 
After the publication of the P. falciparum genome sequence in 2002 and the 
subsequent availability of the annotated genome at PlasmoDB 
(www.plasmodb.org) (Bahl et al., 2003), researchers probed the genomic and EST 
databases with conserved regions of known malaria proteins and motifs of non-
malaria proteins to identify several malaria protein families, for example the 
plasmepsins (Banerjee et al., 2002) and the rhomboids (Baker et al., 2006). 
 
While the above mentioned techniques are adequate to isolate and identify 
parasite proteins, other techniques need to be employed to study protein-protein 
interactions. Some of these include the yeast two-hybrid (LaCount et al., 2005) 
and the phage display system (Smith, 1985). Phage display has only been used to 
study antibody-antigen interactions, for example to identify epitopes that interact 
with AMA-1 antibodies (Coley et al., 2001). This study will use a novel 
application of phage display to identify malaria proteins that interact with human 
erythrocyte spectrin.  
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1.7 Objectives 
 
During the erythrocytic stage of the P. falciparum life cycle the parasite has to 
enter, grow within and escape from the erythrocyte. All three processes utilise 
protein-protein interactions between the parasite and the erythrocyte membrane 
skeleton. Particularly protein-protein interactions with erythrocyte spectrin are of 
interest because spectrin is the main component of the membrane skeleton. 
Therefore, the aim of this project is to use phage display to identify P. falciparum 
proteins that interact with human erythrocyte spectrin. 
 
This will be achieved by: 
• Constructing a P. falciparum phage-display library by inserting P. 
falciparum cDNA into the T7 bacteriophage genome. 
• Biopanning the P. falciparum phage-display library against immobilised 
erythrocyte spectrin. 
• Sequencing the P. falciparum cDNA inserts found in the spectrin-binding 
bacteriophage and identifying the P. falciparum genes that match the 
cDNA inserts in the PlasmoDB database. 
• Cloning the identified P. falciparum genes into expression vectors to 
produce recombinant proteins. 
• Studying the protein-protein interaction between spectrin and the P. 
falciparum proteins with blot overlays. 
• Performing functional and structural studies to further characterise the P. 
falciparum proteins that interact with spectrin. 
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Chapter 2: Phage display 
2.1 Introduction 
2.1.1 Identifying protein-protein interactions 
 
Many processes occurring within the cell depend on protein-protein interactions, 
and therefore the majority of modern life-science research is concerned with 
identifying natural interactions and then studying these interactions in finer detail. 
Protein-protein interactions can be identified by screening a protein against 
multiple compounds or cell and tissue extracts to identify an interacting protein or 
ligand. 
 
Protein-protein interactions rely on the contact between certain amino acids of 
each protein and these interacting amino acid segments can be arranged in two 
ways. Amino acid residues are either located next to each other as a stretch of 
amino acids in their primary protein sequence, or they can be located far apart 
from each other and are brought together by protein folding. An amino acid 
stretch can also form part of a binding site that has to fold into the correct 
conformation for a protein-protein interaction to occur. Binding sites are 
characterised according to their structural and functional characteristics. Structural 
characteristics are studied with x-ray crystallography and relate to the actual 
position of the interacting amino acids within the complete protein structure. 
Functional characteristics are studied by site-directed mutagenesis to determine 
the type of amino acid residues that are important for the protein-protein 
interactions. These amino acids can normally not be replaced by other amino acids 
within the protein sequence. Another type of binding site that can only be 
discovered in vitro has also been characterised. This site does not contain the 
same amino acid sequence as the native protein but still binds to ligands, since it 
mimics the native binding amino acid sequence (Sidhu et al., 2003). 
 
Over the years there has been an increase and improvement in the methods 
applied in elucidating protein-protein interactions. New methods, for example the 
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yeast two-hybrid system (Fields and Song, 1989), have been used, but they are 
very labour-intensive and often not suitable for high-throughput evaluation of 
multiple gene products. Phage display on the other hand, can be used to screen 
multiple molecules. 
 
2.1.2 Phage display technology 
 
Phage display is a combinatorial technology that was introduced to the scientific 
community by Smith in 1985, who inserted segments of the EcoRI endonuclease 
gene between the N-terminal and C-terminal segments of the pIII capsid gene of 
the filamentous bacteriophage f1 (Smith, 1985). Smith was able to isolate 
bacteriophage expressing the endonuclease protein fused to the bacteriophage 
capsid protein by affinity selection with an antibody specific to the endonuclease 
(Smith, 1985). Since then the technique has for example been used to identify 
ligands of peptide receptors (Cesareni, 1992), enzyme substrates (Maenaka et al., 
1996), antibodies against specific antigens (Huse et al., 1992) and to improve or 
modify the affinity of proteins for their binding partners (Lowman et al., 1991). 
 
The novelty of the technique relies on the expression of foreign peptides or 
proteins fused to one of the coat proteins of a bacteriophage, such as f1 (Smith, 
1985, de la Cruz et al., 1988), fd (Parmley and Smith, 1988), M13 (Makowski, 
1993, Devlin et al., 1990), MS2 (Mastico et al., 1993), P4 (Lindqvist and Naderi, 
1995), λ (Sternberg and Hoess, 1995), T4 (Jiang et al., 1997) or T7 (Houshmand 
et al., 1999). The protein fusions are created by inserting a DNA fragment into the 
bacteriophage genome, adjacent to, or in, the DNA sequence of one of the capsid 
proteins of the bacteriophage. Subsequent infection of a bacterial host with the 
modified phage results in the expression of the fusion peptide or protein on the 
capsid surface. If random sequences are inserted, it is possible to obtain a large 
library with 106-109 different peptide or protein sequences, each displayed on a 
different phage (Hoess, 1993, Parmley and Smith, 1988). The phenotype of the 
displayed peptide is physically linked to the DNA sequence inserted in the phage 
 
 
37
genome and because the bacteriophage is infective it can be propagated either 
individually or as a library. 
 
To select for phage displaying peptide sequences, a procedure termed biopanning 
is used (Parmley and Smith, 1988). This process of affinity selection involves 
incubating the phage library with a target peptide or protein that has been 
immobilised on a solid support (Figure 16). Phage displaying the appropriate 
peptide or protein domain bind to the immobilised target protein, while non-
binding phage are removed by washing. Bound phage are eluted from the target 
protein and amplified in bacteria specific for the virus. Amplified viruses can be 
used for further rounds of biopanning, usually three to four times, to obtain phage 
with the strongest binding ability. The DNA of the phage from the final round of 
selection can be sequenced and inserted into an expression system to further 
characterise the peptide. 
 
The advantages of the phage display system are: (1) the creation of a library that 
contains millions of peptides, instead of having to clone each peptide individually; 
(2) the selection of high-affinity phage from a library, even if they are present at 
low levels; (3) the ability to amplify bacteriophage in bacteria, resulting in the 
enrichment of rare binding phage; and (4) the linkage of the displayed peptide 
with its encoding DNA sequence, which allows one to identify and further process 
binding sequences (Hoess, 1993, Sidhu et al., 2003). 
 
Many phage display libraries have been created over the last twenty years and can 
be classified into two categories based on the type of DNA inserted into the 
library. The first is the random peptide library (RPL). RPLs are created by 
inserting synthetic random degenerate oligonucleotides into the phage genome 
(Devlin et al., 1990). These types of libraries display peptides of a predetermined 
length on the bacteriophage surface and because the libraries are universal in 
nature, they can be used to select peptides that react with several different target 
proteins. The main disadvantage of RPLs is that one can isolate peptide mimics 
which have binding abilities similar to that of the native protein, but do not 
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contain the native amino acid sequence. Mimics can however be very useful in 
drug discovery. 
 
 
Figure 16: Biopanning of a phage display library. 
Diagram showing the biopanning process. A T7 phage display library is added to 
the protein of interest that has been immobilised via the streptavidin-biotin 
interaction on a solid surface. Non-binding phage are removed by washing. 
Binding phage are eluted and used for amplification in the bacterial host. After 
amplification the phage are isolated and used for another round of biopanning. 
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The second type of library is the native peptide library (NPL), which is 
constructed from randomly generated fragments of a specific genome (Jacobsson 
and Frykberg, 1998) or reverse transcribed mRNA (Jespers et al., 1995), thereby 
making the insert sizes in NPLs less uniform than those in a RPL. NPLs are gene 
or genome specific and therefore a new library needs to be created every time a 
new organism is studied. The major advantages of NPLs are that native proteins 
that are highly specific to an interaction can be isolated from a library, even if the 
library is relatively small. 
 
Successful selection of a peptide-binding bacteriophage from a phage display 
library depends on the affinity of the displayed peptide for the immobilised target 
protein. Peptide binding in phage display can be influenced by the number of 
peptides displayed on the bacteriophage surface (i.e. the copy number). A large 
copy number (multivalent or polyvalent display) is used to isolate low and high 
affinity binders from a library, whereas a single bacteriophage displayed peptide 
(monovalent display) is used to isolate only high affinity binders (Hoess, 2001). 
Multivalent display is therefore more appropriate for an NPL, because this type of 
library is likely to contain only a few high-affinity binders and a large number of 
low affinity peptides that interact with the target. RPLs on the other hand are often 
used to detect high affinity peptides and therefore monovalent display would be 
more applicable. 
 
2.1.3 Phage display technology in malaria research 
 
Phage display technology has been applied to malaria research, but only in the 
context of studying interactions between antigens and antibodies. These antigen-
antibody studies were performed in three ways.   
 
The first type of experimental approach used phage display to express fragments 
of specific P. falciparum proteins on the surface of the bacteriophage. The repeat 
region of CSP was expressed on the surface of f1 phage either linked to gene III 
or gene VIII and the recombinant phage were used to test the immunogenicity of 
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the displayed peptide fragments in rabbits (de la Cruz et al., 1988, Greenwood et 
al., 1991). Heal and co-workers used the same approach to test the 
immunogenicity of the P. falciparum liver stage antigen-1 (LSA-1) in mice (Heal 
et al., 1999). 
 
The second type of experimental approach used RPLs or fragments of a P. 
falciparum protein displayed on the bacteriophage surface to identify epitopes that 
interacted with specific P. falciparum antibodies. Adda et al. (1999) panned a 
random 15-mer and 17-mer peptide library against a monoclonal antibody which 
was raised against the C-terminal recombinant fragment of P. falciparum RESA. 
The group identified mimotopes which are similar to the peptide motif found in 
the 5’ and 3’ repeat sequences of RESA. Coley and co-workers displayed AMA-1 
fragments on the surface of M13 and panned them against two antibodies known 
to interact with AMA-1. The binding fragments were analysed and mapped to 
specific regions within the AMA-1 protein sequence. Further studies using mutant 
AMA-1 fragments and a random 15-mer fd library were used to identify the exact 
epitope that interacted with the AMA-1 antibody (Coley et al., 2001). Casey et al. 
used a 20-mer RPL to find peptide mimics that interact with a known AMA-1 
antibody. The peptide fragments were subsequently used to isolate other AMA-1 
antibodies from human sera and to create new AMA-1 antibodies in rabbits that 
inhibited parasite invasion (Casey et al., 2004). 
 
The third type of experimental approach used antibody display libraries to find 
antibody fragments that interact with specific P. falciparum proteins. Lundquist 
and co-workers created an antibody phage display library by inserting cDNA from 
human peripheral blood leukocytes from immune individuals into the M13 
genome. The library was biopanned against P. falciparum MSP-3 to isolate three 
antibody fragments that interacted with the parasite protein (Lundquist et al., 
2006). Similar approaches were used to identify human antibodies interacting with 
Pfs48/45  (Roeffen et al., 2001) and MSP-1 (Sowa et al., 2001). 
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RPL phage display was also used to study and identify peptides that interact with 
host cell surfaces. Eda et al. (2004) panned a 7-mer disulfide bond-constrained 
RPL against P. falciparum-infected human erythrocytes. The isolated peptide was 
coupled to a compound with moderate haemolytic activity and added to parasite-
infected erythrocytes. The peptide bound to the surface of the infected 
erythrocytes, which were subsequently lysed by the haemolytic compound, 
thereby inhibiting parasite growth. Ghosh and co-workers injected or fed a 12-mer 
random peptide library to mosquitoes and dissected them to obtain bacteriophage 
that had bound to the salivary glands and the luminal side of the midgut. The 
group isolated one peptide that specifically interacted with both these surfaces and 
inhibited both sporozoite invasion of the salivary glands as well as ookinete 
invasion of the midgut (Ghosh et al., 2001). 
 
This study used phage display to express random P. falciparum protein fragments 
on the surface of bacteriophage T7 by inserting P. falciparum cDNA into the 
bacteriophage genome using the T7Select® Phage Display System. This approach 
is novel because it created an NPL that is based on the P. falciparum genome, 
which was utilised to investigate the interaction of human erythrocyte spectrin 
with P. falciparum peptides. The library can also be used to identify malaria 
proteins involved in any protein-protein interactions. 
 
2.1.4 The T7Select® Phage Display System 
 
Filamentous bacteriophage are non-lytic viruses and assembly of the infective 
viral particle involves the secretion of the capsid protein through the bacterial 
plasma membrane (Smith and Petrenko, 1997). This secretion limits the type of 
proteins that can be expressed on the bacteriophage capsid because a signal 
sequence is required to direct the protein to the plasma membrane of the host 
bacteria. The use of lytic bacteriophage such as P4, T4, T7 and λ that assemble the 
viral particle within the cytoplasm of bacteria and subsequently lyse their host cell, 
has vastly increased the type and number of proteins expressed on phage capsids. 
The T7Select® System created by Novagen (Novagen, Inc., Madison, USA) 
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utilises the double-stranded DNA bacteriophage, T7, to display peptides on the 
bacteriophage surface (Rosenberg et al., 1996).  
 
The 40 kb T7 bacteriophage genome codes for approximately 50 genes. These 
include the early genes, the genes involved in DNA metabolism and the genes 
responsible for the assembly of the bacteriophage (genes 9-18) (van Regenmortel 
et al., 2000). The T7 capsid consists of 415 copies of the T7 capsid protein, which 
are arranged as 60 hexamers on the faces and 11 pentamers at the vertices of the 
shell to make up an icosahedron. The last vertex contains the head-tail connector 
and a short conical tail, that contains six tail fibres, which completes the rest of the 
phage particle (Figure 17) (Swanson, 1999). Phage assembly takes place within 
the Escherichia coli cytoplasm by the formation of a procapsid that contains 
scaffolding protein, capsid protein, the head-tail connector, and an internal protein 
structure. After the bacteriophage DNA has entered the procapsid, the scaffolding 
proteins are released and conformational changes lead to the formation of the 
mature bacteriophage particle to which the tail and tail fibres attach at the head-
tail connector (Cerritelli and Studier, 1996). 
 
 
Capsid proteins 
Head-tail connector 
Tail proteins 
Tail fibres 
Figure 17: The T7 bacteriophage. 
Schematic representation of the structure of the T7 bacteriophage. The 
bacteriophage capsid contains 415 copies of the capsid protein and is connected to 
the tail proteins by the head-tail connector. Six tail fibres extend from the 
bacteriophage tail (Swanson, 1999). 
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The capsid of wildtype T7 is made up of either one form or a mixture of two 
forms of the capsid protein (Rosenberg et al., 1996), protein 10A consisting of 
344 amino acids and protein 10B consisting of 397 amino acids. The 10B protein 
is produced because of a translational frameshift at codon 341 of the capsid gene 
and represents ~10 % of the capsid proteins (Condron et al., 1991). The T7Select® 
System utilises the 10B gene to express peptides on the surface of T7. The 
T7Select10-3 vector was created by removing the frameshift at codon 341 and 
introducing a multiple cloning cassette at codon 348 of the 10B gene (Rosenberg 
et al., 1996) (Figure 18). This modification leads to the production of only the 
10B protein with a fused peptide, and because the size and sequence of the 
attached peptide could have a negative effect on viral assembly, the virus particles 
are amplified in E. coli cells containing an additional plasmid expressing multiple 
copies of the 10A protein. The viral particles created in this system thus only 
express 5-15 fused capsid proteins with peptides of up to 1200 amino acids on 
their surface making it an ideal system to display larger P. falciparum peptide 
fragments with a medium copy number on the bacteriophage surface. 
 
 
Figure 18: The T7Select10-3 vector. 
Diagram showing the creation of the T7Select10-3 vector. The frameshift (codon 
341) responsible for the translation of the 10B capsid protein was removed and the 
nucleotide sequence (codon 348-397) coding for the additional amino acids of the 
10B capsid protein was replaced by a multiple cloning site (codon 348-369) to 
enable the insertion of foreign cDNA (adapted from Rosenberg et al., 1996). 
 
T7 has several propagation properties that make it an ideal phage display system. 
Bacteriophage plaques can be produced within 3 hours at 37 ºC and cultures 
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generally lyse 1-2 hours after infection, which decreases the turnaround time 
between several rounds of panning. The phage particles are extremely robust and 
can withstand the harsh experimental conditions employed in the panning and 
eluting procedure. The viral DNA is easy to isolate and therefore restriction and 
DNA sequence analysis of clones are simple to perform (Rosenberg et al., 1996). 
 
2.2 Methods 
2.2.1 Materials 
 
P. falciparum strain FCR-3 was a gift from the Department of Pharmacy and 
Pharmacology (University of the Witwatersrand, Johannesburg, South Africa). All 
chemical reagents were of analytical or molecular biology grade. Milli-Q water 
prepared with the Milli-QTM Water System (Millipore Corporation, Bedford, 
USA) was used for all experimental procedures. 
 
2.2.2 Spectrin isolation and biotinylation 
Isolation of human spectrin from erythrocytes 
 
Erythrocyte ghosts were obtained from whole human blood by rupturing the 
erythrocytes by hypotonic lysis (Dodge et al., 1963). Twelve 6ml ACD tubes (BD 
Vacutainer Systems, Plymouth, UK) containing human blood donated by 
volunteers, were centrifuged at 800 g for 10 minutes at 4 ºC using a Jouan BR 
3.11 centrifuge (Jouan Inc., Winchester, USA). The plasma and buffy coat were 
removed and the erythrocytes washed three times in cold 0.9 % sodium chloride. 
Erythrocytes were lysed with 30 volumes of cold erythrocyte lysis buffer (3 mM 
sodium phosphate buffer, pH 8, 0.1 mM Na2EDTA, 0.1 mM 
phenylmethanesulphonyl fluoride (PMSF; see Appendix A1 for stock solution; 
Roche Diagnostics Gmbh, Mannheim, Germany) and centrifuged at 25,000 g for 
15 minutes at 4 ºC using a Beckman® J2-21 centrifuge (Beckman Coulter, Inc., 
Fullerton, USA). The supernatant and the residual white cell pellet were removed 
and the ghosts washed a further three times with erythrocyte lysis buffer. Spectrin 
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was extracted from the erythrocyte ghosts by low ionic strength extraction 
(Coetzer and Palek, 1986). This was achieved by adding 30 volumes of fresh 
spectrin extraction buffer (0.1 mM sodium phosphate, pH 8, 0.1 mM Na2EDTA, 
and 0.1 mM 1,4-dithiothreitol (DTT; Roche Diagnostics Gmbh, Mannheim, 
Germany) and centrifuging at 30,000 g for 30 minutes at 4 ºC. DTT prevents 
disulphide bond formation and thereby inhibits the aggregation of spectrin.  The 
supernatant was aspirated until there was a 1:½ ratio of erythrocyte ghosts to 
buffer remaining in the tube. The suspension was incubated overnight at 4 ºC. 
Pefabloc SC (an irreversible protease inhibitor) (Roche Diagnostics Gmbh, 
Mannheim, Germany) was added to a concentration of 0.1 mM. The sample was 
centrifuged at 150,000 g for 30 minutes at 4 ºC, using a Beckman® L8-70M 
ultracentrifuge (Beckman Coulter, Inc., Fullerton, USA) and the supernatant 
containing the crude spectrin extract collected and pooled. 
 
Size exclusion chromatography and concentration of spectrin 
 
Spectrin tetramers and dimers were removed from high molecular weight 
complexes and band 4.1 by size exclusion chromatography (Zail and Coetzer, 
1984). The crude spectrin sample was incubated at 37 ºC for 30 minutes to 
dimerise the spectrin and loaded onto a 3 cm x 100 cm Sepharose® (CL) 4B 
column (kept at 4 ºC) (Pharmacia Fine Chemicals AB, Uppsala, Sweden) 
equilibrated with spectrin column buffer (10 mM sodium phosphate buffer, pH 
7.6, 130 mM KCl, 20 mM NaCl, 1 mM Na2EDTA, 1 mM DTT) at a flow rate of 
20 ml/hr. The elution profile of the collected fractions (2.5ml per tube) was 
plotted using a LKB Bromma 2238 Uvicord S II UV reader (Pharmacia Fine 
Chemicals AB, Uppsala, Sweden) (settings: 280 nm, absorbance 0.5) and a LKB 
Bromma 2210 Recorder (settings: 0.5mm/min, 500mV). Fractions containing only 
the spectrin dimers were pooled and the concentration of a 10 µl sample 
determined with the Coomassie Plus™ Protein Assay Reagent (Pierce 
Biotechnology Incorporated, Rockford, USA). Spectrin tetramers were not used 
for the biotinylation procedure because they eluted just after the high molecular 
weight complexes and contamination with other erythrocyte membrane proteins 
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was possible. The spectrin dimers were concentrated to 2.5 ml using an Amicon 
Stirred Ultrafiltration Cell kept on ice (Model 8050; Millipore Corporation, 
Bedford, USA) that contained an Ultracel Amicon YM 10 Disc Membrane 
(molecular weight exclusion limit of 100,000 Da; Millipore Corporation, Bedford, 
USA). The concentration procedure was performed with nitrogen (African 
Oxygen Limited, Johannesburg, South Africa) set at 0.7 atm. The sample was 
further concentrated to ~5 mg/ml with a 0.5-3 ml Slide-A-Lyzer® Dialysis cassette 
(Pierce Biotechnology Incorporated, Rockford, USA) and Polyethylene glycol 
2000 (PEG 2000) (Sigma-Aldrich Corporation, St. Louis, USA). 
 
Biotinylation of purified spectrin 
 
The concentrated spectrin sample was dialysed against phosphate buffered saline 
(PBS; 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.2) 
for 2-3 hours at 4 ºC using a 0.5-3 ml Slide-A-Lyzer® Dialysis cassette. The 
spectrin was biotinylated for 2-4 hrs at room temperature with continuous stirring 
in a reaction that contained a molar ratio of 1:10 of D-biotin-N-
hydroxysuccinimide ester (Roche Diagnostics Gmbh, Mannheim, Germany) to 
spectrin dimers (MW 460 kDa) (Figure 19). 
 
 
Figure 19: The biotinylation reaction. 
(adapted from Roche Applied Science, 1999) 
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The sample was dialysed overnight at 4 ºC against PBS to remove free biotin and 
centrifuged at 8,500 g for 10 minutes at room temperature using a Sorvall® RMC-
14 Refrigerated Microcentrifuge (Sorvall Products, L.P., Newtown, USA). The 
supernatant was diluted to a final concentration of 1 mg/ml with PBS. One 
hundred microlitre aliquots were stored at -20 ºC. 
 
Analysis of spectrin 
 
The biotinylated spectrin was electrophoresed on a Laemmli SDS-polyacrylamide 
gel (Laemmli, 1970) and a gradient Fairbanks SDS-polyacrylamide gel (Coetzer 
et al., 1988, Fairbanks et al., 1971) to analyse its purity. 
 
Ten micrograms spectrin and 45 µg erythrocyte membrane proteins were prepared 
by adding 5 x Suspension Solution (50 mM Tris-HCl, 5 mM Na2EDTA, 5 % SDS 
(w/v), 25 % sucrose (w/v), pH 8), 40 x sucrose/dye (2.5 % sucrose (w/v), 0.5 % 
bromophenol blue (w/v)) and 2 % β-mercaptoethanol (v/v) and heating the sample 
for 2 minutes in boiling water. A 14 cm x 16 cm x 1.5 mm Laemmli SDS-
polyacrylamide gel containing a stacking gel composed of 4 % polyacrylamide 
(29.2 % acrylamide/0.8 % bisacrylamide (w/v) stock solution) in lower gel buffer 
(375 mM Tris-HCl, pH 8.8) and 0.1 % SDS (w/v) and a resolving gel composed 
of 12 % polyacrylamide in upper gel buffer (125 mM Tris-HCl, pH 6.8) and 0.1 % 
SDS (w/v), was cast and the spectrin electrophoresed against the erythrocyte 
membrane proteins at 75 V for 17 hours with Laemmli running buffer (25 mM 
Tris, 192 mM glycine, 0.1 % SDS (w/v). The protein bands were stained with 
Coomassie Blue stain (0.05 % Coomassie Blue R-250 (w/v) (BDH Laboratory 
Supplies, Poole, UK), 25 % isopropanol (v/v), 10 % glacial acetic acid (v/v)). 
 
A 14 cm x 16 cm x 1.5 mm Fairbanks SDS-polyacrylamide gel was set up with an 
exponential polyacrylamide gradient of 3.5-17.5 % (40 % acrylamide/1.5 % 
bisacrylamide (w/v) stock solution) in Tris acetate buffer (40 mM Tris, 20 mM 
sodium acetate, 1 mM Na2EDTA, pH 7.4) and 0.2 % SDS (w/v). Protein samples 
were solubilised the same way as for the Laemmli SDS-polyacrylamide gel. Five 
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micrograms spectrin was electrophoresed against 20 µg erythrocyte membrane 
proteins at 45 V for 17 hours using Tris acetate buffer containing 0.1 % SDS 
(w/v). The protein bands were stained with Coomassie Blue stain. 
 
To test successful biotinylation of spectrin, one well from a Streptawell plate 
(transparent, 12x8-well strips; Roche Diagnostics Gmbh, Mannheim, Germany) 
was coated with 0.5 µg of biotinylated spectrin in 200 µl Tris buffered saline 
(TBS; 10 mM Tris-HCl, 150 mM NaCl, pH 8), by allowing the protein to bind for 
1 hour at 4 ºC. A second control well was incubated with 200 µl TBS. The wells 
were washed 3 times with 300 µl TBS-T (TBS with 0.12 % Tween®-20 (v/v) 
(Calbiochem®, San Diego, USA), blocked with 200 µl 3 % Bovine Serum 
Albumin Fraction V (w/v) (Roche Diagnostics Gmbh, Mannheim, Germany) in 
TBS and analysed with a 1:100 dilution of a rabbit anti-α-spectrin and rabbit anti-
β-spectrin primary polyclonal antibody mix (prepared at St. Elizabeth’s Medical 
Center, Boston, USA), followed by a 1:1000 dilution of goat anti-rabbit IgG 
peroxidase (Roche Diagnostics Gmbh, Mannheim, Germany). The secondary 
antibody was detected with 0.5 mg/ml 4-chloro-1-napthol (Sigma-Aldrich 
Corporation, St. Louis, USA) and 0.1 % hydrogen peroxide solution (Sigma-
Aldrich Corporation, St. Louis, USA). 
 
2.2.3 P. falciparum culturing 
 
P. falciparum cultures (~5 % parasitaemia and ~5 % haematocrit) were 
maintained in 175 cm3 culture flasks (Nunc™, Roskilde, Denmark) with 30 ml 
RPMI-1640 medium containing 25 mM HEPES (Invitrogen Ltd, Renfrewshire, 
UK) supplemented with 20 mM glucose (Saarchem (Pty) Ltd., Wadeville, South 
Africa), 44 mg hypoxanthine (Sigma-Aldrich Corporation, St. Louis, USA), 0.05 
mg/ml gentamycin (Sigma-Aldrich Corporation, St. Louis, USA), 0.2 % sodium 
bicarbonate (w/v) (adapted from Trager and Jensen, 1976). Before use, the filter 
sterilised medium (SterivexTM-GS 0.2 µm Filter unit, Millipore Corporation, 
Bedford, USA) was gassed with 100 % carbon dioxide (African Oxygen Ltd., 
Johannesburg, South Africa) until the pH indicator changed to a orange-yellow 
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colour, and 10 % heat inactivated AB plasma (v/v) was added to the medium. The 
cultures were examined daily by staining a blood smear with the Rapid 
Haematology Stain (Diagnostic Media Products, NHLS, Sandringham, South 
Africa). The culture medium was changed daily and the parasitaemia and 
haematocrit levels were controlled by removing a portion of parasitised cells from 
the flask and adding fresh human erythrocytes (donated by volunteers) that had 
been washed with sterile PBS. Cultures were grown in a 37 ºC Nuaire™ IR 
Autoflow incubator (Nuaire™, Plymouth, USA). 
 
2.2.4 P. falciparum mRNA isolation 
Total RNA isolation 
 
Total RNA was obtained from the parasites using the guanidinium isothiocyanate 
isolation method described by Chomczynski and Sacchi (1987). All RNA 
isolation experiments were performed in an RNase-free environment (as described 
in Ausubel et al., 1994). Parasite suspensions from four 175 cm3 culture flasks 
(mixed cultures with a 10-20 % parasitaemia) were centrifuged for 5 minutes at 
900 g using a Jouan BR 3.11 centrifuge. Thirty millilitres 0.05 % saponin (w/v, 
dissolved in PBS; USB Corporation, Cleveland, USA) was added to each tube to 
lyse the parasite-infected erythrocytes. The samples were incubated for 5 minutes 
at room temperature, followed by centrifugation at 900 g for 10 minutes. Parasite 
pellets were washed three times in PBS. The 100-200 µl parasite pellets were 
lysed with 5 ml 4 M guanidinium isothiocyanate (Sigma-Aldrich Corporation, St. 
Louis, USA) solution containing 25 mM sodium citrate, pH 7, 0.5 % lauryl 
sarcosine (w/v) (Sigma-Aldrich Corporation, St. Louis, USA), and 0.1 M β-
mercaptoethanol (Merck KGaA, Darmstadt, Germany). The total RNA was 
removed from the cellular debris by adding 1/10 volume 2 M sodium acetate, pH 
4, an equal volume phenol pH 4.2 (MP Biomedicals, LLC, Aurora, USA), and 1/5 
volume chloroform and centrifuging the mixed sample at 1,500 g for 15 minutes 
at 4 ºC. An equal volume of chloroform was added to the aqueous phase and the 
centrifugation step repeated. One millilitre aliquots of the supernatant were 
pipetted into RNaseZap® (Ambion Inc., Austin, USA) treated 2.0 ml Eppendorf 
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tubes (Eppendorf AG, Hamburg, Germany) and an equal volume of 100 % cold 
isopropanol added. The samples were incubated at -20 ºC for 1-2 hours and 
centrifuged at 16,000 g for 10 minutes at 4 ºC in a Sorvall® RMC-14 Refrigerated 
Microcentrifuge. The pellets were air dried for 1 hour at room temperature and 
resuspended in a total volume of 120 µl nuclease-free water (Promega 
Corporation, Madison, USA). A total of 10 µl of the sample was kept aside for 
spectrophotometric analysis at 260 and 280 nm (as described in Ausubel et al., 
1994) and visualisation on a 1 % agarose gel (containing 0.5 µg/ml ethidium 
bromide (Sigma-Aldrich Corporation, St. Louis, USA)) in Tris EDTA acetic acid 
buffer (TEA buffer; 40 mM Tris, 1 mM Na2EDTA, pH 8, 0.1 % glacial acetic acid 
(v/v)). 
 
mRNA isolation 
 
mRNA was separated from the total RNA using the Dynabeads® mRNA Direct™ 
Kit (Dynal A.S, Oslo, Norway), which uses magnetic Oligo (dT)25 beads that bind 
mRNA poly-A tails to extract mRNA directly from cells. The protocol was 
therefore modified to extract mRNA from total RNA. The 110 µl total RNA 
sample was made up to 1 ml with Binding/Lysis Buffer and added to the magnetic 
particles (250 µl Dynabeads® Oligo (dT)25 bead suspension from the stock, 
washed with 250 µl Binding/Lysis Buffer). The mRNA was allowed to bind to the 
beads for 5 minutes at room temperature while continuously inverting the tube by 
hand. The Binding/Lysis Buffer was removed by placing the tube on the Magnetic 
Particle Separator (Roche Diagnostics Gmbh, Mannheim, Germany) and 
aspirating the supernatant. Beads were washed twice by continuously inverting the 
sample for 5 minutes at room temperature using 1 ml Washing Buffer A and once 
with 1 ml Washing Buffer B. mRNA was eluted from the beads in 25 µl 10 mM 
Tris-HCl, pH 7.5 by heating the sample to 65 ºC for 2 minutes. The concentration 
and purity of the mRNA was determined by spectrophotometric analysis at 260 
and 280 nm and visualisation on a 1 % agarose gel in TEA buffer. 
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2.2.5 P. falciparum phage display library creation 
P. falciparum cDNA synthesis 
 
The OrientExpress™ cDNA Kit (Novagen, Inc., Madison, USA) was used to 
create the P. falciparum phage display library according to the protocol of the 
manufacturer. P. falciparum mRNA was reverse transcribed in the presence of 5-
methyl dCTP to protect internal EcoRI and HindIII restriction sites. The P. 
falciparum mRNA strand was digested by RNase H and double stranded DNA 
synthesised using the reverse transcribed DNA strand as the template. A single 
directional linker was added to both sides of the dsDNA (Figure 20). The linker 
has an internal EcoRI site and a HindIII site is created at the 3’ end of the 
construct by a combination of the poly-A tail and part of the linker. Digestion 
with EcoRI and HindIII thus facilitated directional cloning of the dsDNA into the 
T7Select®10-3b Vector (Figure 20 and vector map in Appendix A2). The protocol 
in the OrientExpress™ cDNA Manual (Novagen, 1999a) was modified by 
precipitating the DNA with ethanol instead of isopropanol. The library creation 
procedure was monitored by incorporating 5 µCi [α-32P]dATP (specific activity = 
3000 Ci/mmol; Amersham Biosciences, Ltd., Buckinghamshire, UK) into the first 
and second strand synthesis reaction and electrophoresing the P. falciparum 
dsDNA against size markers (Appendix A1) on a 8 % denaturing polyacrylamide 
gel. 
 
 
Figure 20: Double digestion of the linker and P. falciparum insert. 
Diagram showing the creation of the EcoRI/HindIII P. falciparum insert after 
addition and double digestion of a single linker. Red nucleotides = P. falciparum 
DNA; blue nucleotides = directional linker; green lines = EcoRI and HindIII 
restriction sites. 
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The P. falciparum library was created using 4 µg P. falciparum mRNA. The 
mRNA and 2 µg of a two-base anchored primer cocktail (P129, P130, P131, 
P132) (Integrated DNA Technologies, Inc., Coralville, USA) (reaction volume = 
20 µl) (Figure 21) were heated at 70 ºC for 10 minutes to reduce RNA secondary 
structure. The sample was cooled on ice and the mRNA subjected to first strand 
synthesis with 800 units MMLV Reverse Transcriptase in the presence of 1 x First 
Strand Buffer, 10 mM DTT and 0.5 x Methylated dNTP Mix for 1 hour at 37 ºC 
(reaction volume = 50 µl). The MMLV enzyme was subsequently inactivated by 
heating to 70 ºC for 10 minutes. Second strand synthesis entailed digesting the 
mRNA template with 1.6 units RNase H and completing the DNA synthesis with 
50 units DNA polymerase I in the presence of 1 x Second Strand Buffer, 2.4 mM 
DTT and 0.08 x Methylated dNTP Mix for 90 minutes at 15 ºC (reaction volume 
= 250 µl). 
 
 
Figure 21: Anchored 14-mer primers for P. falciparum cDNA synthesis. 
 
The dsDNA was purified by phenol (pH 7.9)/chloroform/ isoamyl alcohol 
(25:24:1) extraction. The dsDNA was precipitated for 20 minutes at -70 ºC with 
10 µg Glycogen, an equal volume of 4 M Ammonium Acetate, pH 4.8 and two 
and a half volumes 100 % cold ethanol, followed by centrifugation at 16,000 g for 
30 minutes at 4 ºC. The pellet was washed with 70 % ethanol and air dried for 20 
minutes before being resuspended in 20 µl TE Buffer. DNA ends were blunted 
with 1.5 units T4 DNA Polymerase, 1 x Flush Buffer, 5 mM DTT, and 3 mM 
dNTP Mix for 20 minutes at 11 ºC (reaction volume = 30 µl), followed by phenol-
chloroform extraction and ethanol precipitation as above. The pellet was 
resuspended in 10 µl TE Buffer. One hundred picomoles Directional 
EcoRI/HindIII Linkers and the DNA were phosphorylated in the presence of 5 
units T4 Polynucleotide Kinase, 1 x Ligation Buffer, 0.1 mM ATP, and 10 mM 
 
 
53
DTT for 5 minutes at 37 ºC and then ligated to each other in the presence of 6-8 
Weiss units T4 DNA Ligase for 20 hours at 16 ºC (reaction volume = 20 µl). The 
ligase was heat inactivated at 70 ºC for 10 minutes, before the DNA was subjected 
to restriction digestion with 100 units HindIII in 1 x HindIII Buffer for 2 hours at 
37 ºC (reaction volume = 100 µl), followed by restriction digestion with 100 units 
EcoRI in 1 x EcoRI Adjustment Buffer for 4 hours at 37 ºC (reaction volume = 
115 µl). The DNA was purified with phenol-chloroform as above and fragments 
smaller than 300 bp removed by size exclusion chromatography through 1 ml Gel 
Filtration Resin (Sepharose® 4B) equilibrated with Column Buffer. The 250 µl 
eluate was subjected to ethanol precipitation as above with 1 µg Glycogen but no 
addition of 4 M Ammonium Acetate and resuspended in 20 µl TE Buffer. The 
concentration and purity of vector-ready DNA was determined by 
spectrophotometric analysis at 260 and 280 nm. 
 
Ligation and viral packaging 
 
P. falciparum DNA was inserted into the T7 vector using the T7Select® System 
(Novagen, Inc., Madison, USA) according to the instructions of the manufacturer. 
A molar ratio of 1500 bp DNA insert (estimation of the average length of the 
inserts after DNA synthesis) to vector of 1:1 to 3:1 should be used for the ligation 
reaction (Novagen, 2000b). Therefore, ~0.05 pmol P. falciparum DNA was 
ligated to 0.02 pmol T7Select® Vector Arms in the presence of 0.4-0.6 Weiss 
units T4 DNA Ligase, 1 mM ATP, 1 x Ligase Buffer, and 10 mM DTT for 16 
hours at 16 ºC (reaction volume = 5 µl). The 5 µl ligation reaction was packaged 
in 12.5 µl T7Select® Packaging Extract for 2 hours at room temperature and the 
reaction terminated with 132.5 µl sterile Luria broth (LB; 1 % Bacto™ Tryptone 
(w/v) (Becton, Dickinson and Co., Sparks, USA), 0.5 % Yeast Extract (w/v) 
(Oxoid Ltd., Basingstoke, UK), 1 % NaCl (w/v), 1 % 10 mM Tris-HCl, pH 7.5 
(v/v)) supplemented with 50 µg/ml ampicillin (Roche Diagnostics Gmbh, 
Mannheim, Germany). Ten microlitres of the packaged sample was kept aside for 
a 103-106 dilution assay. The remaining packaging mixture was added to a 50 ml 
log phase BLT5403 E. coli culture (bacterial cells provided in kit; Novagen, Inc., 
 
 
54
Madison, USA) grown in M9LB medium (LB medium supplemented with 0.4 % 
glucose (w/v), 1 mM MgSO4, 1 x M9 salts (18.7 mM NH4Cl, 22 mM KH2PO4, 
22.5 mM Na2HPO4)) containing 50 µg/ml ampicillin and incubated at 37 ºC while 
shaking at 225 rpm in a Labotec® Orbital Shaker (Labotec, Midrand, South 
Africa) until lysis was observed (3-4 hours). Sodium chloride was added to a final 
concentration of 0.5 M and the suspension centrifuged at 8,000 g for 10 minutes 
using a Beckman® J2-21 centrifuge. Ten microlitres of the bacteriophage-
containing supernatant was kept aside for a 106-109 dilution assay to determine the 
bacteriophage concentration. The remainder of the supernatant was kept at 4 ºC 
for daily use, or stored long term at –70 ºC with an equal volume of 80 % glycerol 
(v/v) (Saarchem (Pty) Ltd., Wadeville, South Africa). 
 
Dilution assay 
 
The packaging efficiency and total plaque forming units were determined by a 
103-106 dilution assay. The bacteriophage concentration of an amplified culture 
was determined from a 106-109 dilution assay.  
 
The assay involved setting up the above mentioned serial dilutions in LB medium. 
One hundred microlitres of each dilution was added to 250 µl log phase BLT5403 
E. coli cells and 3 ml warm top agarose (1 % tryptone (w/v), 0.5 % yeast extract 
(w/v), 0.5 % NaCl (w/v), 0.6 % SeaKem LE agarose (w/v) (FMC® BioProducts, 
Rockland, USA)). The mixture was poured onto 20 ml agar plates (LB medium, 
1.5 % agar (w/v) (Oxoid Ltd., Basingstoke, UK) containing 50 µg/ml ampicillin. 
Inverted plates were incubated at 37 ºC until plaques formed (3-4 hours). The 
plaque forming units (pfu) per ml (phage titre), total number of pfu (library size), 
and packaging efficiency and concentration were determined from the following 
formulae (Novagen, 2000b): 
phage titre (pfu/ml) = (number of plaques on plate) x dilution x 10 
where 10 takes into account the 0.1 ml of the dilution plated 
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library size (pfu) = phage titer x total sample volume 
where total sample volume is the 0.15 ml final volume used during packaging reaction 
 
packaging efficiency (pfu/µg) = library size / amount vector DNA 
where 0.5 µg vector DNA was used in packaging reaction 
 
DNA insert analysis by polymerase chain reaction (PCR) 
 
Plaques were removed from agar plates and placed into 50 µl 10 mM Na2EDTA, 
pH 8. The samples were vortexed and incubated at 65 ºC for 10 minutes. After 
cooling, the tubes were centrifuged at 16,000 g for 3 minutes at 4 ºC using a 
Sorvall® RMC-14 Refrigerated Microcentrifuge. One microlitre phage lysate was 
mixed with 0.5 µl T7SelectUP Primer (5 pmol/µl) (Novagen, Inc., Madison, 
USA), 0.5 µl T7SelectDOWN Primer (5 pmol/µl) (Novagen, Inc., Madison, USA), 
12.5 µl PCR Master Mix (Promega Corporation, Madison, USA), and 10.5 µl H2O. 
The sample was placed in the Eppendorf Mastercycler® Gradient machine 
(Eppendorf AG, Hamburg, Germany) under the cycling conditions shown in 
Table 2 (Novagen, 2000b). Ten microlitres of the PCR product was visualised 
against the 100bp DNA Ladder (Promega Corporation, Madison, USA) on a 1% 
agarose gel in TEA buffer. 
 
Table 2: Cycling parameters for T7 insert amplification. 
Segment Cycles Temperature Time 
1 1 80 ºC 2 min 
2 1-35 94 ºC 50 sec 
  50 ºC 1 min 
  72 ºC 1 min 
3 1 72 ºC 6 min 
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2.2.6 P. falciparum phage display library biopanning 
Binding spectrin to Streptavidin Magnetic Particles 
 
Hundred microlitres biotinylated spectrin was bound to 50 µl Streptavidin 
Magnetic Particles (Roche Diagnostics Gmbh, Mannheim, Germany) at room 
temperature for 1 hour by continuous inversion by hand to prevent the beads from 
settling at the bottom of the tube. Unbound spectrin was removed by placing the 
beads on the Magnetic Particle Separator. The beads were washed four times with 
500 µl PBS containing 0.05 % Tween®-20 (v/v) and kept in 500 µl PBS at 4 ºC 
until further use. The PBS was removed before the use of the beads. 
 
Biopanning the P. falciparum library against spectrin 
 
The biopanning process entailed incubating the P. falciparum phage display 
library with spectrin bound to Streptavidin Magnetic Particles. Bacteriophage that 
did not interact with spectrin were washed away and bound bacteriophage eluted 
from the beads and amplified in E. coli. The biopanning was performed four times 
to ensure specific enrichment of bacteriophage interacting with spectrin. 
 
The multiplicity of infection (MOI) for the biopanning procedure can be 
calculated from the following formula: 
MOI = volume of phage used (ml) x phage titre (pfu/ml) / library size (pfu) 
 
Five hundred microlitres of the P. falciparum phage display library (1 x 107 
pfu/ml diluted in PBS) was bound to 100 µl Streptavidin Magnetic Particles for 1 
hour at room temperature by continuous inversion by hand. This background 
selection step was performed to eliminate bacteriophage that could bind to the 
streptavidin-coated beads. The suspension was placed on the Magnetic Particle 
Separator and the unbound bacteriophage removed and added to the spectrin-
coated beads. Bacteriophage were allowed to bind to the beads for 1 hour at room 
temperature while continuously inverting the tube by hand. Unbound 
bacteriophage were removed and the beads transferred to a 15 ml tube (Nunc™, 
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Roskilde, Denmark) and washed three times with 10 ml PBS containing 0.05 % 
Tween®-20 (v/v), for 10 minutes at room temperature. A final wash was 
performed with 10 ml PBS. Bound bacteriophage were eluted from the beads by 
incubating them in 250 µl PBS containing 1 % SDS (w/v) for 15 minutes at room 
temperature. The supernatant was added to a 50 ml log phase BLT5403 E. coli 
culture grown in M9LB medium supplemented with 50 µg/ml ampicillin and 
incubated overnight at 37 ºC using a Labotec® Orbital Shaker (225 rpm). Sodium 
chloride was added to a final concentration of 0.5 M and the suspension 
centrifuged at 8,000 g for 10 minutes using a Beckman® J2-21 centrifuge. A 106-
109 dilution assay was performed to determine the bacteriophage concentration 
and the biopanning procedure repeated three times. 
 
2.2.7 DNA sequencing of P. falciparum inserts 
 
The nucleotide sequence of the P. falciparum DNA fragments coding for the 
peptides that interact with spectrin was analysed by Sanger sequencing (Sanger et 
al., 1977). Sequencing was accomplished by first isolating the bacteriophage 
DNA from a plaque and then amplifying the P. falciparum DNA fragment by 
PCR using the T7SelectUP and T7SelectDOWN Primers. The remainder of the 
plaque was excised from the agar plate and placed into 500 µl phage extraction 
buffer (20 mM Tris-HCl, 100 mM NaCl, 6 mM MgSO4, pH 8) and stored at 4 ºC. 
The double stranded DNA product was prepared for the sequencing reaction with 
ExoSap-IT® (USB Corporation, Cleveland, USA). This enzyme cocktail contains 
exonuclease I, which digests residual primers, and shrimp alkaline phosphatase, 
which dephosphorylates unincorporated nucleotides. The prepared DNA was 
sequenced using the T7 Sequenase version 2.0 DNA sequencing kit (Amersham 
Biosciences, Ltd., Buckinghamshire, UK) in the presence of [α-32P]dATP and the 
T7SelectUP Primer. 
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2.2.8 Identification and analysis of P. falciparum inserts 
P. falciparum database gene search 
 
The sequence of each insert was compared to the PlasmoDB (Version 4.4, 
available at http://plasmodb.org) (Bahl et al., 2003) P. falciparum genomic 
sequence (nt) database and the P. falciparum annotated genes (nt) databases using 
the WashU-BLASTN 2.0 search algorithm (gapped alignment using a Blosum62 
matrix). P. falciparum genes showing a 95 % or higher identity to the query 
sequence were further analysed by establishing the reading frame of the DNA in 
the T7 bacteriophage. The nucleotide sequence was translated into the amino acid 
sequence using Gene Runner (version 3.05) (Hastings Software Inc., Hastings, 
USA) and compared to the PlasmoDB annotated protein database using the 
WashU-BLASTP 2.0 algorithm (using a gapped Blosum62 matrix). Identical 
results for the best matches from both queries, as well as a +1 reading frame in the 
amino acid sequence query, indicated that these P. falciparum genes code for 
proteins that interact with spectrin. 
 
Peptide alignment and motif scan 
 
The amino acid sequences of the peptides displayed on the bacteriophage surface 
were compared to each other with ClustalW (http://www.ebi.ac.uk/clustalw/) 
(Chenna et al., 2003) and analysed with Motif Scan (http://myhits.isb-sib.ch/cgi-
bin/motif_scan) (Pagni et al., 2004) to determine if there were any amino acid or 
motif similarities between all the spectrin-binding peptides. Motif Scan compared 
the peptide sequence to the Prosite and the Pfam peptide motif databases. 
 
2.3 Results 
2.3.1 Spectrin preparation 
 
SDS-PAGE analysis of the crude spectrin extract (Figure 22) showed that small 
amounts of protein 4.1, actin, and protein 4.9 had been co-extracted from the 
 
 
59
erythrocyte ghosts, but no ankyrin contamination was evident. A Fairbanks SDS-
polyacrylamide gel was used to verify the absence of ankyrin, because ankyrin co-
migrates with β-spectrin on a Laemmli SDS-polyacrylamide gel. 
 
Size exclusion chromatography (Figure 23) was used to purify the spectrin dimers 
and tetramers from the contaminating erythrocyte membrane proteins. The small 
protein peak before the spectrin tetramers consisted of high molecular weight 
(HMW) spectrin/protein 4.1/actin complexes. The protein peak after the spectrin 
dimers contained the other contaminating membrane proteins seen in Figure 22. 
 
Purified spectrin dimers were concentrated and used for the biotinylation reaction. 
Tetramers were excluded because there was a risk of contamination with the 
HMW complexes. 
 
 
Figure 22: Spectrin isolation from human erythrocytes. 
Photographs of a Laemmli (a) and Fairbanks (b) gel showing spectrin and 
additional proteins isolated from erythrocytes after hypotonic lysis and low ionic 
strength extraction. Lane M contains 45 µg (a) and 20 µg (b) erythrocyte 
membrane proteins respectively and lane 1 contains 10 µg (a) and 5 µg (b) 
spectrin respectively. 
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Figure 23: Size exclusion chromatography of spectrin. 
Elution profile of crude spectrin passed through a Sepharose® (CL) 4B column. 
Spectrin tetramers (SpT; 920 kDa) elute before spectrin dimers (SpD; 460 kDa). 
The first small peak contains high molecular weight complexes (HMW: 
spectrin/protein 4.1/actin) and the last peak contains the low molecular weight 
proteins (LMW: actin and protein 4.1). 
 
The total amount and concentration of protein, as well as the percentage yield of 
spectrin dimers after each step of the procedure are listed in Table 3. The spectrin 
dimers obtained after biotinylation were only 23 % of the crude spectrin extract 
because the high molecular weight complexes, actin and protein 4.1 were removed 
during size exclusion and spectrin tetramers were also not included in the 
concentration and biotinylation procedure. Furthermore, only 39 % of the spectrin 
dimers (after size exclusion) were recovered at the end of the biotinylation 
procedure because a large amount of protein was lost during the concentration and 
particularly in the dialysis steps.  
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Table 3: Spectrin dimer yields during spectrin processing. 
 Total amount protein (mg) 
Protein 
concentration 
(mg/ml) 
Yield from total 
spectrin (%) 
Yield from 
spectrin 
dimers (%) 
Crude spectrin 
extract  18.5 1.85 100 - 
Spectrin tetramers 
after size exclusion 1.3 0.06 7.0 - 
Spectrin dimers after 
size exclusion 10.9 0.15 59 100 
Spectrin dimers after 
concentration 7.7 3.06 42 70 
Spectrin dimers after 
biotinylation 4.3 2.27 23 39 
 
Analysis of the biotinylated spectrin dimers on Laemmli and Fairbanks SDS-
polyacrylamide gels showed that the spectrin samples were >90 % pure (Figure 
24) and that the visible contaminant was actin. These gels seem to contain less 
spectrin than Figure 22 even though similar amounts were loaded and Bradford 
analysis was used to determine the spectrin concentration in the samples. 
However, the Bradford reagent contains Coomassie G-250 Dye which binds to 
basic and aromatic groups in amino acid side chains (Pierce, 2005). Biotin 
contains two NH-groups in its structure, which could bind additional Coomassie 
G-250 Dye, thereby overestimating the amount of protein present in the sample. 
The percentage yield of spectrin dimers after biotinylation would therefore also 
have been lower. 
 
The spectrin biotinylation was checked by coating a Streptawell with the 
biotinylated spectrin and then detecting the spectrin with α- and β- spectrin 
antibodies. The well containing spectrin turned light purple with 4-chloro-1-
napthol, while the well containing no spectrin remained clear (results not shown). 
This indicates that the spectrin was biotinylated successfully and would therefore 
bind to streptavidin. 
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Figure 24: Biotinylated spectrin. 
Photographs of a Laemmli (a) and Fairbanks (b) gel showing biotinylated 
spectrin. Spectrin was purified by size exclusion chromatography and 
subsequently biotinylated. Lane M contains 45 µg (a) and 20 µg (b) erythrocyte 
membrane proteins respectively and lane 1 contains 10 µg (a) and 5 µg (b) 
biotinylated spectrin respectively. 
 
2.3.2 P. falciparum phage display library construction 
 
Two mRNA isolations were performed from mixed P. falciparum cultures, 
depicted in Figure 25 and listed in Table 4. Four 175 cm3 culture flasks were used 
for each isolation. 
 
The isolated mRNA had a lower A260/A280 ratio than that of pure mRNA which is 
2 (as described in Ausubel et al., 1994) and was thus either contaminated with 
proteins, or the Dynabeads® Oligo (dT)25 beads that had not been completely 
removed from the mRNA sample (Dynal®, 2000). 
 
 
 
63
 1 
2
3
Figure 25: P. falciparum cultured in human erythrocytes. 
Photograph showing a P. falciparum culture at 1000x magnification. The 
parasite’s nuclear material is stained by the methylene blue component of the 
Rapid Haematology Stain. Early trophozoites (rings) (1) have the shape of a ring 
within the erythrocyte, the trophozoite (2) appears as a large circular body within 
the erythrocyte, and schizonts (3) are small ovoid bodies inside the erythrocytes. 
 
Table 4: P. falciparum mRNA isolation. 
mRNA 
isolation 
Culture 
parasitaemia and 
composition  
Total RNA mRNA 
Percentage mRNA 
isolated from total 
RNA 
1 
20 %; 
~2/3 R* 
~1/3 T/S#
403 µg 
(3.7 µg/µl) 
7.7 µg 
(0.31 µg/µl) 
A260/A280 = 1.5 
1.9 
2 
10 %; 
~2/3 R 
~1/3 T/S 
169 µg 
(1.5 µg/µl) 
3.8 µg 
(0.15 µg/µl) 
A260/A280 = 1.75 
2.3 
* R = rings 
# T/S = trophozoites and schizonts 
 
Figure 26 shows the P. falciparum total RNA containing the 28s (4104 bp), 18s 
(1384 bp) and 5s ribosomal RNA (rRNA) subunits (Daily et al., 2004), as well as 
mRNA. Visualisation of the P. falciparum mRNA on a 1 % agarose gel (result not 
shown) revealed mRNA as a faint smear with only traces of 18s and 28s rRNA 
subunits present. rRNA was a contaminant because the P. falciparum genome is 
AT-rich and Oligo (dT)25 beads were used for the isolation procedure. 
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Figure 26: P. falciparum total RNA. 
Agarose gel showing total RNA isolated from P. falciparum cultures. The 28s 
(4104 bp), 18s (1384 bp), and 5s rRNA subunits are the predominant forms of 
RNA. The faint mRNA smear can be seen in the region of the 28s and 18s rRNA.   
 
The phage display library was created with 4 µg P. falciparum mRNA from the 
second mRNA isolation. DNA synthesis was monitored by the addition of [α-
32P]dATP in the first and second strand synthesis reactions. The P. falciparum 
DNA generated during second strand synthesis is shown in Figure 27 as a smear. 
The majority of the P. falciparum DNA was greater than 722 bp. 
 
The [α-32P]dATP labelled P. falciparum DNA was also used to monitor the gel 
filtration procedure (Figure 28). The gel filtration column retains DNA smaller 
than 300 bp and therefore the initial fractions eluted from the column should 
contain the large DNA fragments. Fraction 3 contained the DNA that was greater 
than 722 bp and was used for the ligation reaction. This fraction contained 963 ng 
DNA at a concentration of 3.85 ng/µl with an A260/A280 absorbance ratio of 1.4. 
This ratio is lower than 1.8-1.9 which is the A260/A280 absorbance ratio of pure 
DNA (as described in Ausubel et al., 1994), indicating that the sample was 
contaminated with protein or aromatic substances, such as phenol. The size 
markers in Figure 28 show up as multiple bands due to non-specific amplification 
during the PCR reaction and the sensitivity of the radioisotope. 
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Figure 27: Second strand synthesis from P. falciparum cDNA. 
Autoradiograph of a denaturing polyacrylamide gel showing P. falciparum DNA 
synthesised in the presence of [α-32P]dATP. Lanes M1 and M2 contain 1 µl 
molecular weight markers, synthesized by PCR utilising primers specific for 
human erythrocyte α-spectrin (exon 2; 347 bp) and band 3 (exon 18 and 19; 722 
bp) respectively. Lane 1 contains 2 µl P. falciparum dsDNA, which migrates as a 
smear of >722 bp. 
 
 
Figure 28: Gel filtration of P. falciparum DNA. 
Autoradiograph of a denaturing polyacrylamide gel showing elution fractions of 
P. falciparum DNA after gel filtration. Lanes M1 and M2 contain 1 µl molecular 
weight markers, which were synthesized by PCR utilising primers specific for 
human erythrocyte α-spectrin (exon 2; 347 bp) and band 3 (exon 18 and 19; 722 
bp) respectively. Lanes 1-7 represent the following elution fractions: fraction 1 = 
0.1 ml; fraction 2 = 0.2 ml; fraction 3 = 0.25ml; and fractions 4-7 = 0.1ml each. 
Two microlitres of each DNA fraction was electrophoresed after it had been 
precipitated with ethanol and resuspended in 20 µl TE buffer. 
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One microlitre of this sample, containing 0.05 pmol of ~1500 bp DNA (size 
estimation based on OrientExpressTM cDNA Manual), was used for the ligation 
reaction. This gave an insert to vector ratio of 2.5:1, which is well within the 
recommended ratio range for the ligation reaction (Novagen, 2000b). The ligated 
fragments were packaged into viral particles to create the P. falciparum phage-
display library. The characteristics of this library were compared to those of a 
library created with the T7Select® Packaging Control DNA (Novagen, Inc., 
Madison, USA) (Table 5). The P. falciparum library was much smaller than the 
control library and had a much lower packaging efficiency. 
 
Table 5: P. falciparum phage display library characteristics. 
Library Phage titre (pfu/ml) 
Library size 
(pfu) 
Packaging efficiency 
(pfu/µg) 
P. falciparum 3.01 x 107 4.52 x 106 9.03 x 106
T7Select® Packaging Control 4.53 x 109 6.80 x 108 1.36 x 109
 
Amplification of randomly selected plaques from the P. falciparum phage-display 
library showed DNA inserts of mainly 50-200 bp in length (Figure 29) and the 
largest DNA fragment found to date was 1200 bp (result not shown). 
 
 
Figure 29: DNA inserts from the P. falciparum phage-display library. 
Agarose gel showing the PCR product of P. falciparum inserts in T7 
bacteriophage plaques. All fragments include 107 bp of the T7Select10-3b vector 
sequence. Lane M contains the Promega 100 bp DNA Ladder. Lanes 1-11 contain 
10 µl of the PCR product synthesised with the T7Up and T7Down Primers. 
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2.3.3 Biopanning 
 
Biopanning was initially performed in Streptawell plates before the method with 
the Streptavidin Magnetic Particles was established. One hundred microlitres of a 
P. falciparum phage display library that had a concentration of 4.5 x 107 pfu/ml 
was added to two wells containing immobilised spectrin. This gave the binding 
reaction a multiplicity of infection (MOI) of 1, which means that only one 
bacteriophage copy of each unique P. falciparum DNA insert was present in the 
sample.  A titering assay was performed on the binding phage in the first well to 
monitor enrichment and the second well was used for phage amplification for the 
next round of biopanning. Table 6 shows that the enrichment in the first two 
rounds of biopanning was within the 103-105 pfu range. The third and fourth 
round of biopanning however showed a decrease in binding indicating that 
sufficient enrichment had already been achieved in the second round of 
biopanning. 
 
Table 6: Bacteriophage enrichment. 
Biopanning round Number of binding phage (pfu) 
1st 4.5x104
2nd 4.5x105
3rd 2.1x105
4th 1.1x105
 
Once the method with the Streptavidin Magnetic Particles was established a 
mixture of two P. falciparum libraries was biopanned against purified spectrin. 
The first library was discussed in section 2.3.2 and the second library was 
provided by Roberto Lanzillotti and had a library size of 6.2 x 105 pfu. The new 
combined library had a size of 2.6 x 106 pfu and was used at a MOI of 2 for 
biopanning. This means that at least two copies of each phage were present in the 
500 µl sample of 1 x 107 pfu/ml bacteriophage used in the first round of 
biopanning. Biopanning with the Streptavidin Magnetic Particles resulted in a 
phage enrichment similar to that observed during biopanning with the Streptawell 
plates (results not shown). 
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After the fourth round of biopanning 80 plaques were selected for PCR 
amplification with the T7SelectUP and T7SelectDOWN Primers. Of these only 44 
were sequenced because the remaining PCR products were barely visible on a 1% 
agarose gel. The PCR amplification could have been poor for numerous reasons, 
such as impurities in the DNA template that prevented the Taq DNA polymerase 
from functioning properly, or insufficient DNA template or secondary structures 
within the DNA sequences that prevented the primers and Taq DNA polymerase 
from binding to the DNA template. The aim of this project was however not to 
isolate all possible parasite peptides that bind to spectrin and therefore the failed 
PCR amplifications were not repeated. Thirteen of the sequenced DNA inserts 
consisted of A-stretches (Figure 30a) and the remaining 31 DNA fragments 
showed 14 different DNA sequences rich in adenosines and thymidines which is 
typical for the P. falciparum genome. 
 
Four of the 14 P. falciparum DNA fragments did not have the linker region 
between the T7 vector DNA and the P. falciparum DNA (Figure 30b), indicating 
that the EcoRI enzyme had cleaved the P. falciparum DNA internally. First and 
second strand synthesis were performed in the presence of 5-methyl dCTP to 
protect the DNA from the restriction enzymes that are used during the linker 
digestion procedure, and EcoRI should not cleave methyl-protected DNA. It has 
however been shown that EcoRI sites that are flanked by a guanosine or cytidine 
can be cleaved by the enzyme when the DNA is fully and hemi-methylated 
(Tasseron-de Jong et al., 1988). 
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Figure 30: P. falciparum DNA insert sequences. 
Autoradiographs (a, b & c) showing DNA sequences that were isolated from 
plaques and diagram (d) showing the cloning procedure facilitated by directional 
linkers. The autoradiographs represent 8 % denaturing polyacrylamide gels of a P. 
falciparum A-stretch (a) and P. falciparum DNA sequences without (b) and with 
(c) the linker region. The linker region is absent in (b) because EcoRI cleaved the 
methyl-protected P. falciparum DNA internally. Red nucleotides = P. falciparum 
DNA; blue nucleotides = directional linker; black nucleotides = vector 
nucleotides; green line = EcoRI restriction site. 
 
2.3.4 Gene identification and peptide analysis 
 
All 14 sequences found after fourth round biopanning were identified in the 
PlasmoDB genomic sequence (nt) database (Table 7). However, only 12 of these 
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sequences were found in the annotated gene section of the database. Five of the 
genes were expressed in the correct frame (they had a +1 frame when compared to 
the PlasmoDB annotated protein database). One fragment was inserted backwards 
(-2 frame). This is surprising because the directional linker used for the cloning 
procedure, should only allow the fragment to be inserted into the +1, +2, or the +3 
frame. 
 
Table 7: P. falciparum genes identified after fourth round biopanning. 
PlasmoDB gene 
name or 
Chromosome 
number 
Insert 
size 
(bp) 
Percentage 
nucleotide 
identity 
Reading 
frame 
Special 
features 
Predicted 
PlasmoDB 
protein 
PFA0125c ~150 96 +1 - putative Ebl-1 like protein 
PFE0980c ~250 97 +1 - hypothetical protein 
MAL8P1.104 ~400 100 +1 
no 5’ 
EcoRI/Hind III 
linker 
hypothetical 
protein 
MAL8P1.151 ~60 96 +1 - hypothetical protein 
PFI1570c ~100 97 +1 
no 5’ 
EcoRI/Hind III 
linker 
putative amino-
peptidase 
PF10_0232 ~1200 90 +2 - hypothetical protein 
MAL13P1.249 ~200 100 +2 - hypothetical protein 
PFC0135c ~100 97 +3 
no 5’ 
EcoRI/Hind III 
linker 
conserved 
protein 
PF08_0131 ~300 100 +3 - 1-cys peroxidoxin 
PFL2095w ~200 100 +3 - 
translation 
initiation factor 
SUI1, putative 
PFF0125c ~350 98 -2 inserted backwards 
hypothetical 
protein 
MAL7_5.8s ~100 98 - no translation 5.8s rRNA 
Chromosome 11 ~300 99 +2 intron of PF_0370 - 
Chromosome 13 ~200 97 - intergenic - 
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When the nucleotide sequences of the +2, +3 and -2 frame DNA inserts were 
translated with Gene Runner, it was found that the majority of the inserts were 
expressed as small peptides with four to eight amino acids since premature stop 
codons terminated translation. The +1 frame sequences were expressed as 
peptides with 20 or more amino acids (Figure 31). 
 
The majority of the expressed peptides contained numerous positively (mainly 
lysine) and negatively (mainly aspartate) charged amino acids (Figure 31), but no 
consistent charge pattern was observed. Two of the in-frame sequences 
(PFE0980c and MAL8P1.104) also contained stretches of polar uncharged 
asparagine residues and PFE0980c had two repetitive amino acid sequences, 
namely KDN and KENNNNKGN. 
 
A ClustalW alignment with all the peptide fragments showed no sequence 
similarities (results not shown), and motif and profile searches did not reveal any 
putative motif that was present in every sequence (Table 8). Two sequences 
(PFF0125c & MAL7_5.8s) contained no motif and the other sequences contained 
a mixture of N-glycosylation and N-myristoylation sites, as well as protein kinase 
C, casein kinase II, and cyclic adenosine monophosphate- and cyclic guanosine 
monophosphate-dependent protein kinase phosphorylation sites. These are all 
post-translational modification sites that could be used by the parasite to regulate 
its proteins. A putative bacterial immunoglobulin-like domain 1 (Big-1) was 
found in several of the shorter out-of-frame sequences. This domain is generally 
associated with several other domains in bacteria and phage surface proteins that 
mediate bacteria host-cell interactions (Finn et al., 2006). The complete domain is 
normally over 50 amino acids in length and only segments thereof were identified 
in the ≤8 amino acid spectrin-binding sequences. 
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Figure 31: Peptides isolated after fourth round biopanning. 
Diagram showing the amino acid sequences of the peptides isolated after fourth 
round biopanning against spectrin. The gene name as well as the expression frame 
is given. The amino acids are colour coded according to class and charges are 
shown above the amino acids. Red = polar uncharged; purple = nonpolar 
aliphatic; blue = aromatic; pink = positively charged; green = negatively charged. 
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Table 8: Motifs and profiles of the P. falciparum spectrin-binding peptides. 
Gene name Motif/Profile (amino acid sequence) 
1 N-glycosylation site (NSSI) Chromosome 11 
Big-1* domain profile (NSSI) 
1 N-glycosylation site (NQTS) 
Chromosome 13 
Big-1 domain profile (ANQT--SQTN) 
PF08_0131 Big-1 domain profile (MFLTFI) 
PFF0125c - 
1 Protein kinase C phosphorylation site (TLK) 
PFL0295w 
Big-1 domain profile (ETTLK-SF) 
Arginine-rich region profile 
PF10_0232 
Cysteine-rich region profile 
MAL7_5.8s - 
MAL8P1.151 1 cAMPP
**- and cGMP***-dependent protein kinase 
phosphorylation site (KK T) 
PFI1570c 1 Casein kinase II phosphorylation site (SXXD) 
1 N-glycosylation site (NMSD) 
3 Casein kinase II phosphorylation sites (SVVD; TNTE; SXXD) PFA0125c 
1 Protein kinase C phosphorylation site (SLK) 
2 N-glycosylation sites (NNTE) 
3 N-myristoylation sites (GNKENN; GNIENN) 
Asparagine-rich region profile 
PFE0980c 
Lysine-rich region profile 
6 N-glycosylation sites (NSTT; NNSG; NHTN; NTSI; NNTN; 
NNSS) 
1 Casein kinase II phosphorylation site (TSID) 
5 N-myristoylation sites (GNNIND; GNNSGK; GINHTN; 
GNWING; GNNKNS) 
4 Protein kinase C phosphorylation sites (SGK; SNK; SKK) 
MAL8P1.104 
Asparagine-rich region profile 
* Big-1 = bacterial immunoglobulin-like domain 1  
** cAMP = cyclic adenosine monophosphate  
*** cGMP = cyclic guanosine monophosphate 
 
2.4 Discussion 
 
A P. falciparum phage display library was created by inserting DNA fragments 
generated from P. falciparum mRNA into the T7Select10-3 vector. The library 
was used to isolate several P. falciparum peptides that interact with human 
erythrocyte spectrin. 
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2.4.1 Library creation and bacteriophage selection 
Characteristics of the P. falciparum phage display library 
 
The phage display library was created from mRNA that had been isolated from 
mixed P. falciparum cultures to ensure that transcripts from all the parasite stages 
of the erythrocytic phase were present. This P. falciparum phage display library 
was however not representative of all the P. falciparum mRNA transcripts. 
Several mRNA transcripts and especially rare mRNAs, which transcribe as low 
copy numbers in the parasite, were probably not present in the library because 
only a small amount of the isolated mRNA was used for reverse transcription and 
only a portion of the P. falciparum DNA was used for the ligation and packaging 
reaction. Some DNA was also lost during the multiple processing steps that 
involved phenol-chloroform extraction and ethanol precipitation. 
 
First strand synthesis was performed with anchored poly-T primers that should 
have bound to the poly-A tail at the 3’ end of each mRNA strand. However, most 
of the P. falciparum DNA inserts that were isolated after fourth round biopanning 
coded for an internal region of the respective P. falciparum gene. The primers 
would have bound within the mRNA sequences because the P. falciparum 
genome is 80% AT-rich (Gardner et al., 2002) and parasite genes contain 
adenosine-stretches that translate into the low complexity regions commonly 
found in P. falciparum proteins (Pizzi and Frontali, 2001). 
 
The size of the P. falciparum inserts of the phage display library was checked by 
PCR and it was found that most of the amplified inserts were between 50 and 200 
bp in length. This was surprising because the gel filtration step should have 
removed DNA fragments smaller than 300 bp prior to ligation to the 
bacteriophage DNA. This seemed to be the case since α-32P labelled dsDNA was 
>722 bp after gel filtration (Figure 28), although the incorporation of less [α-
32P]dATP into the smaller DNA fragments would have made them less visible. 
The EcoRI digestion prior to ligation could also have cleaved the P. falciparum 
DNA internally, thereby creating smaller DNA fragments, even though the EcoRI 
 
 
75
sites should have been protected by methylation. This was confirmed by the 
isolation of several bacteriophage that contained P. falciparum DNA inserts 
without a 5’ linker region. Insert lengths could have been increased by reverse 
transcribing the mRNA at a higher temperature, such as 55 ºC. Elevated 
temperatures remove hairpin loops from the mRNA template, which can be 
responsible for early termination of the transcription reaction. However, higher 
temperatures can degrade the mRNA template, but this could be prevented with 
the addition of a RNA chaperone such as T4 bacteriophage gene 32 protein in the 
reaction, thereby stabilising the mRNA template (Piche and Schernthaner, 2005). 
Phage display insert sizes may also be increased by using a gel filtration resin 
with a higher molecular weight cut-off. The collection of smaller gel filtration 
fractions and subsequently using only those fractions with large cDNA could also 
improve the insert composition of the phage display library. 
 
The presence of DNA fragments smaller than 300 bp could have been responsible 
for the small library size and low packaging efficiency. The molar ratio of insert 
to vector that was used for the ligation reaction (2.5:1) was calculated on the 
assumption that the prepared P. falciparum DNA was approximately 1.5 kb in 
length (Novagen, 2000b). If most of the fragments were smaller, then the molar 
ratio would have been much higher.  
 
Biopanning against spectrin 
 
The biopanning procedure was initiated with a background binding step to 
eliminate bacteriophage binding to streptavidin. None of the spectrin-binding 
peptides contained the streptavidin binding motif HPQ or any of the weaker 
binding motifs HPN, HPM, and HPL (Devlin et al., 1990), indicating that the 
background binding step was sufficient to prevent any non-specific interactions. 
 
Biopanning with the first P. falciparum phage display library was performed with 
a MOI of 1 which should be sufficient to isolate high affinity bacteriophage 
(Novagen, 2000b). When the second P. falciparum phage display library was used 
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for biopanning, the MOI was raised to 2, to ensure that all the primary 
recombinants had a chance to bind to spectrin. Some bacteriophage replicate at a 
slower rate than others, because the DNA insert present in the bacteriophage 
interferes with replication (Wang and Yu, 2004) and therefore the other 
bacteriophage would outgrow the slower growing phage during each round of 
biopanning. Increasing the multiplicity of infection during biopanning ensures that 
the slow growing bacteriophage can also bind to spectrin. 
 
The number of phage recovered from the first and second round of biopanning 
should be in the range of 103–105 pfu, increasing to >106 pfu in the third and 
fourth rounds. When no further increase in phage number is observed, enrichment 
is unlikely to occur with additional rounds of biopanning (Novagen, 2000b). 
However, bacteriophage enrichment was only observed during the first two 
rounds of biopanning. This could be due to the small library size (small number of 
primary recombinants) of the P. falciparum phage display library, which enables 
most of the different spectrin binding bacteriophage to bind within the first two 
rounds of biopanning. 
 
Bacteriophage displaying small peptides were isolated more frequently during 
fourth round biopanning than those displaying larger peptides. The peptide-
binding regions on spectrin could have been more accessible to smaller peptides 
than to the larger ones. Identical small peptides were also isolated several times 
indicating that enrichment did occur during biopanning. 
 
2.4.2 Spectrin-binding bacteriophage 
Characteristics of the P. falciparum DNA inserts 
 
All the sequenced DNA inserts were identified in the PlasmoDB database. Two of 
the sequences did not match any of the annotated genes, one of which was located 
in the intron of PF11_0370 and the other between two genes on chromosome 13. 
Another sequence was identified as part of the 5.8s rRNA. This was surprising 
because P. falciparum mRNA was used to create the library and this should have 
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excluded introns, intergenic regions and rRNA. An explanation for isolating 
introns and intergenic regions is that the DNA fragments could be part of P. 
falciparum genes that have either not been correctly annotated, or belong to a 
gene that still has to be annotated in the PlasmoDB database. The other 
explanation for the presence of these three isolated sequences is that genomic 
DNA could have contaminated the total RNA isolated from the parasites, but this 
is highly unlikely since genomic DNA is double stranded and only single stranded 
DNA can bind to the beads. The most likely scenario is that rRNA and pre-mRNA 
containing introns were isolated from the total RNA with the Dynabeads® Oligo 
(dT)25 beads due to the AT-richness of the genome. 
 
The insert that was identified as part of PFF0125c was found in the -2 frame. The 
linkers that were used to insert the P. falciparum DNA into the T7 vector only 
allow the inserts to be cloned in the +1, +2 or +3 frame, thus indicating that the 
insert is part of a gene that is transcribed from the complementary strand of 
PFF0125c. PlasmoDB lists another gene (PFF0120w) on the complementary 
strand approximately 1000 nucleotides downstream from PFF0125c, so it is very 
unlikely that the insert is part of that gene. Therefore this P. falciparum insert 
could again be part of a gene that still has to be annotated in the PlasmoDB 
database.  
 
Characteristics of the bacteriophage-displayed peptides and the P. 
falciparum proteins that interact with spectrin 
 
The P. falciparum peptides that bound to spectrin showed no single common 
motif or profile when compared to each other. The peptides were composed of a 
variety of positively and negatively charged and polar uncharged amino acids, the 
most prevalent being lysine, aspartate and asparagine. The codons for these amino 
acids are AAA (lysine), GAU (aspartate) and AAU (asparagine) and are often 
found in P. falciparum proteins due to the A+T richness of the P. falciparum 
genome (Gardner et al., 2002). Asparagine and lysine are also very common in 
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the hydrophilic low complexity regions of P. falciparum proteins (Pizzi and 
Frontali, 2001) and will be discussed further in the following chapter.  
 
Three peptides contained only polar uncharged amino acids, while the rest of the 
peptides contained a variety of polar uncharged and charged amino acids. The 
polar uncharged amino acids presumably bound to the spectrin surface via 
hydrogen bonds and the charged amino acids bound to spectrin via hydrogen 
bonds and electrostatic interactions, since the outer amino acids of each triple 
helical bundle of spectrin are mainly positively and negatively charged (Figure 5). 
The biopanning procedure yielded five DNA inserts out of twelve that expressed 
the peptides in the +1 frame. This correlates well with the fact that only one in 
every three inserts will be in the +1 frame when an expression library is created 
with directional linkers (compared to one in six in-frame inserts when the library 
is created without directional linkers). Even though the other peptides were not in 
the correct frame, they could be peptide mimics. The study of these mimics could 
provide further information on the interactions between P. falciparum proteins 
and spectrin. 
 
The five in-frame peptides isolated after fourth round biopanning are part of P. 
falciparum proteins identified in the PlasmoDB database. Three of the proteins 
have been described as hypothetical and the other two as a putative Ebl-1 like 
protein and a putative aminopeptidase. Approximately 60.9 % of the P. 
falciparum genome contains genes that have no assigned function or homology to 
genes of other organisms (Gardner et al., 2002), which matches with three of the 
five spectrin-binding proteins being described as hypothetical proteins. 
 
2.4.3 Identifying protein-protein interactions with phage display 
 
The P. falciparum phage display library and the techniques employed here were 
successfully used to isolate peptides that interact with spectrin. The library 
creation was time-consuming and expensive, but once it was established, the 
biopanning procedure was rapid and cost effective.  
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A disadvantage of phage-display is that more than one library needs to be created 
to ensure a full representation of mRNA transcripts. This was however not a 
critical issue in this study because the aim was not to isolate all the P. falciparum 
spectrin-binding peptides. The chance of isolating more peptides was however 
increased by combining two P. falciparum phage display libraries for the 
biopanning procedure. 
 
An advantage specific to the T7Select® Phage Display System is the use of 
directional linkers during the cloning procedure. Directional linkers ensure that 
cDNA can only be inserted into the vector in one of three frames in contrast to all 
six frames when directional linkers are omitted from the cloning procedure. This 
decreases the risk of isolating false positives in a NPL, because at least one third 
of the isolated sequences should be expressed as in-frame peptides. 
 
Another major advantage of the phage display system is that once the libraries 
have been created, they can be used to identify peptides that interact with any 
immobilised ligand, thus making phage display a very powerful tool in the 
elucidation of parasite-host protein-protein interactions. 
 
In conclusion, five genes, namely PFI1570c, MAL8P1.151, MAL8P1.104, 
PFE0980c and PFA0125c, that code for P. falciparum proteins that interact with 
erythrocyte spectrin, were chosen for cloning and recombinant protein expression 
to further analyse and characterise these parasite proteins. 
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Chapter 3: Recombinant spectrin-binding P. 
falciparum proteins 
3.1 Introduction 
3.1.1 Expression of P. falciparum recombinant proteins 
 
The successful production of biologically active recombinant proteins depends on 
the expression micro-environment and the compatibility of the native gene 
sequence with the expression host. Over the years, E. coli has been the preferred 
expression host, because the bacterium is easy to manipulate genetically and very 
cost-effective to maintain in culture. Successful expression of proteins within E. 
coli is influenced by the structural features of the inserted gene, the transcription 
efficiency and stability of the transcribed mRNA, the correct and efficient 
translation, correct protein folding (i.e. solubility), toxicity of the protein and the 
degradation of the protein by proteases (Schumann and Ferreira, 2004). 
 
Recently, two large scale P. falciparum recombinant protein production studies 
attempted to define some of the factors that affect the expression and solubility of 
recombinant parasite proteins. In the first study Mehlin et al. (2006) attempted to 
express recombinant proteins that spanned several P. falciparum protein classes. 
Out of the 1000 genes, 337 recombinant proteins were expressed and only 63 of 
these were soluble. In the second study Vedadi et al. (2007) selected a set of 468 
P. falciparum genes, which coded for putative haemoglobin metabolism, 
biosynthesis, hypothetical, exported and apicoplast-targeted proteins. The group 
increased their sample size to 1008 genes, by selecting orthologues from six other 
Apicomplexan species, namely P. yoelii yoelii, P. vivax, P. berghei, P. knowlesi, 
Cryptosporidium parvum and Toxoplasma gondii. Only 304 proteins were 
expressed in soluble form and only 36 of these were successfully crystallised. The 
results from both studies highlight the difficulties and the low success rates that 
are often encountered when cloning and expressing P. falciparum recombinant 
proteins. They also indicate that a trial and error based approach, utilising several 
strategies, is generally necessary to express soluble parasite proteins (Figure 32). 
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These strategies reduce the problems associated with the physical characteristics 
of the recombinant protein, the gene and mRNA that code for the protein and the 
micro-environment of the expression host.   
 
 
Figure 32: Strategies to obtain soluble recombinant P. falciparum proteins 
from E. coli. 
Diagram showing the downstream applications that can be employed to obtain 
soluble recombinant proteins. Two strategies can be followed once a protein is 
produced in inclusion bodies. The first is to denature and subsequently refold the 
protein. The other strategy includes the modification of culture conditions and/or 
the protein, to aid the bacterial cell to produce soluble protein (Sorensen and 
Mortensen, 2005b). 
 
Protein modifications 
 
P. falciparum proteins are generally larger than their respective homologues in 
other species and often possess long, disordered loops within their structures 
(reviewed in Aravind et al., 2003). These features, as well as the presence of long 
repetitive amino acid stretches within the protein sequence (Singh et al., 2004), 
contribute to the insolubility of P. falciparum proteins when they are expressed in 
heterologous systems. The removal of these structures as well as the omission of 
transmembrane regions, signal peptides, transit peptides and export motifs from 
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the protein of interest should enhance the successful expression of soluble 
recombinant P. falciparum proteins (Vedadi et al., 2007). Mehlin et al. (2006) 
also found that protein size and pI were good predictors for P. falciparum protein 
expression and solubility. Larger proteins were more difficult to express, a high pI 
caused insolubility and a low pI decreased expression but increased solubility. In 
addition, proteins with a relatively high homology to E. coli proteins were more 
likely to express in soluble form. Vedadi et al. (2007) however found that protein 
size and pI could not be used to predict the successful expression of soluble 
Apicomplexan proteins. 
 
The solubility of some proteins can be enhanced by modifying the recombinant 
protein by tag-technology or by site-directed mutagenesis of protease-specific 
sites or other regions that destabilise the protein structure. Tag-technology 
attaches a reporter protein, for example the green fluorescent protein (Pedelacq et 
al., 2006), or a solubility tag, such as the maltose binding protein (MBP) (Kapust 
and Waugh, 1999), the N-utilising substance A (NusA) (Zheng et al., 2003), or 
glutathione-S-transferase (GST), to the recombinant protein. These tags may be 
used to purify the soluble fusion protein and it is assumed that a correctly folded 
tag suggests a correctly folded recombinant protein.  
 
DNA and mRNA modifications 
 
Fifty-four percent of P. falciparum genes contain introns (Gardner et al., 2002), 
requiring the use of cDNA for cloning the full length gene. Due to the 80.6 % AT-
richness of the genome (Gardner et al., 2002), parasite genes are characterised by 
long, continuous stretches of adenosines and thymidines, making error-free PCR 
amplification of the genes problematic. The use of a high fidelity DNA 
polymerase mix, which contains Tgo and Taq DNA polymerase can decrease the 
introduction of errors during amplification, because the Tgo DNA polymerase has 
a 3’-5’ exonuclease proofreading activity that increases the fidelity of DNA 
synthesis ~3-fold (Roche Applied Science, 2004) when compared to the fidelity of 
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Taq DNA polymerase, which has a total error rate of 1 x 10-4 to 2 x 10-5 errors per 
base pair (Tindall and Kunkel, 1988). 
 
The AT-richness of the P. falciparum genome also interferes with protein 
expression in E. coli in other ways. For example, AT-richness results in a different 
codon usage in the parasite when compared to the expression host (Appendix A3). 
Certain E. coli tRNAs, that correspond to amino acids that are abundant in P. 
falciparum proteins, may therefore only be available in limited amounts. This can 
cause ribosomal stalling, which leads to translational errors such as amino acid 
substitutions, frameshifts, and premature translation termination (Sorensen and 
Mortensen, 2005a). A high content of AT-repeats within the mRNA template can 
also cause the ribosomal unit to stall (Flick et al., 2004). E. coli sporadically 
substitutes amino acids located in the low-complexity regions of the P. falciparum 
sequence, resulting in expressed proteins which appear homogenous by SDS-
PAGE, but some molecules have the incorrect amino acid sequence (Schneider et 
al., 2005). However, both P. falciparum protein expression studies mentioned 
previously (Mehlin et al., 2006, Vedadi et al., 2007) stated that codon usage and 
AT-content had minimal effect on protein expression. 
 
Other factors may also complicate protein production. There is evidence that P. 
falciparum proteins bind their own mRNA (Zhang and Rathod, 2002), thereby 
inhibiting protein expression. Parasite genes also often contain cryptic E. coli start 
sites (Turgut-Balik et al., 2001) that cause the expression of truncated proteins. 
 
Several strategies can be used to overcome codon bias and ribosomal stalling. One 
strategy, termed codon optimisation, uses gene synthesis to create a P. falciparum 
sequence with codons reflecting the tRNA pool of the host E. coli system. This 
approach should theoretically increase expression levels and alleviate the 
occurrence of translational errors (Calderone et al., 1996). It can however also 
influence the stability of the mRNA, thereby reducing transcription levels (Wu et 
al., 2004). Mehlin et al. (2006) successfully used codon optimisation to express 
12 P. falciparum proteins that did not express in E. coli from their native genes, 
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but all the proteins were insoluble. In contrast, codon harmonisation relies on the 
modification of the P. falciparum sequence by site-directed mutagenesis to match 
the codon usage of E. coli, but instead of replacing all the codons, only codons 
that interfere with protein translation (i.e. where the ribosomal unit stalls) and 
folding are replaced (Hillier et al., 2005). Substitution of only a few codons may 
enable translation in E. coli to occur in the same manner as translation in the 
parasite. Codon optimisation and harmonisation can be very time-consuming and 
expensive and therefore the use of other strategies is often preferred. For example, 
an E. coli host that has been co-transformed with a plasmid that contains the genes 
encoding the rare E. coli tRNAs can be used (Calderone et al., 1996). 
 
Manipulation of the expression host 
 
Expressed proteins will only be soluble when the correct structure is formed 
during the post-translational folding process. Newly synthesised polypeptides 
remain in an intermediate folded form within the bacterial cytoplasm until 
chaperones fold the proteins into their functional forms (reviewed in Mogk et al., 
2002). Incorrectly folded proteins accumulate as aggregates within the cell and 
tend to be toxic. To cope with this toxicity, E. coli stores the aggregates as 
confined structures termed inclusion bodies (reviewed in Mogk et al., 2002). In 
general, eukaryotic proteins are more prone to inclusion body formation within E. 
coli, because the bacterium does not possess the appropriate redox environment to 
introduce the correct disulphide bonds and post-translational modifications into 
the recombinant proteins (Weickert et al., 1996). 
  
Protein solubility within the E. coli host can be enhanced by co-expressing the 
protein with a plasmid encoding additional E. coli chaperones, some of which 
drive folding attempts and others that prevent protein aggregation (reviewed in 
Mogk et al., 2002). Inclusion body formation can also be inhibited or minimised 
by controlling the temperature and the expression rate of the host cell. Growing E. 
coli at 37 ºC has been shown to increase the formation of inclusion bodies, 
because the hydrophobic interactions causing protein aggregation are favoured at 
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these temperatures (Kiefhaber et al., 1991). Lowering the temperature on the other 
hand, favours the slower and correct folding of the protein, resulting in the 
formation of fewer inclusion bodies. The expression rate of the host cell can be 
controlled with promoters that tightly regulate transcription and prevent ‘leaky’ 
expression of the protein (Weickert et al., 1996). Gradually increasing the level of 
inducer, using a natural inducing agent, inducing the cultures at post-log phase 
(Flick et al., 2004), or slowly increasing the plasmid copy number during 
culturing (Trepod and Mott, 2002) can also be employed to control expression rate. 
These methods decrease the induction level, which in turn reduces the protein 
concentration within the cell, which favours correct protein folding to produce 
higher amounts of soluble protein (Weickert et al., 1996). 
 
However, if soluble recombinant protein expression in E. coli is not successful, 
another host, for example the yeast Pichia pistoria (Yokoyama, 2003), can be 
used. Expression from a baculovirus vector in insect or mammalian cells (Kost et 
al., 2005) provides another alternative. Mehlin et al. (2006), for example, used 17 
P. falciparum proteins, which expressed as insoluble proteins in E. coli and 
expressed them in the baculovirus-insect cell system. All these proteins were 
expressed as soluble recombinant proteins, but only one showed a high yield. 
Cell-free protein synthesis, based on the coupled transcription-translation system 
of E. coli or wheat embryos (Yokoyama, 2003), could also be used in an attempt 
to express soluble recombinant P. falciparum proteins. 
 
3.1.2 Chemical processing of inclusion bodies 
 
If none of the above mentioned strategies yield soluble recombinant P. falciparum 
proteins, the inclusion bodies can be processed directly to obtain soluble proteins. 
This method involves solubilising inclusion bodies with urea or guanidinium 
hydrochloride and subsequently refolding the denatured protein in vitro by 
dilution, dialysis or on-column refolding methods (reviewed in Mogk et al., 2002). 
Protein refolding is however time consuming and there is no guarantee that the 
protein has been refolded into its native state. In addition, protein refolding is not 
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always conducive to high product yields, and in the case of refolded enzymes the 
activity may also be lost. 
 
3.2 Methods 
3.2.1 The spectrin-binding P. falciparum proteins 
 
Table 9 lists the nucleotide regions of MAL8P1.104, MAL8P1.151, PFA0125c 
and PFE0980c that were used for cloning. The spectrin binding region lies in the 
middle of these ~1.5 kb fragments and because these genes are large, only one 
segment of each gene (excluding introns) was cloned. In contrast, most of the 
PFI1570c gene (lacks 2 & 8 amino acids at the N- & C-terminus respectively) was 
used for the cloning procedure, because it is fairly small and consists of one exon. 
 
Table 9: DNA fragments used for cloning. 
PlasmoDB gene name Size of gene (bp) 
Introns 
present in 
gene 
Spectrin 
binding 
region 
Cloning region 
PFI1570c 1713 no 646-771 7-1689 
MAL8P1.151 4092 yes 2751-2811 2578-4056 
PFA0125c 4704 yes 2914-3060 2182-3750 
MAL8P1.104 5325 no 3151-3561 2449-4155 
PFE0980c 7467 yes 1261-1521 1156-2670 
 
3.2.2 Cloning 
Isolation of P. falciparum genomic DNA 
 
DNA was isolated from P. falciparum FCR-3 cultures by a method adapted from 
Hang et al. (1995), which entails lysing the erythrocytes and subsequently 
rupturing the parasites by boiling. Two hundred microlitres whole parasite 
suspension (Section 2.2.3; removed after the parasites were resuspended in fresh 
medium) were combined with 400 µl lysis buffer (0.2 % NaCl (w/v), 1 % Triton® 
X-100 (v/v) (BDH Laboratory Supplies, Poole, UK), 1 mM EDTA) and vortexed 
to ensure complete lysis of the erythrocytes. The sample was centrifuged at 
13,000 g for 10 minutes at 4 ºC in an Eppendorf 5415 R Centrifuge (Eppendorf 
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AG, Hamburg, Germany). The supernatant was removed and the pellet washed 
twice by resuspension in 100 µl wash buffer (10 mM Tris-HCl, 50 mM KCl, pH 
8.3), brief vortexing and centrifugation at 16,000 g for 5 minutes at 4 ºC. One 
hundred microlitres of PCR buffer (10 mM Tris-HCl, 50 mM KCl, 1.5 mM MgCl2, 
pH 8.3) was added to the pellet and the sample boiled for 10 minutes. The 
concentration of the DNA was determined by spectrophotometric analysis at 260 
nm (as described in Ausubel et al., 1994). 
 
Amplification of P. falciparum gene fragments 
 
P. falciparum gene segments were amplified using primers containing appropriate 
restriction enzyme sites to facilitate cloning of the genes into the pET-15b 
(Novagen, Inc., Madison, USA) or pGEX-4T-2 (Amersham Biosciences, Ltd., 
Buckinghamshire, UK) expression vectors (vector maps in Appendix A2). The 
primers (Figure 33) contained 19-24 nucleotides matching the P. falciparum gene, 
6 nucleotides at the 5’ end matching the BamHI, NdeI or XhoI restriction sites, 
followed by 5-6 nucleotides 5’ to the BamHI and XhoI or ~11 nucleotides 5’ to the 
NdeI restriction site to ensure complete digestion by the restriction enzymes. All 
the downstream primers, except PFS16, contained an additional stop codon at the 
end of the P. falciparum sequence. PFI1570c was amplified with primers for both 
vectors, while MAL8P1.104 and PFA0125c were amplified with primers for pET-
15b, and MAL8P1.151 and PFE0980c were amplified with primers for pGEX-4-
T2. The four latter sequences could not be inserted into both vectors because they 
contained either XhoI or NdeI restriction sites within their gene sequence. 
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Figure 33: P. falciparum primers. 
Diagram showing the primers used to amplify the P. falciparum genes. The 
restriction sites and stop codon sites are marked. NdeI and BamHI sites were used 
to clone the DNA into pET-15b (primers PFS17/PFS20, PFS21/PFS22, 
PFS27/PFS28) and BamHI and XhoI were used to clone the DNA into pGEX-4T-
2 (primers PFS15/PFS16, PFS23/PFS24, PFS25/PFS26). 
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Approximately 500 ng P. falciparum DNA was amplified with 300 nM of each 
primer (Inqaba Biotechnical Industries, Pretoria, South Africa) in the presence 1 x 
High Fidelity PCR Master (Roche Diagnostics Gmbh, Mannheim, Germany) 
under the conditions listed in Table 10 and Table 11 using the Eppendorf 
Mastercycler® Gradient machine (reaction volume = 50 µl). The amplification 
reaction was divided into two segments to allow initial annealing of the primer to 
the P. falciparum specific region in the first five cycles, followed by 30 cycles 
with a higher annealing temperature, which was determined from the lower Tm 
(given by the oligonucleotide manufacturer) of each primer pair. The extension 
step was performed at 68 ºC instead of 72 ºC to slow down the activity of the Taq 
DNA polymerase so that it can cope with the AT-richness of the P. falciparum 
gene sequences. Three microlitres of the amplicons were visualised against a 1 kb 
DNA Ladder (Promega Corporation, Madison, USA) on a 1 % agarose gel in 
TEA buffer. The remaining sample was subjected to phenol-chloroform extraction 
and ethanol precipitation (as described in Ausubel et al., 1994) and resuspended in 
45 µl nuclease-free water. 
 
Table 10: Annealing temperatures for P. falciparum gene specific primer sets. 
P. falciparum 
gene Primer set 
1st Annealing 
temperature 
2nd Annealing 
temperature Vector 
PFI1570c PFS15/PFS16 57 ºC 68 ºC pGEX-4T-2 
PFI1570c PFS17/PFS20 57 ºC 68 ºC pET-15b 
MAL8P1.104 PFS21/PFS22 46 ºC 65 ºC pET-15b 
MAL8P1.151 PFS23/PFS24 58 ºC 65 ºC pGEX-4T-2 
PFE0980c PFS25/PFS26 54 ºC 65 ºC pGEX-4T-2 
PFA0125c PFS27/PFS28 47 ºC 65 ºC pET-15b 
 
Table 11: Cycling parameters for P. falciparum genomic DNA amplification. 
Segment Cycles Temperature Time 
1 1 94 ºC 2 min 
2 1-5 94 ºC 45 sec 
  1st annealing temp 1 min 
  68 ºC 2 min 
3 1-30 94 ºC 45 sec 
  2nd annealing temp 1 min 
  68 ºC 2 min 
4 1 68 ºC 7 min 
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Restriction enzyme digestion of the PCR products 
 
The 45 µl DNA samples were digested overnight at 37 ºC in the presence of 20 
units NdeI (Promega Corporation, Madison, USA) (for ligation into pET-15b) or 
XhoI (Promega Corporation, Madison, USA) (for ligation into pGEX-4T-2) with 1 
x Buffer D (Promega Corporation, Madison, USA) and 10 µg acetylated Bovine 
Serum Albumin (Promega Corporation, Madison, USA). The sample was 
subjected to phenol-chloroform extraction followed by ethanol precipitation and 
resuspension in 45 µl nuclease-free water. The sample was digested at 37 ºC for 4 
hours with 20 units BamHI (Promega Corporation, Madison, USA) in the 
presence of 1 x Buffer E (Promega Corporation, Madison, USA) and 10 µg 
acetylated bovine serum albumin (BSA). Phenol-chloroform extraction and 
ethanol precipitation were repeated and the DNA resuspended in 5 µl nuclease-
free water. 
 
Isolation and restriction enzyme digestion of the plasmid vector 
 
Plasmids were isolated from E. coli by alkaline lysis (as described in Ausubel et 
al., 1994). E. coli containing the pET-15b vector or pGEX-4T-2 vector were 
grown in 10 ml LB medium, containing 50 µg/ml ampicillin, overnight at 37 ºC in 
a Labotec® Orbital Shaker (225 rpm). Two millilitre aliquots of the cells were 
centrifuged at 16,000 g for 2 minutes at room temperature in an Eppendorf 5415 R 
Centrifuge. The pellets were resuspended in 100 µl cold 50 mM glucose, 10 mM 
Na2EDTA, 25 mM Tris-HCl, pH 8 and incubated at room temperature for 5 
minutes. The EDTA chelates divalent metal ions, primarily magnesium and 
calcium. Removal of these cations destabilises the cell membrane and also inhibits 
DNases. Glucose maintains the osmolarity and prevents the buffer from bursting 
the cells. Two hundred microlitres 0.2 M NaOH, 1 % SDS (w/v) (prepared on the 
day of use) was added to the suspension and mixed by carefully tapping the tube. 
The SDS detergent ruptures the E. coli plasma membrane, while the NaOH 
loosens the cell walls and denatures the bacterial and plasmid DNA. The bacterial 
DNA becomes linearised and the circular plasmid DNA remains topologically 
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constrained. One hundred and fifty microlitres 3.3 M acetic acid, 1.6 M potassium 
acetate (prepared on the day of use) was added, the sample vortexed and placed on 
ice for 15 minutes, followed by centrifugation at 16,000 g for 5 minutes at 4 ºC. 
Potassium acetate renatures the circular plasmid DNA, while the linear single 
stranded bacterial DNA precipitates in the high salt environment. SDS forms a 
precipitate with the potassium acetate, allowing it to be removed from the plasmid 
DNA. After phenol-chloroform extraction and ethanol precipitation (no addition 
of sodium acetate), the pellet was resuspended in 100 µl Tris EDTA buffer (TE 
buffer; 1 mM Na2EDTA, 10 mM Tris-HCl, pH 7.5) containing 5 µg DNase-free 
Ribonuclease A (Fermentas International Inc., Burlington, Canada) and incubated 
at 37 ºC for half an hour before addition of 40 µl 3.3 M acetic acid, 1.6 M 
potassium acetate. Ribonuclease A digests any remaining RNA in the plasmid 
DNA sample. The sample was subjected to phenol-chloroform extraction and 
ethanol precipitation after which the DNA pellets were pooled and resuspended in 
175 µl nuclease-free water. The pET-15b vector was digested with NdeI and 
BamHI and the pGEX-4T-2 vector was digested with XhoI and BamHI. A 1 hour 
incubation at 37 ºC in the presence of 5 units calf intestinal alkaline phosphatase 
(Roche Diagnostics Gmbh, Mannheim, Germany) was performed before the final 
phenol-chloroform extraction step to prevent religation of the vector. Both vectors 
were stored in a final volume of 200 µl nuclease-free water. 
 
Ligation of the PCR fragments into the expression vector 
 
The amplified DNA was inserted into the vector with the Rapid Ligation Kit 
(Roche Diagnostics Gmbh, Mannheim, Germany). One microlitre DNA and 0.5 µl 
vector were visualised against 10 µl MassRuler™ DNA Ladder, Mix (Fermentas 
International Inc., Burlington, Canada) on a 1 % agarose gel in TEA buffer to 
determine the concentration of both samples. A 1:4 molar ratio of vector to insert 
was diluted in 1 x DNA Dilution Buffer (Roche Diagnostics Gmbh, Mannheim, 
Germany) (volume = 10 µl; total amount of DNA ≤200 ng). Five units T4 DNA 
Ligase and 1 x DNA Ligation Buffer were added to the DNA and the mixture 
incubated at 16 ºC for 30 minutes in the Eppendorf Mastercycler® Gradient 
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machine (reaction volume = 21µl). A second ligation reaction without amplified 
DNA was set up as a control reaction. 
 
Transformation of DH5α™ E. coli or BL21-Codon Plus® (DE3)-
RIL E. coli cells 
 
DH5α™ E. coli cells (Invitrogen Ltd, Renfrewshire, UK) and BL21-Codon Plus® 
(DE3)-RIL E. coli cells (Stratagene, La Jolla, USA) were made competent with 
PIPES buffer. Ten millilitres LB medium (containing 50 µg/ml chloramphenicol 
(Sigma-Aldrich Corporation, St. Louis, USA) for the BL-21 cells)  was inoculated 
with either DH5α™ or BL21-Codon Plus® (DE3)-RIL E. coli cells and grown 
overnight at 37 ºC in a Labotec® Orbital Shaker (225 rpm). The 10 ml culture was 
used to inoculate 100 ml LB medium (containing 50 µg/ml chloramphenicol for 
the BL-21 cells) and grown for another further 90 minutes at 37 ºC with shaking. 
The cells were centrifuged at 4,000 g for 15 minutes at 4 ºC using the Beckman® 
J2-21 centrifuge and the spent medium removed. The pellet was resuspended in 
10 ml cold sterile PIPES buffer (10 mM 1,4-piperazinediethanesulphonic acid 
(Sigma-Aldrich Corporation, St. Louis, USA), 100 mM CaCl2,  15 % glycerol 
(v/v), pH 7) and incubated on ice for 20 minutes. The cells were centrifuged at 
4,000 g for 10 minutes at 4 ºC and the supernatant discarded. The pellet was 
resuspended in 2 ml PIPES buffer and the cells stored at -70 ºC as 100 µl aliquots. 
Competent DH5α™ E. coli cells were transformed with the ligation reaction. 
Plasmids with the correct DNA inserts were subsequently used to transform 
competent BL21-Codon Plus® (DE3)-RIL E. coli cells for the expression studies. 
This BL21 (DE3) strain was chosen because it contains the ColE1-compatible, 
pACYC-based plasmid with extra copies of the argU, ileY, and leuW tRNA genes 
(Stratagene, 2005).   
 
Five microlitres ligation reaction or 3 µl purified plasmid was added to 25 µl 
competent E. coli cells and mixed gently by tapping the tube. The sample was 
incubated on ice for 30 minutes and subsequently placed in a 42 ºC waterbath for 
1½ minutes, followed by a 5 minute incubation on ice. The cell suspension was 
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spread on agar plates containing either 50 µg/ml ampicillin for the DH5α™ E. coli 
cells, or 50 µg/ml ampicillin and 50 µg/ml chloramphenicol for the BL21-Codon 
Plus® (DE3)-RIL E. coli cells. The plates were inverted and incubated overnight 
at 37 ºC in a Heraeus incubator (Heraeus Instruments, Hanau, Germany). 
 
Restriction enzyme analysis of the plasmid constructs 
 
DH5α E. coli colonies containing plasmids were placed into 14 ml Falcon® tubes 
(Becton Dickinson Labware, Franklin Lakes, USA) containing 2 ml LB medium, 
supplemented with 50 µg/ml ampicillin, and grown at 37 ºC overnight in a 
Labotec® Orbital Shaker (225 rpm). The plasmids were extracted from the DH5α 
E. coli cells with the FastPlasmid™ Mini Kit (Eppendorf AG, Hamburg, 
Germany). This kit is based on the alkaline lysis method and isolates ~20 µg high-
copy plasmid DNA from a 1.5 ml E. coli culture. A single solution lyses bacterial 
cells, denatures and solubilises cellular components, degrades RNA, and traps 
DNA on a matrix. The resuspended cell mixture is transferred to a mini spin 
column that binds the plasmid DNA, which is subsequently washed with an 
alcohol-based solution to remove any remaining impurities. The plasmid DNA is 
eluted from the column with 50 µl low-salt elution buffer. Ten microlitres of the 
pET-15b-P. falciparum gene construct was digested with 10 units StyI (Fermentas 
International Inc., Burlington, Canada) and 10 units EcoRI (Fermentas 
International Inc., Burlington, Canada) in 2 x Tango™ Buffer (Fermentas 
International Inc., Burlington, Canada) for 1 hour at 37 ºC. Double digestion of 10 
µl pGEX-4T-2-P. falciparum was performed with 10 units EcoRV (Fermentas 
International Inc., Burlington, Canada) and 10 units EcoRI with the identical 
buffer and incubation conditions. Ten microlitres of the reactions were 
electrophoresed against the Promega 1 kb DNA Ladder and the Promega 100 bp 
Ladder on a 1 % agarose gel in TEA buffer. Constructs showing the correct 
digestion pattern were sequenced by Inqaba Biotechnical Industries (Pretoria, 
South Africa) and used for transformation of BL21-Codon Plus® (DE3)-RIL cells. 
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3.2.3 Protein expression 
 
Expression in pET-15b and pGEX-4T-2 is controlled by different promoters, 
namely the tac promoter in pGEX-4T-2 and the T7 promoter in pET-15b. 
Expression of the P. falciparum proteins from the pET-15b plasmid can therefore 
only occur in E. coli cells that have the T7 RNA polymerase gene inserted into 
their genome. BL21-Codon Plus® (DE3)-RIL E. coli cells containing the P. 
falciparum constructs were grown in 10 ml LB medium containing 200 µg/ml 
ampicillin and 200 µg/ml chloramphenicol overnight at 37 ºC using a Labotec® 
Orbital Shaker prior to induction with isopropylthiogalactoside (IPTG, a 
nonmetabolisable inducing agent; Promega Corporation, Madison, USA) or 
Overnight Express™ Instant TB Medium (Novagen, Inc., Madison, USA). 
Overnight Express™ medium is a modified terrific broth that allows the bacteria 
to autoinduce in the presence of lactose (secondary energy source) once the 
glucose (primary energy source) from the medium has been depleted by the 
bacteria. Induction with IPTG was performed by inoculating 48 ml LB broth with 
2 ml of the P. falciparum construct-containing culture and growing the cells for 4 
hours at 37 ºC with shaking. The culture was induced with 1 mM IPTG and grown 
for 15 hours at 37 ºC with shaking. Induction with Overnight Express™ Instant 
TB Medium was performed by inoculating 240 ml Overnight Express™ Instant 
TB Medium with the 10 ml P. falciparum construct-containing culture and 
growing the cells at room temperature for 24 hours using a Red Rotor PR70-230V 
shaker (Hoefer Scientific Instruments, San Francisco, USA). Whole cell extracts 
were analysed by separating the proteins on a 10 % Laemmli SDS-polyacrylamide 
gel, followed by western transfer with Towbin buffer  (25 mM Tris, 192 mM 
glycine, 20 % methanol (v/v), pH 8.3) (Towbin et al., 1979) onto Hybond™-C 
Extra Nitrocellulose membrane (Amersham Biosciences, Ltd., Buckinghamshire, 
UK). The fusion-tags were detected with 1:1,500 Penta•His HRP Conjugate 
antibody (Qiagen GmbH, Hilden, Germany) dilution or 1:120,000 Anti-GST HRP 
Conjugate antibody (Amersham Biosciences, Ltd., Buckinghamshire, UK) 
dilution and chemiluminescence with the SuperSignal® West Pico 
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Chemiluminescent Substrate (Pierce Biotechnology Incorporated, Rockford, 
USA). 
 
3.2.4 Recombinant P. falciparum aminopeptidase purification 
 
An E. coli culture expressing the P. falciparum aminopeptidase (PFI1570c) was 
lysed by sonication or chemical lysis with BugBuster™ HT (Novagen, Inc., 
Madison, USA) and the histidine-tagged protein isolated from the bacterial 
proteins by affinity selection with nickel coated HIS-Select™ Magnetic Agarose 
Beads (Sigma-Aldrich Corporation, St. Louis, USA). 
 
A 250 ml BL21-Codon Plus® (DE3)-RIL E. coli culture grown in Overnight 
Express™ Instant TB Medium was centrifuged at 10,000 g for 10 minutes at 4 ºC 
using a Beckman® J2-21 centrifuge. The cell pellet was frozen at -70 ºC for 5 
minutes and resuspended in 2 ml His-lysis/binding buffer (50 mM sodium 
phosphate buffer, pH 8, 150 mM NaCl) containing 1 µl Protein Inhibitor Cocktail 
Set III (100 mM 4-(2-Aminoethyl) benzenesulphonyl fluoride hydrochloride, 80 
µM Aprotinin, 5 mM Bestatin; 1.5 mM E-64; 2 mM Leupeptin, 1 mM Pepstatin 
A; Calbiochem®, San Diego, USA). The suspension was sonicated 6 times on ice 
water with a Bandelin Sonoplus UW 2070 sonicator (Bandelin Electronics, Berlin, 
Germany) set to 15 seconds with 6 x 10 % cycles at 75 % power. The suspension 
was allowed to cool for 45 seconds between each sonication. The suspension was 
centrifuged at 16,000 g for 10 minutes at 4 ºC, using an Eppendorf 5415 R 
Centrifuge and the supernatant containing the soluble protein collected. Imidazole 
(Sigma-Aldrich Corporation, St. Louis, USA) was added to the soluble fraction to 
a final concentration of 1 mM and the solution added to 30 µl packed HIS-
Select™ Magnetic Agarose Beads and allowed to bind for 1 hour at room 
temperature using the GFL® 3025 rotator (Gesellschaft für Labortechnik m.b.H. & 
Co., Burgwedel, Germany). The beads were placed on a magnetic separator and 
the supernatant removed. The beads were washed 5 times for 1 minute with 300 
µl His-wash buffer (50 mM sodium phosphate buffer, pH 8, 150 mM NaCl, 
20mM imidazole, 1 mM PMSF) and the protein eluted from the beads by 
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incubating them in 150µl His-elution buffer (50 mM sodium phosphate buffer, pH 
8, 150 mM NaCl, 200mM imidazole, 1 mM PMSF) for 15 min with occasional 
shaking by hand. A second elution was performed with 100 µl His-elution buffer. 
The supernatant containing the purified protein was collected and stored at 4 ºC 
until further use. Purification was monitored by separating the protein fractions on 
a 12 % Laemmli SDS-polyacrylamide gel, western transfer with Towbin buffer 
onto Hybond™-C Extra Nitrocellulose membrane and detection of the histidine-
tag with 1:1,500 Penta•His HRP Conjugate antibody dilution and 
chemiluminescence with the SuperSignal® West Pico Chemiluminescent 
Substrate. 
 
3.3 Results 
3.3.1 Cloning and expression of spectrin-binding P. falciparum 
proteins 
 
Segments of the genes coding for the five spectrin-binding peptides were used for 
the cloning and expression procedure. Figure 34 shows the linearised vector DNA 
and the PCR products prepared by double digestion with NdeI/BamHI (pET-15b) 
or XhoI/BamHI (pGEX-4T-2). PFI1570c was cloned into both vectors because the 
gene did not contain XhoI or NdeI digestion sites and there was a one base pair 
difference between the two PFI1570c amplicons because different primers were 
used for amplification. 
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Figure 34: Vectors and P. falciparum amplicons before ligation. 
Agarose gels showing (a) the NdeI/BamHI digestion of the pET-15b constructs 
and (b) the XhoI/BamHI digestion of the pGEX-4T-2 constructs. Lane M in both 
gels contains 10 µl Promega 1 kb Ladder. Gel (a) shows: 0.5 µl pET-15b plasmid 
(a1, 5696 bp); 1 µl of the P. falciparum genes in pET: PFI1570c (a2, 1691 bp), 
MAL8P1.104 (a3, 1715 bp), and PFA0125c (a4, 1577 bp). Gel (b) shows: 0.5 µl 
pGEX-4T-2 plasmid (b1, 4945 bp); 1 µl of the P. falciparum genes in pGEX: 
PFI1570c (b2, 1690 bp), MAL8P1.151 (b3, 1485 bp), and PFE0980c (b4, 1524 
bp). 
 
The presence of the correct inserts in the vector plasmids was confirmed by a 
double digestion of the plasmid constructs. The vector maps and the unique DNA 
patterns after the double digestion can be seen in Figure 35 and Figure 36. All the 
pET-15b clones (Figure 35b) digested with EcoRI and StyI, have three DNA 
bands in common, namely 246 bp (very faint on the gel), 2325 bp, and 2992 bp. 
The different P. falciparum DNA inserts give rise to the additional two DNA 
bands because they all contain an internal EcoRI site. The 145 bp fragment 
generated from pET-15b digestion is too small to be visible. The pGEX-4T-2 
clones (Figure 36b) digested with EcoRI and EcoRV do not have DNA fragments 
in common because the EcoRI restriction site located in the pGEX-4T-2 cloning 
cassette was removed from the vector when the P. falciparum amplicons were 
inserted into the plasmid. 
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 Figure 35: pET-15b vector containing P. falciparum inserts. 
Vector maps (a) and an agarose gel showing (b) the EcoRI/StyI double digestion 
of pET-15b plasmid without and with the P. falciparum inserts. All the constructs 
share the 246, 2325 and 2992 bp fragments from pET-15b. The P. falciparum 
inserts have two DNA fragments that result from an internal EcoRI restriction site. 
Vector maps: red = P. falciparum gene; white = His-tag; green = ampicillin 
resistance gene; blue = lac repressor gene; purple = restriction enzyme sites. 
Agarose gel: lanes M1 and M2 = 10 µl Promega 1 kb and 100 bp Ladder; lanes 1-4 
= 10 µl of the double digests of each construct, namely: 1 = pET-15b; 2 = pET-
15b-PFI1570c (703 & 1123 bp); 3 = pET-15b-MAL8P1.104 (766 & 1084 bp); 4 = 
pET-15b-PFA0125c (796 & 916 bp). 
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Figure 36: pGEX-4T-2 vector containing P. falciparum inserts. 
Vector maps (a) and an agarose gel showing (b) the EcoRI/EcoRV double 
digestion of pGEX-4T-2 plasmid without and with the P. falciparum inserts. 
pGEX-4T-2 EcoRI-4949 is part of the cloning cassette and is therefore not present 
in the P. falciparum constructs. The P. falciparum constructs contain internal 
EcoRI and/or EcoRV sites. Vector maps: red = P. falciparum gene; white = 
glutathione-S-transferase; green = ampicillin resistance gene; blue = lac repressor 
gene; purple = restriction enzyme sites. Agarose gels: lanes M1 and M2 = 10 µl 
Promega 1 kb and 100 bp Ladder; lanes 1-4 = 10 µl of the double digests of each 
construct, namely: 1 = pGEX-4T-2 (1791 & 3179 bp); 2 = pGEX-4T-2-PFI1570c 
(2425 & 3973 bp); 3 = pGEX-4T-2-MAL8P1.151 (3040 & 3590 bp); 4 = pGEX-
4T-2-PFE0980c (816, 2461 & 3192 bp). 
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One colony of each construct was selected for automated sequencing and 
transformation into E. coli BL-21 (DE3) cells. The pGEX-4T-2-PFI1570c clone 
contained no Taq DNA polymerase errors. The pET-15b-PFI1570c clone 
contained one silent error (T1542C), which still coded for lysine (Appendix A4). 
pET-15b-PFA0125c had a 27 nucleotide insertion at base 595, resulting in the 
translation of 9 extra amino acids (QEQEEEKQE). This construct also had an 
A503G substitution that caused the translation of an arginine instead of a 
glutamine. pGEX-4T-2-MAL8P1.151 and pGEX-4T-2-PFE0980c contained a 
deletion in a stretch of adenosines (1205-1219 and 777-788 respectively). The 
deletions caused a frame shift in the sequences, resulting in the introduction of an 
early stop codon. The deletions could however also have been a sequencing 
artefact because the errors occurred in a stretch of adenosines. Sequencing of 
pET-15b-MAL8P1.104 was not successful. 
 
All the proteins were expressed in BL21 (DE3) E. coli cells by induction with 
IPTG. The tagged proteins could not be distinguished from the E. coli proteins 
when stained with Coomassie dye and could only be detected by probing with tag-
specific antibodies (Figure 37), indicating that the proteins were not expressed at 
high levels within E. coli. Only the histidine-tagged PFI1570c was expressed as 
one band at the correct molecular weight of 66.919 kDa (3a). The GST-tagged 
PFI1570c was expressed at the correct molecular weight of 91.463 kDa (b3), but it 
also contained two additional bands similar in size to GST (26 kDa). The 
remaining constructs expressed multiple recombinant proteins (except a5) that 
were smaller than expected (a4-5, b4-5). The Taq DNA polymerase errors should 
have caused PFA0125c (a5), MAL8P1.151 (b4) and PFE0980c (b5) to be 
expressed at 61.2, 53.6 and 35 kDa (due to premature stops in the sequence), but 
the immunoblot showed protein bands at 43, 43 and 28 kDa respectively. This 
indicates that expression of these P. falciparum proteins in E. coli causes 
ribosomal stalling and thus early termination of translation. There is however also 
a possibility that not all the tagged proteins were visualised on the immunoblots 
because of the low protein expression levels. 
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Figure 37: Expression of spectrin-binding P. falciparum proteins. 
Laemmli gels (left) and immunoblots with the Penta•His™ and anti-GST HRP 
Conjugate antibodies (right) showing the whole cell extracts from E. coli 
containing the pET-15b (a) and pGEX-4T-2 (b) plasmid constructs. The black 
arrows indicate where the tagged proteins should occur in the immunoblot. Lane 
M contains 3 µg erythrocyte membrane proteins. The remaining lanes contain 10 
µl BL21 (DE3) E. coli whole cell extracts from each construct. Lanes 1 = 
uninduced vector; 2 = induced vector (GST = 26 kDa); 3 = induced PFI1570c 
(66.9 kDa & 91.5 kDa); a4 = induced MAL8P1.104 (65.7 kDa); a5 = induced 
PFA0125c (60.1 kDa); b4 = induced MAL8P1.151 (86.6 kDa); b5 = PFE0980c 
(85.8 kDa). 
 
A small amount of GST was present in the uninduced pGEX-4T-2 protein sample 
(Figure 37b1) indicating that low level transcription of the tag occurs when the 
cells have not been induced. Leaky expression from the pGEX-4T-2 plasmids 
occurs because transcription of the gene of interest is performed by an inherent E. 
coli RNA polymerase and the transcription levels are controlled by only one 
promoter, namely the tac promoter. Expression from the pET plasmid is 
controlled by two T7 promoters. The first promoter controls the expression of T7 
RNA polymerase which has been cloned into the E. coli genome. This T7 RNA 
polymerase is required for the transcription of the gene from the pET-15b plasmid, 
which is controlled by the second T7 promoter (Novagen, 2003). The regulation 
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of expression in pET-15b is therefore much more controlled than that of pGEX-
4T-2. The histidine-tag of the pET-15b plasmid can not be seen on the 
polyacrylamide gel or the immunoblot, because it is very small and therefore runs 
off the gel. Leaky expression of this tag could therefore also occur in E. coli. 
 
3.3.2 Purification of the P. falciparum aminopeptidase 
 
Only the P. falciparum aminopeptidase (pET-15b-PFI1570c) was expressed as a 
single band at the correct molecular weight in the expression study and was 
therefore chosen for purification. Aminopeptidase expression was initially 
induced with 0.4 and 1 mM IPTG at 37 ºC or room temperature, but most of the 
protein formed inclusion bodies (Figure 38 lane IPTG 37 ºC IS and result not 
shown for room temperature experiment). Therefore Overnight Express™ Instant 
TB Medium was used instead of IPTG. The cultures were also grown at room 
temperature, which improved the solubility of the aminopeptidase as seen in 
Figure 38 (lane ON Exp RT S). 
 
Due to low expression levels and the large proportion of insoluble protein, large 
culture volumes had to be used to obtain sufficient amounts of soluble protein. In 
the expression, induction and solubility studies the E. coli cells were lysed by 
chemical lysis with BugBuster™ HT. This type of lysis only works effectively 
when the correct ratio of wet cell paste to chemical lysis reagent is used. This was 
not feasible for large scale expression of the aminopeptidase because the protein 
expressed at very low levels within the host cells and a large proportion of the 
protein was insoluble. Sonication, which lyses cells by shear force and cavitation, 
was thus applied to lyse the cells that had been resuspended in a small volume of 
His-lysis/binding buffer. 
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Figure 38: Induction and solubility study of recombinant P. falciparum 
aminopeptidase. 
Laemmli gel (left) and immunoblot with the Penta•His™ HRP Conjugate 
antibody (right) showing the whole cell, insoluble and soluble protein fractions 
obtained from E. coli pET-15b-PFI1570c cultures grown and induced under 
different culture conditions (listed above lanes). Lane M contains 3 µg erythrocyte 
membrane proteins and lane U contains 10 µl of the uninduced BL21 (DE3) E. 
coli whole cell extract. The remaining lanes each contain 10 µl E. coli whole cell 
extracts (W), 10 µl of the insoluble protein fraction (IS) and 10 µl of the soluble 
protein fraction (S) when the cells were either grown in LB and induced with 
IPTG at 37 ºC, or grown in Overnight Express™ Instant TB Medium at room 
temperature or 37 ºC. 
 
Figure 39 shows the progressive lysis of the BL21 (DE3) E. coli cells after each 
sonication step. BugBuster™ HT was used to completely lyse the whole cell 
extract and the insoluble pellets before electrophoresis on the polyacrylamide gel. 
The amount of aminopeptidase present in the soluble fractions increased with each 
sonication step. After the sixth sonication step a second band appeared below the 
aminopeptidase protein band (6 IS) in the insoluble fraction. Sonication generates 
heat, which in conjunction with the shear forces can damage the P. falciparum 
aminopeptidase as well as the protease inhibitors that were added to the His-
lysis/binding buffer prior to sonication. Inactivation of the protease inhibitors 
could therefore have caused the reactivation of a protease that cleaves the P. 
falciparum aminopeptidase, resulting in the additional protein band in the 
immunoblot. The fact that this band only occurs in the insoluble fractions can 
however not be explained. 
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Figure 39: Sonication study of recombinant P. falciparum aminopeptidase. 
Laemmli gels (left) and immunoblots with the Penta•His™ HRP Conjugate 
antibody (right) showing insoluble and soluble E. coli pET-15b-PFI1570c cell 
fractions obtained after sonication. Lane M = 3 µg erythrocyte membrane 
proteins; lane W = 10 µl E. coli whole cell extracts; the remaining lanes contain 
10 µl of soluble (S) and insoluble (IS) protein after each sonication step (listed 
above lanes). 
 
The aminopeptidase was isolated from the E. coli proteins by affinity selection 
with the HIS-Select™ Magnetic Agarose Beads (Figure 40). To prevent 
degradation of the aminopeptidase a protease inhibitor mix was added to the E. 
coli cells before lysis. Twenty mM imidazole was used to remove non-binding 
proteins from the beads and 200 mM imidazole eluted the aminopeptidase from 
the magnetic beads. 
 
Purification from a 250 ml E. coli culture yielded ~120 µg soluble aminopeptidase 
from the first elution and ~70 µg from the second elution. Only a small amount of 
protein was obtained at the end of the purification procedure because of the low 
protein expression and insolubility of the P. falciparum aminopeptidase. A 
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substantial amount of protein was also lost during the washing steps (Figure 40 1-
5), especially in the last two steps, which only removed a small amount of 
contaminants. These two washes were not omitted because pure P. falciparum 
aminopeptidase was required for enzymatic the activity studies (see Chapter 4). 
 
 
Figure 40: Affinity purification of recombinant P. falciparum 
aminopeptidase. 
Laemmli gel (left) and immunoblot with the Penta•His™ HRP Conjugate 
antibody (right) showing the purification of P. falciparum aminopeptidase. Lane 
M = 3 µg erythrocyte membrane proteins; U & W = 10 µl uninduced and induced 
whole cell extract of the 10 ml E. coli culture; S = 10 µl of the 2 ml soluble 
protein fraction after six sonication steps; Ub = 10 µl of the 2 ml protein fraction 
that did not bind to the HIS-Select™ Magnetic Agarose Beads; 1-5 = 20 µl of 
each 300 µl 20 mM imidazole wash; 1st = 1 µl of the first 150 µl 200 mM 
imidazole elution; 2nd = 1 µl of the 100 µl second 200 mM imidazole elution. 
 
3.3.3 P. falciparum spectrin-binding protein features 
 
Table 12 gives some of the information available on the PlasmoDB database for 
the five cloned P. falciparum proteins. The putative Ebl-1 like protein is involved 
in the invasion pathway and is the only one of the five proteins that contains 
transmembrane domains and a hydrophobic N-terminal signal sequence. This 
signal sequence ensures that the protein is processed via the endoplasmic 
reticulum. None of the proteins contain a VTS or PEXEL motif that codes for a 
vacuolar transport signal, which is responsible for the translocation of the protein 
across the parasitophorous vacuole into the erythrocyte. According to the 
PlasmoDB database the putative aminopeptidase is involved in haemoglobin 
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digestion and one hypothetical protein, coded for by MAL8P1.104, forms part of 
the structure of the nuclear pore. The spectrin binding region of the putative 
aminopeptidase does not fall within a low complexity region in contrast to the 
four other proteins. 
 
Table 12: PlasmoDB data for the spectrin-binding P. falciparum proteins. 
Gene name PFA0125c MAL8P1.104 MAL8P1.151 PFE0980c PFI1570c 
Protein name 
putative 
Ebl-1 like 
protein 
hypothetical 
protein 
hypothetical 
protein 
hypothetical 
protein 
putative 
amino-
peptidase 
PlasmoDB 
putative pathways 
merozoite 
invasion 
structure of 
the nuclear 
pore 
none none 
haemo-
globin 
digestion 
Signal peptide yes no no no no 
Transmembrane 
domains yes no no no no 
Spectrin binding 
region in a low 
complexity region 
yes yes yes yes no 
 
Yeast two-hybrid data (Table 13) (LaCount et al., 2005) are only available for two 
hypothetical proteins (MAL8P1.104 & PFE0980c) and the putative Ebl-1 like 
protein (PFA0125c). The putative histone acetyltransferase Gcn5 (PF08_0034) 
interacted with two of the spectrin-binding proteins (PFA0125c & MAL8P1.104) 
and is involved in transcription or chromatin metabolism. The authors also 
categorised PFA0125c and MAL8P1.104 in protein networks involved in host cell 
invasion and transcription/chromatin metabolism respectively. 
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Table 13: Yeast two-hybrid data for the spectrin-binding P. falciparum 
proteins. 
Gene Interacting gene Interacting protein 
PF08_0034* putative histone acetyltransferase Gcn5 
PF10_0081* putative 26S proteasome regulatory subunit 4 
PF11_0278* hypothetical protein 
PF13_0228# putative 40S ribosomal subunit protein S6 
PF14_0100# cytidine triphosphate synthetase 
PF14_0241* putative basic transcription factor 3b 
PFC0465c* hypothetical protein 
PFI0975c# hypothetical protein 
PFI1090w* putative s-adenosylmethionine synthetase 
PFI1445w# RhopH2 
PFL0830w* hypothetical protein 
PFA0125c 
PFL2335w# hypothetical protein 
MAL7P1.171* hypothetical protein 
MAL8P1.104*# hypothetical protein 
MAL8P1.153# hypothetical protein 
PF08_0034* putative histone acetyltransferase Gcn5 
PF08_0060# asparagine-rich antigen 
PF11_0241# hypothetical protein 
PF14_0334* putative NAD(P)H-dependent glutamate synthase 
PFA0430c# hypothetical protein 
PFB0130w# putative polyprenyl synthetase 
PFE0130c# hypothetical protein 
PFE1590w# early transcribed membrane protein 
PFF0590c* homologue of human HSPC025 
PFI0225w*# hypothetical protein 
PFL0275w# hypothetical protein 
PFL0350c* hypothetical protein 
MAL8P1.104 
PFL0815w# putative DNA-binding chaperone 
PFE0980c PF11_0402# hypothetical protein 
* gene was prey and # gene was bait  
(Data were obtained from LaCount et al., 2005) 
 
Table 14 and Figure 41 give the mass spectroscopy (Florens et al., 2002, Florens 
et al., 2004) and microarray data (Le Roch et al., 2003) for the spectrin-binding P. 
falciparum proteins. The DeRisi Lab microarray results (Bozdech et al., 2003) 
were very similar and are not shown. Mass spectrometry analysis of the putative 
aminopeptidase detected the protein at the infected red blood cell membrane, 
which supports the fact that this protein interacts with spectrin. The proteomics 
data are not as extensive as the microarray data and therefore the mRNA and 
protein expression profiles do not always correlate. For example, the highest 
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mRNA levels for MAL8P1.104 occurred in early rings and merozoites (Figure 41), 
but the protein was only detected in gametocytes and sporozoites. The differences 
in the mRNA and protein expression profiles could also be due to post-
transcriptional regulation in the malaria parasite by unknown signals that delay the 
translation of mRNA into the protein (Le Roch et al., 2004). 
 
Table 14: Protein and mRNA expression data for the spectrin-binding P. 
falciparum proteins. 
Gene name Protein name 
Life cycle stage in which 
protein is expressed 
Life cycle stage in which mRNA 
is expressed at high levels 
merozoite merozoite 
sporozoite - PFA0125c 
putative 
Ebl-1 like 
protein - late schizont 
gametocyte - 
sporozoite - MAL8P1.104 hypothetical protein 
- merozoite 
sporozoite sporozoite 
MAL8P1.151 hypothetical protein - early and late schizont 
gametocyte - 
merozoite - 
sporozoite sporozoite 
- early and late trophozoite 
PFE0980c hypothetical protein 
- early schizont 
trophozoite & schizont early and late trophozoite 
gametocyte gametocyte 
iRBC membrane - 
merozoite - 
PFI1570c 
putative 
amino-
peptidase 
sporozoite - 
iRBC = infected red blood cell. 
Data sets are from P. falciparum strain 3D7 (Florens et al., 2002, Florens et al., 2004, Le Roch et al., 2003, Bozdech et al., 
2003). 
 
The levels of mRNA expression of the five spectrin-binding P. falciparum 
proteins varied considerably when compared to each other (Figure 41). For 
example, the putative aminopeptidase had very high mRNA expression levels, 
suggesting that the protein is required in large quantities and could therefore have 
many enzymatic functions to perform during the erythrocytic life cycle. In 
contrast, the PFE0980c gene expressed low levels of mRNA, suggesting that the 
hypothetical protein product may only have a single specific function. 
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PFI1570c (putative aminopeptidase)
MAL8P1.151 (hypothetical protein)
PFE0980c (hypothetical protein)
PFA0125c (putative Ebl-1 like protein)
MAL8P1.104 (hypothetical protein)
 
 
Figure 41: Absolute mRNA expression levels for the spectrin-binding P. 
falciparum proteins. 
Graphs showing the Winzeler Lab (Le Roch et al., 2003) microarray absolute 
expression profiles for the mRNA transcripts of the Ebl-1 like protein, putative 
aminopeptidase and the three hypothetical proteins. Colours and sampling points: 
blue = sorbitol synchronised cultures; pink = temperature synchronised cultures; 
grey = expression level less than 10 (too close to background); S = sporozoite; ER 
= early ring, LR = late ring; ET = early trophozoite; LT = late trophozoite; ES = 
early schizont; LS = late schizont; M = merozoite; and G = gametocyte. 
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3.4 Discussion 
3.4.1 Cloning and P. falciparum protein expression 
 
Automated sequencing revealed one silent mutation in the putative 
aminopeptidase sequence and insertions and deletions in the other P. falciparum 
constructs. Taq DNA polymerase has a total error rate of 1 x 10-4 to 2 x 10-5 errors 
per base pair (Tindall and Kunkel, 1988) and therefore a high fidelity mix, which 
also contained a DNA polymerase with a 3’-5’ exonuclease proofreading activity, 
was used for the amplification procedure. This Tgo DNA polymerase, however, 
only increases the fidelity of DNA synthesis ~3-fold and does not guarantee error-
free amplified DNA sequences. The AT-richness of the P. falciparum genome and 
the presence of adenosine and thymidine stretches within gene sequences could 
also have caused the DNA polymerases to slip, thereby creating deletions. In 
addition, the silent mutation and the 27 nucleotide (9 amino acids) insertion may 
not be true errors, but may reflect a discrepancy between the P. falciparum FCR-3 
and 3D7 genomes. The PlasmoDB database is based on the 3D7 genome and 
genes were amplified from FCR-3 genomic DNA. Finally, errors could have been 
introduced during the sequencing reaction or when the sequencing template was 
prepared by PCR from the bacterial colony. 
 
Low expression levels were exhibited by all the proteins and tag-specific 
antibodies had to be used to detect them in the BL21 (DE3) E. coli protein 
extracts. Large P. falciparum proteins (>60 kDa) are thought to be less stable in E. 
coli (Mehlin et al., 2006) and all the plasmid constructs were created from gene 
fragments that were ~1.5 kb in size, thus translating into proteins that would be 
larger than 60 kDa. Some P. falciparum proteins are also toxic to E. coli cells 
(Cinquin et al., 2001), which would slow the growth rate of the cells and less 
protein would be produced. To improve expression of recombinant proteins a 
different heterologous host may be used, for example, the baculovirus/insect cell 
system, yeast or mammalian cells. 
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Two P. falciparum constructs contained deletions responsible for frameshifts and 
the introduction of premature stop codons in the DNA sequences. Induction of E. 
coli cells containing these constructs, however, resulted in the expression of 
multiple smaller protein bands that did not match the expected truncated protein 
sizes. E. coli sometimes does not faithfully maintain the coding sequence of the 
inserted gene (Mehlin et al., 2006) and introduces mutations and frameshifts into 
the sequences during replication. The translated proteins are subsequently 
expressed as several differently sized proteins or as proteins with an incorrect 
amino acid sequence. The instability of the transcribed mRNA and the presence of 
secondary structures within the mRNA could also result in the translation of fewer 
and smaller proteins (Wu et al., 2004). 
 
Only the PFI1570c gene that was inserted in the pET-15b plasmid expressed a 
single protein of the correct size and was therefore chosen for protein purification. 
Induction with IPTG, however, produced only small amounts of the 
aminopeptidase, mainly as inclusion bodies. E. coli cultures were therefore grown 
in Overnight Express™ Instant TB Medium at room temperature. The medium 
and growth conditions ensured that the bacteria grew slowly to a post-log phase 
with glucose as their main nutrient source. Once the glucose was depleted, lactose 
was used as a substitute nutrient source and natural inducing agent when 
converted to allolactose by β-galactosidase in the bacterial cell (Lehninger et al., 
1993). These changed conditions decelerated the action of the translation 
machinery inside the host cell, which facilitated the smooth passage of the 
ribosomal unit along the mRNA template to allow it to produce a full-length 
polypeptide chain. Slower translation also allowed the recombinant protein to 
transfer from the unstable intermediate phase to the correctly folded protein (Flick 
et al., 2004) while the protein was still being translated, thereby decreasing the 
formation of inclusion bodies.  
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3.4.2 Characteristics of the P. falciparum spectrin-binding 
proteins 
 
One of the five analysed P. falciparum proteins, namely the Ebl-1 like protein, 
which is also known as EBA-181/JESEBL, had a hydrophobic signal peptide and 
transmembrane domains. This protein is a microneme protein and the signal 
sequence is responsible for transport of the protein to the endoplasmic reticulum, 
from where it will eventually be redirected, via other signals, to the microneme. 
EBA-181/JESEBL does not require a vacuolar localisation signal (Marti et al., 
2004, Hiller et al., 2004) for transport into the parasitophorous vacuole or the 
erythrocyte cytoplasm, because it is involved in erythrocyte invasion. None of the 
other proteins contained signal sequences or vacuolar localisation signals, but a 
lack of known signals does not exclude the relocation of these four proteins into 
the erythrocyte cytosol, because transport could be facilitated by signals and 
mechanisms that have as yet not been identified. The P. falciparum 
aminopeptidase was detected at the infected red blood cell membrane by mass 
spectroscopy (Florens et al., 2004) which correlates with findings from this study. 
 
The spectrin binding regions in four of the five proteins were located within low 
complexity regions. The exception was the binding region of the putative 
aminopeptidase. P. falciparum low complexity regions are composed of soluble 
unstructured amino acid loops (particularly lysine and asparagine) and are located 
between secondary structural elements of the protein. They are oriented toward 
the external surface of the protein and may not interfere with the function of the 
rest of the protein (Aravind et al., 2003). Low complexity regions are common in 
several Plasmodium species and therefore they have been thought to facilitate 
immune evasion by eliciting a non-productive antibody response against the 
repetitive amino acid stretches (Anders, 1986). These regions do however play a 
functional role in protein-protein interactions in other organisms (Liu et al., 2002), 
and the presence of spectrin-binding regions within the P. falciparum low 
complexity areas provides proof that the parasite also uses these sequences to 
interact with host proteins. 
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3.4.3 Possible functions of the spectrin-binding proteins in the 
erythrocytic phase of the P. falciparum life cycle 
 
The Ebl-1 like protein (EBA-181/JESEBL) has been found to interact with the 
trypsin-resistant receptor E on the erythrocyte surface (Gilberger et al., 2003) 
during invasion. The yeast two-hybrid data showed that EBA-181/JESEBL also 
interacted with several other P. falciparum proteins, one of them being RhopH2 
(PFI1445w) (LaCount et al., 2005), which is a component of the rhoptry high 
molecular weight complex (RhopH). In ring stage parasites, components of the 
RhopH complex are distributed throughout the erythrocyte and parasitophorous 
vacuolar membranes and are presumed to play a role in the establishment of the 
parasitophorous vacuole (Kaneko et al., 2005). EBA-181/JESEBL also interacts 
with the 10 kDa domain of protein 4.1. This domain stabilises the interaction 
between spectrin and actin in the junctional complex, and it is thought that 
binding of EBA-181/JESEBL to protein 4.1 blocks the repair of the erythrocyte 
membrane during invasion  (Lanzillotti and Coetzer, 2006). Additionally, 
simultaneous binding of EBA-181/JESEBL to protein 4.1 and spectrin could 
disrupt the structure of the junctional complex, thereby destabilising the 
erythrocyte membrane skeleton and allowing the parasite to pass into the 
erythrocyte. 
 
According to the PlasmoDB database, the hypothetical protein coded for by 
MAL8P1.104, is a structural component of the nuclear pore ring and the yeast 
two-hybrid data showed that this protein was involved in transcription and 
chromatin metabolism (LaCount et al., 2005). The nuclear pore is used to shuttle 
mRNA between the nucleus and the cytoplasm and therefore the MAL8P1.104 
mRNA should be transcribed throughout the parasite erythrocytic life cycle, 
which is confirmed by microarray data (Le Roch et al., 2003, Bozdech et al., 
2003). MAL8P1.104 could also be a structural component of the new transporters 
and channels of the NPP that are introduced into the erythrocyte membrane and 
the underlying skeleton as the parasite grows. The interaction between 
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MAL8P1.104 and spectrin could form an anchoring point for the transporters and 
channels. 
 
MAL8P1.151 and PFE0980c code for hypothetical proteins and have no assigned 
function in the PlasmoDB database. This study provides evidence that they 
interact with spectrin and could thus play a role in any of the processes requiring 
contact with the erythrocyte membrane. 
 
PFI1570c codes for an aminopeptidase which plays a role in haemoglobin 
digestion (Dalal and Klemba, 2007). However, the enzyme also interacts with the 
erythrocyte membrane as evidenced by mass spectrometry data (Florens et al., 
2004) and results from this study, indicating that it could therefore perform 
additional functions in the parasite and infected erythrocyte. These functions will 
be discussed further in Chapter 4. 
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Chapter 4: Characterisation of P. falciparum M18 
aspartyl aminopeptidase 
4.1 Introduction 
4.1.1 Enzymes and proteases 
 
Enzymes are the reaction catalysts of biological systems and are thus the 
functional units that degrade or synthesise macromolecules, transform chemical 
energy, or regulate other enzymes by activating or deactivating them. Proteases, 
or peptidases are enzymes that hydrolyse the amide bonds of the polypeptide 
backbone of proteins (Lehninger et al., 1993). 
 
Enzymes work by lowering the activation energy of a reaction, thereby allowing 
the reaction to occur a lot faster when compared to an uncatalysed reaction. 
Enzyme activity can be affected by inhibitors, or activators, as well as temperature, 
pH, and substrate concentration. Because enzymes are proteins, their activity 
depends upon the integrity of the native protein conformation, and denaturation of 
the protein, or the dissociation of the enzyme into subunits, therefore destroys the 
catalytic activity (Lehninger et al., 1993). 
 
4.1.2 Metalloproteases 
 
Proteases that bind metal ions in their active site are known as metalloproteases. 
In contrast to proteases that are only activated by metal ions, the metal ion in 
metalloproteases is normally tightly bound in the active site and is therefore 
retained in the enzyme during purification (Palmer, 1995). Metalloproteases can 
be distinguished from other enzymes by treatment with metal chelating agents 
such as EDTA or 1,10-phenanthroline, which remove the metal ion from the 
active site, thereby inactivating the enzyme (Bugg, 2004). 
 
Metal cofactors play either a structural or catalytic role in metalloenzymes. 
Structural cofactors are normally bound by four amino acids, which are generally 
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cysteines (Figure 42a). In contrast, catalytic metal ions are coordinated by three 
amino acids and an activated water molecule (Figure 42b) (Auld, 2001). 
Magnesium is probably the most commonly used catalytic cofactor and functions 
as a nucleophile or a Lewis acid in the active site. Zinc is often used to maintain 
the tertiary structure of the enzyme, but proteases do exist, that use zinc as a 
Lewis acid to either activate a water molecule and/or a carbonyl group of a 
substrate for subsequent base-catalysis or nucleophilic attack by an amino acid 
group in the active site. Some metalloproteases bind two cofactors in a co-
catalytic active site (Figure 42c). In this instance, the metal ions are held in place 
by five amino acids and one water molecule. One amino acid, usually an aspartate, 
coordinates both metal ions and the water molecule bridges them. Finally, 
enzymes also employ metal ions as redox reagents when none of the amino acid 
side groups in the active site can act in this capacity. 
 
 
Figure 42: Zinc binding in the active site of a metalloprotease. 
Diagram showing how zinc is coordinated by amino acids in a structural (a), 
catalytic (b) and co-catalytic (c) active site. The zinc atom in the structural site is 
bound by four amino acids, whereas the zinc ion in the catalytic site is only bound 
by three amino acids and a water molecule. The zinc ions in the co-catalytic site 
are bound by five amino acids and water. One of the amino acids coordinates both 
metal ions. Zn = zinc; H2O = water; C = cysteine; D = aspartate; E = glutamate;  
H = histidine (adapted from Auld, 2001). 
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4.1.3 P. falciparum metalloproteases 
 
Wu et al. (2003) identified 92 putative P. falciparum proteases, which is 59 more 
than those originally recognised by Gardner in the first genome publication 
(Gardner et al., 2002). Some of the new proteases include a calpain, a 
metacaspase and a signal peptidase that are essential for parasitic activity. 
 
Only a small number of Plasmodium proteases have been characterised in vitro 
and in vivo. As mentioned in the first chapter, Plasmodium proteases are involved 
in erythrocyte entry, the digestion of haemoglobin and exit from the erythrocyte. 
P. falciparum entry proteases include PfSUB-1 (Blackman et al., 1998), PfSUB-2 
(Hackett et al., 1999), gp76 (Roggwiller et al., 1996), and the rhomboids (Baker 
et al., 2006). Digestion proteases include the plasmepsins (Banerjee et al., 2002), 
falcipains (Shenai et al., 2000, Sijwali and Rosenthal, 2004, Sijwali et al., 2001) 
and falcilysin (Eggleson et al., 1999). Some of the digestion proteases as well as a 
37 kDa acidic protease (Deguercy et al., 1990) and the SERAs (Li et al., 2002) are 
responsible for parasite escape. 
 
When this study was initiated, only two Plasmodium metalloproteases had been 
characterised, namely PfA-M1, which belongs to the M1 family of zinc 
metallopeptidases (Florent et al., 1998) and falcilysin, a M16 metalloprotease 
(Eggleson et al., 1999). In January 2006, the M17 leucyl aminopeptidase 
(PfM17LAP) was characterised by Gardiner et al. (2006) and in August 2007, 
when this study had just been completed, Teuscher et al. (2007) released a 
publication describing the P. falciparum aspartyl aminopeptidase (PfM18AAP) 
encoded by PFI1570c, which is the subject of this study. All these 
metalloproteases are involved in haemoglobin digestion, but additional enzymatic 
roles have been described for PfA-M1 and falcilysin during erythrocyte reinvasion 
(Allary et al., 2002) and apicoplast transit peptide degradation (Ponpuak et al., 
2007), respectively. This study provides evidence for additional roles of 
PfM18AAP. 
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4.2 Methods 
4.2.1 Aminopeptidase sequence and structure analysis 
 
The PfM18AAP amino acid sequence was used to search the Protein Data Bank 
(PDB) (http://www.rcsb.org/pdb/home/home.do) (Berman et al., 2000) to identify 
crystal structures that could be used to predict the tertiary structure of PfM18AAP. 
The protein names of the identified crystal structures, PfM18AAP and the Homo 
sapiens aspartyl aminopeptidase were used to search the MEROPS database 
(http://merops.sanger.ac.uk/) (Rawlings et al., 2006) to identify the family and 
clan that each protease belongs to and the protease alignment. This, as well as 
alignments created with ClustalW (http://www.ebi.ac.uk/clustalw) (Chenna et al., 
2003), were used to compare the proteins with each other and to locate putative 
motifs in the homologues. Motifs and transmembrane domains were detected with 
ScanProsite (http://au.expasy.org/tools/scanprosite/) (Gattiker et al., 2002) and 
SOSUI (http://bp.nuap.nagoya-u.ac.jp/sosui/) (Hirokawa et al., 1998) respectively, 
and secondary structures were predicted with Jpred 
(http://www.compbio.dundee.ac.uk/~www-jpred/) (Cuff et al., 1998). Jpred was 
used, because the program gives the results of six secondary structure prediction 
algorithms and also integrates these results into one user-friendly output sequence. 
Crystal structures were viewed and manipulated with the DeepView Swiss-
PdbViewer, version 3.7 (SP5) (http://www.expasy.org/spdbv/) (Guex and Peitsch, 
1997). 
 
4.2.2 Characterisation of recombinant PfM18AAP 
His-tag removal and protein precipitation 
 
A one litre E. coli culture containing pET-15b-PFI1570c was grown and 
recombinant (r) PfM18AAP purified as described in section 3.2.4. Five hundred 
microlitres from the first elution and 250 µl from the second elution (both elutions 
performed without PMSF) were combined and dialysed for 15 minutes in seven 
100 µl Slide-A-Lyzer® Mini Dialysis Units (Pierce Biotechnology Incorporated, 
Rockford, USA) against Cleavage Buffer (50 mM Tris-HCl, 10 mM CaCl2, pH 
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8.0). Two hundred microlitres Thrombin-Agarose (Sigma-Aldrich Corporation, St. 
Louis, USA) (50% slurry) was centrifuged at 500 g for 5 minutes at 4 ºC using the 
Eppendorf 5415 R Centrifuge, the supernatant removed, the Thrombin-Agarose 
resuspended in 1 ml Cleavage Buffer and centrifuged for 5 minutes. The wash 
with 1 ml Cleavage Buffer was repeated and the Thrombin-Agarose finally 
resuspended in 75 µl 10 x Cleavage Buffer. The dialysed rPfM18AAP sample was 
added to the Thrombin-Agarose and placed on the Mini Labroller™ (Labnet 
International, Inc., Woodridge, USA) for 4 hours at room temperature to remove 
the 6His-tag. The sample was centrifuged for 5 minutes at 500 g and the 
supernatant collected. Residual protein was removed from the Thrombin-Agarose 
with 50 µl Cleavage Buffer and added to the first supernatant. PMSF was added to 
a final concentration of 1 mM to inhibit any secondary proteases and the 
thrombin-cleaved rPfM18AAP added to 30 µl HIS-Select™ Magnetic Agarose 
Beads for 15 minutes at room temperature. The beads were removed and 2 µl 
thrombin-cleaved rPfM18AAP kept aside to determine the amount of protein 
present by electrophoresing the sample through a Laemmli SDS-polyacrylamide 
gel against 1, 0.5 and 0.25 µg BSA and staining the gel with Coomassie Blue. 
Nine volumes cold 100 % ethanol were added to the remaining thrombin-cleaved 
rPfM18AAP sample and the mixture incubated overnight at -20 ºC, followed by 
centrifugation at 16,000 g for 20 minutes at 4 ºC. The ethanol was removed and 1 
ml cold 90 % ethanol (v/v) added to wash the pellet. The sample was centrifuged 
at 16,000 g for 5 minutes, the protein pellet air-dried for 30 minutes at room 
temperature and resuspended in isoelectric focusing (IEF) buffer (O'Farrell, 1975) 
(9.5 M urea, 2 % Nonidet P40 (NP-40) (w/v) (Roche Diagnostics Gmbh, 
Mannheim, Germany), 1.6 % Bio-Lyte® pH 5/8 Ampholyte (v/v) (Bio-Rad 
Laboratories, Hercules, USA), 0.4 % Bio-Lyte® pH 3/10 Ampholyte (v/v) (Bio-
Rad Laboratories, Hercules, USA), 5 % β-mercaptoethanol (v/v)) to give a final 
thrombin-cleaved rPfM18AAP concentration of ~ 1µg/µl. The volume of buffer 
required for resuspension was calculated from the amount of protein present in the 
thrombin-cleaved rPfM18AAP sample before precipitation. 
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Isoelectric focusing 
 
The pI of rPfM18AAP without the His-tag was determined by IEF using the 
O’Farrell method (O'Farrell, 1975). Glass tubes (15 cm x 3 mm) were soaked 
overnight in chromic acid (33 ml saturated potassium dichromate, 1 litre sulphuric 
acid) and rinsed thoroughly with distilled water and 70 % ethanol (v/v). The 
bottoms of the tubes were sealed with Parafilm® (Pechiney Plastic Packaging, 
Menasha, USA). A 3.5 % polyacrylamide mixture (2.75 g urea, 665 µl 28.4 % 
acrylamide/1.6 % bisacrylamide (w/v) mix, 250 µl Bio-Lyte® 3/10 Ampholyte, 1 
ml 10 % NP-40 (v/v) in a final volume of 5 ml) was prepared and degassed for 1 
minute. Twenty-three microlitres freshly prepared 10 % ammonium persulphate 
and 3.5 µl TEMED were added and the tubes filled up to 10 cm with the 
polyacrylamide mixture. The gel solution was overlaid with water and allowed to 
set for 2 hours. The water was removed and replaced with 20 µl IEF buffer and 
the gels allowed to set for another 2 hours. The IEF buffer was replaced with fresh 
20 µl IEF buffer. The lower chamber of the Shandon Vertical Electrophoresis 
Chamber (Shandon Scientific Company Ltd., London, UK) was filled with 0.01 
M phosphoric acid (Merck KGaA, Darmstadt, Germany). The IEF tube gel was 
placed in the system and the upper chamber filled with 0.02 M NaOH (degassed 
for 1 hour). The gel was prefocused at 200 V for 15 minutes, followed by 300 V 
for 30 minutes and finally 400 V for 30 minutes. The upper buffer was removed 
and 30 µl 2-D SDS-PAGE Standards (Bio-Rad Laboratories, Hercules, USA) 
mixed with 3-5 µg thrombin-cleaved rPfM18AAP (1 µg/µl) loaded onto the gel. 
The sample was overlaid with 10 µl sample overlay solution (9 M urea, 0.8 % 
Bio-Lyte® 5/8 Ampholyte (v/v), 0.2 % Bio-Lyte® 3/10 Ampholyte (v/v)) and the 
gel electrophoresed at 400 V for 16 hours followed by 500V for one hour. One 
microlitre of concentrated bromophenol blue (50 % glycerol (v/v), 0.01 mg/ml 
bromophenol blue (BDH Laboratory Supplies, Poole, UK) was added to the top of 
the gel and allowed to electrophorese into the gel for 3-5 minutes to be able to 
identify the top end of the gel after it has been extruded from the glass tube. The 
glass tube was removed from the apparatus and the gel carefully extruded with 
water into 10 ml equilibration buffer (124 mM Tris-HCl, 10 % glycerol (v/v), 2 % 
 
 
121
SDS (w/v), 8.6 mM DTT, pH 6.8). The gel was soaked for 10 minutes and 
carefully loaded onto a 14 cm x 16 cm x 3 mm Laemmli SDS-polyacrylamide gel 
consisting of a resolving gel containing 13 % polyacrylamide and a stacking gel 
without wells containing 4 % polyacrylamide. The IEF gel was secured onto the 
second dimension gel and two wells formed with a single comb tooth at both ends 
of the IEF tube gel using 0.5 % agarose solution (0.5 % SeaKem LE agarose (w/v) 
in Laemmli running buffer). Fifteen microlitres denatured whole erythrocyte 
membrane marker and 15 µl Page Ruler™ Prestained Protein Ladder (Fermentas 
International Inc., Burlington, Canada) were loaded in the wells and the gel 
electrophoresed with Laemmli running buffer at 75 V for 18 hours. The gel was 
fixed overnight in one litre fixing solution (50 % isopropanol (v/v), 7 % glacial 
acetic acid (v/v)) on the Red Rotor PR70-230V shaker (set to 2) followed by 
several rinses in milli-Q water. The gel was incubated overnight in milli-Q water 
and silver stained (Hoefer Scientific Instruments, 1994) by incubating the gel in 
one litre 0.032 mM DTT for 1 hour with shaking using the Red Rotor PR70-230V 
shaker (set to 2). The solution was removed and replaced with 400 ml 0.1 % silver 
nitrate (w/v) (Sigma-Aldrich Corporation, St. Louis, USA) and the gel incubated 
for another hour. The silver nitrate was removed and the gel briefly rinsed with 
milli-Q water. The gel was rinsed twice with 200 ml developing solution (800 ml 
3 % Na2CO3 (w/v) with 400 µl 37 % formaldehyde (v/v) (Sigma-Aldrich 
Corporation, St. Louis, USA) added just before use). Finally, 400 ml developing 
solution was added to the gel, which was placed on a shaker for 5-10 minutes. As 
soon as protein spots appeared the developing solution was removed and the gel 
rinsed several times with milli-Q water and left overnight in milli-Q water. A dark 
background was destained (Gharahdaghi et al., 1999) by incubating the gel for 30 
seconds to 2 minutes in 400 ml destaining solution (100 mM sodium thiosulphate 
(Sigma-Aldrich Corporation, St. Louis, USA), 30 mM potassium ferricyanide 
(Sigma-Aldrich Corporation, St. Louis, USA), prepared separately and mixed in 
equal volumes prior to use), followed by several rinses in milli-Q water. The pI of 
thrombin-cleaved rPfM18AAP was estimated by comparing the rPfM18AAP 
protein spots in relation to those of the 2-D SDS-PAGE Standards. 
 
 
122
Molecular weight determination by denaturing polyacrylamide 
electrophoresis 
 
The molecular weight of denatured rPfM18AAP was calculated from the relative 
mobility (Rm) values of the protein when 500 ng rPfM18AAP, 500 ng BSA and 
20 µg erythrocyte membrane proteins were electrophoresed through a Laemmli 
SDS-polyacrylamide gel containing a 12 % resolving gel and a 4 % stacking gel. 
A standard curve consisting of the relative mobility (Y-axis) and molecular weight 
(X-axis) of each standard was plotted on semi-log paper and used to determine the 
molecular weight of rPfM18AAP. 
 
Native oligomeric state determination using Ferguson plots 
 
The number of subunits present in the native form of rPfM18AAP was determined 
by Ferguson plots (Ferguson, 1964, Hedrick and Smith, 1968, Sigma-Aldrich, 
2005). The plots are constructed from the Rm values of standards and the protein 
of interest after the proteins have been electrophoresed through non-denaturing 
gels (Liu et al., 1982). Tube gels with varying polyacrylamide percentages were 
prepared the following way. Glass tubes (12 cm x 6 mm) were cleaned and 
prepared as in the isoelectric focusing section. A 1 % agarose solution was placed 
in a 43 ºC waterbath. The non-denaturing gel mixture containing the desired 
percentage polyacrylamide (from a 40 % acrylamide/1.5 % bisacrylamide stock 
(w/v)) and 1 x Tris acetate buffer (pH 7.4) in a final volume of 2.4 ml was placed 
in the 43 ºC waterbath. Two hundred microlitres 1.5 % ammonium persulphate, 
200 µl 0.5 % TEMED and 1.2 ml 1 % agarose were added and the glass tubes 
filled up to 11.5 cm with the gel mixture. The gel was overlaid with water and 
placed in ice water for 3 minutes. Gels were left to polymerise overnight at room 
temperature and placed in the Shandon Vertical Electrophoresis Chamber. Ten 
microlitres bromophenol tracking dye (50 % sucrose (w/v), 0.05 % bromophenol 
blue (w/v)) was added to 20 µg rPfM18AAP (containing 0.01 mM DTT), 10 µg 
BSA or 10 µg spectrin and the samples loaded onto the different percentage tube 
gels according to Table 15. The gels were electrophoresed in the cold room with 1 
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x Tris acetate buffer containing 0.008 % β-mercaptoethanol (v/v) at 4 mA per gel 
until the bromophenol blue tracking dye reached the end of the gels. The gels 
were carefully extruded from the glass tubes with water and stained with 
Coomassie Blue stain. 
 
Table 15: Polyacrylamide percentages for the native gels. 
Protein Percentage polyacrylamide 
Spectrin 2; 2.5; 3; 3.5 
BSA 6; 7; 8; 9 
rPfM18AAP 2; 3; 4; 5; 6; 7; 8; 9; 10 
 
The Rm values of each standard and rPfM18AAP were calculated by dividing the 
distance the protein travelled by the distance the bromophenol tracking dye 
travelled. The 100 [Log (Rm x 100)] values for each protein were plotted against 
the gel concentration and the retardation coefficient (KR) of each protein standard 
determined from the slope of each standard (Hedrick and Smith, 1968, Sigma-
Aldrich, 2005). The negative values of KR were plotted against the molecular 
weight of each standard on log-log paper and the approximate molecular weight 
of rPfM18AAP read from the second graph (Hedrick and Smith, 1968, Sigma-
Aldrich, 2005). 
 
Immunoblotting of non-denaturing gels 
 
Fifteen micrograms rPfM18AAP was electrophoresed on non-denaturing 
polyacrylamide gels as described in the previous section. The gels were cut in half 
length wise and one half stained with Coomassie Blue stain. The other half was 
incubated for 10 minutes in 48 mM Tris, 39 mM glycine, 0.0375 % SDS (w/v), 
20 % methanol (v/v), pH 9.2 (Bjerrum and Schafer-Nielsen, 1986) and the 
proteins transferred onto a Hybond™-C Extra Nitrocellulose membrane with the 
same buffer for 36 hours at 4 ºC. The histidine-tag of rPfM18AAP was detected 
with 1:1,500 dilution of the Penta•His™ HRP Conjugate antibody and 
chemiluminescence with the SuperSignal® West Pico Chemiluminescent 
Substrate. 
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4.2.3 Protein overlays 
 
Binding studies were performed by blot overlays of rPfM18AAP with spectrin, 
trypsin digested spectrin (Lawler et al., 1984) and erythrocyte membrane proteins. 
The proteins of interest were transferred or spotted onto nitrocellulose membranes 
in the following ways: 
 
Dot blot preparation: One hundred nanograms rPfM18AAP (Section 3.2.4), 100 
ng BSA, 2 µg spectrin tetramers and 2 µg spectrin dimers (Section 2.2.2) were 
spotted onto two strips of Hybond™-C Extra Nitrocellulose membrane and air 
dried. 
 
Slot blot preparation: One hundred nanograms rPfM18AAP, 100 ng BSA, 1 µg 
spectrin tetramers and 1 µg spectrin dimers were applied to two Hybond™-C 
Extra Nitrocellulose membranes in a Bio-Rad Bio-Dot® SF chamber (Bio-Rad 
Laboratories, Hercules, USA) connected to Millipore Vacuum Pump XF 54 230 
50 (Millipore Corporation, Bedford, USA). 
 
Erythrocyte membrane protein overlay: One hundred nanograms rPfM18AAP 
(positive control), 100 ng BSA (negative control) and 20 µg erythrocyte 
membrane proteins were electrophoresed on a 14 cm x 16 cm x 1.5 mm 9 % 
Laemmli and a 14 cm x 16 cm x 1.5 mm 3.5-17.5 % Fairbanks SDS-
polyacrylamide gel (Section 2.2.2) and the protein bands transferred onto a 
Hybond™-C Extra Nitrocellulose membrane (Section 4.2.2). Five hundred 
nanograms rPfM18AAP, 500 ng BSA and 20 µg erythrocyte membrane proteins 
were electrophoresed on a second Laemmli and Fairbanks SDS-polyacrylamide 
gel and stained with Coomassie Blue stain. 
 
Spectrin tryptic digest overlay: Spectrin was isolated from human erythrocytes as 
described in section 2.2.2. Four hundred micrograms spectrin was prepared for the 
digestion reaction by adding 10 x digestion buffer (10 x: 100 mM sodium 
phosphate buffer, pH 7.5, 1.5 M NaCl, 50 mM Na2EDTA, 50 mM β-
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mercaptoethanol) followed by 1 µg trypsin (0.2 µg/µl) (Sigma-Aldrich 
Corporation, St. Louis, USA) per 100 µg spectrin. The sample was incubated at 4 
ºC for 18 hours and the digest stopped by adding 1 % (v/v) 0.1 M Pefabloc SC. 
One hundred nanograms rPfM18AAP (positive control), 100 ng BSA (negative 
control) and three lanes containing 40 µg trypsin digested spectrin were 
electrophoresed on a 14 cm x 16 cm x 1.5 mm Laemmli SDS-polyacrylamide gel 
at 65 V for 18 hours. The Laemmli gel contained a 10 % separating gel (40 % 
acrylamide/1.5 % bisacrylamide stock (w/v) in lower gel buffer (375 mM Tris-
HCl, pH 8.3), 0.1 % SDS (w/v) and 2 mM EDTA (pH 7.4). The 2.66 % stacking 
gel contained upper gel buffer (125 mM Tris-HCl, pH 6.8), 0.1 % SDS (w/v) and 
2 mM EDTA (pH 7.4). The proteins were transferred onto a Hybond™-C Extra 
Nitrocellulose membrane (Section 4.2.2). Two of the lanes containing the trypsin 
digested spectrin were cut off from the nitrocellulose membrane and the spectrin 
fragments analysed with separate 1:500 α- and β-spectrin polyclonal antibodies, 
followed by a 1:20,000 goat anti-rabbit IgG peroxidase (Section 2.2.2) and 
detection by chemiluminescence with the SuperSignal® West Pico 
Chemiluminescent Substrate. Five hundred nanograms rPfM18AAP, 500 ng BSA 
and 40 µg trypsin digested spectrin were electrophoresed on a second Laemmli 
SDS-polyacrylamide gel and stained with Coomassie Blue stain. 
 
The overlays were performed as follows: All the membranes were blocked for 1 
hour at room temperature in 5 % BSA Fraction V (w/v) in TBS. One slot or dot 
blot membrane was placed in 2 ml 50 mM Tris-HCl buffer (pH 7.5) containing 
2.5 ng/µl rPfM18AAP, while the other slot or dot blot membrane was placed into 
2 ml 50 mM Tris-HCl buffer (pH 7.5) and incubated for 1 hour at room 
temperature on the Mini Labroller™. The membranes were then washed two 
times for 10 minutes in wash buffer A (20 mM Tris-HCl, 500 mM NaCl, 0.12 % 
Tween®-20 (v/v), 0.2 % Triton® X-100 (v/v), pH 7.5) and once for 10 minutes in 
HRP-TBS buffer (10 mM Tris-HCl, 150 mM NaCl, pH 7.5). The membranes 
containing the erythrocyte membrane proteins and the spectrin tryptic digest were 
incubated for 1 hour in 30 ml 50 mM Tris-HCl buffer (pH 7.5) containing 1.25 
ng/µl rPfM18AAP and subsequently washed 4 times for 10 minutes in wash 
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buffer A and once for 10 minutes in HRP-TBS buffer. All membranes were fixed 
for 20 minutes at room temperature with HRP-TBS buffer containing 0.5 % (v/v) 
formaldehyde, followed by incubation for 20 minutes in HRP-TBS buffer 
containing 2 % glycine. Glycine was used to inactivate remaining reactive 
aldehyde groups (Tisdale, 2002). The membranes were washed twice for 10 
minutes in Tween/Triton buffer (20 mM Tris-HCl, 500 mM NaCl, 0.05 % 
Tween®-20 (v/v), 0.2 % Triton® X-100 (v/v), pH 7.5) and once for 10 minutes 
with HRP-TBS buffer and subsequently incubated for 1 hour at room temperature 
with a 1:1,500 dilution of the Penta•His™ HRP Conjugate antibody. The 
membranes were washed twice for 10 minutes with Tween/Triton buffer and once 
for 10 minutes with HRP-TBS buffer and the antibody detected by 
chemiluminescence with the SuperSignal® West Pico Chemiluminescent 
Substrate. 
 
4.2.4 Enzyme activity assay 
 
The enzyme activity assay was based on a coupled enzyme reaction (Wilk et al., 
1998). If rPfM18AAP is active, it will cleave the aspartate from the Asp-Ala-Pro-
β-Napthylamide substrate, thereby liberating Ala-Pro-β-Napthylamide (Figure 
43a). This product becomes the substrate for dipeptidyl peptidase IV, which 
cleaves alanine-proline from the β-Napthylamine chromogen (Figure 43b). The 
chromogen is chemically converted to an azo dye, which can be quantitated with a 
spectrophotometer at 580 nm. Azo dye creation entails diazotising β-
Napthylamine with sodium nitrite under acidic conditions (Figure 43c). Excess 
nitrite is removed with ammonium sulphamate before N-1-
Naphthylethylenediamine is coupled to the diazotised β-Napthylamine to form the 
azo dye (Figure 43d) (Goldbarg and Rutenburg, 1958, Alur et al., 2001). 
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Figure 43: Substrate cleavage by rPfM18AAP, diazotisation and azo dye 
coupling reaction. 
Diagram showing the cleavage of aspartate from Asp-Ala-Pro-β-Napthylamide by 
rPfM18AAP (a) and the subsequent removal of alanine-proline from the 
chromogen by dipeptidyl peptidase IV (b). β-Napthylamine is diazotised by 
sodium nitrite under acidic conditions (c) and N-1-Naphthylethylenediamine is 
added to form the azo dye (b), which can be analysed with a spectrophotometer. 
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A 500 ml E. coli culture containing pET-15b-PFI1570c was grown, lysed and 
rPfM18AAP purified as described in section 3.2.4. The 250 µl 1st His elution (no 
PMSF added) was dialysed for 15 minutes against 50 mM Tris-HCl buffer (pH 
7.5) using three 100 µl Slide-A-Lyzer® Mini Dialysis Units and the concentration 
of a 10 µl sample determined with the Coomassie Plus™ Protein Assay Reagent. 
The desired concentration of H-Asp-Ala-Pro-β-Napthylamide (Peptides 
International, Louisville, USA) (10 or 100 mM stock dissolved in dimethyl 
sulphoxide (DMSO; BDH Laboratory Supplies, Poole, UK) in 50 mM Tris-HCl 
buffer, pH 7.5, containing 0.0025 U dipeptidyl peptidase IV from Porcine kidney 
(Sigma-Aldrich Corporation, St. Louis, USA), was equilibrated in a 37 ºC 
waterbath for 5 minutes. rPfM18AAP (2.5 µg) was added to give a final volume 
of 50 µl and the sample incubated at 37 ºC for 15 minutes in the waterbath. The 
enzymatic reaction was terminated with 50 µl 10 % trichloroacetic acid (w/v) 
(Sigma-Aldrich Corporation, St. Louis, USA). Hundred microlitres 0.1 % NaNO2 
(w/v) (Riedel de Haën A.G., Hannover, Germany) was added and the sample 
incubated at room temperature for 3 minutes, followed by the addition of 100 µl 
0.5 % ammonium sulphamate (w/v) (Sigma-Aldrich Corporation, St. Louis, USA) 
and incubation for 3 minutes at room temperature. The azo dye was created by 
adding 200 µl 0.05 % N-(1-napthyl)ethylenediamine dihydrochloride (w/v) 
(Sigma-Aldrich Corporation, St. Louis, USA) and incubating the solution at room 
temperature for 45 minutes. 
 
A standard curve containing 0.05, 0.1, 0.3, 0.5, 0.7, 0.8, 1, and 1.2 mM β-
Napthylamine was set up using a 2 mM β-Napthylamine solution (prepared from a 
100 mM β-Napthylamine stock solution dissolved in DMSO) (Sigma-Aldrich 
Corporation, St. Louis, USA). The 50 µl samples were treated with trichloroacetic 
acid, sodium nitrite, ammonium sulphamate and N-(1-Naphthyl)ethylenediamine 
dihydrochloride in the same way as the enzymatic reaction.  
 
All the samples were analysed at 580 nm using the Beckman DU®-65 
spectrophotometer (Beckman Coulter, Inc., Fullerton, USA) and the amount of 
product formed during the enzymatic reaction determined from the standard curve. 
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The velocity of the enzymatic reaction and the specific activity of the enzyme was 
calculated with the following formulae: 
velocity (nmol/min) = amount product / reaction time 
 
specific activity (nmol/min/mg) = velocity / amount of enzyme 
 
Enzymatic reactions were compared with each other by calculating the relative 
activity. 
 
pH and ionic strength study 
  
The pH study entailed setting up the enzyme assay containing 0.3 mM H-Asp-
Ala-Pro-β-Napthylamide in 50 mM Tris-HCl buffer at pH 6.8, 7.5, 8.0, 8.5 and 
9.0, or 0.1 M sodium citrate buffer at pH 5.3, 6.0 and 6.5. The relative activity of 
the enzymatic reactions was plotted against the pH. 
 
The ionic strength study was performed by setting up the enzyme assay with 0.3 
mM H-Asp-Ala-Pro-β-Napthylamide in 50 mM Tris-HCl buffer (pH 7.5) 
containing 50 or 150 mM NaCl. 
 
Temperature study 
 
The enzyme assay containing 0.3 mM H-Asp-Ala-Pro-β-Napthylamide in 50 mM 
Tris-HCl buffer (pH 7.5) (pH adjusted to each temperature) was performed at 25, 
30, 33, 37 and 39 ºC in the Eppendorf Mastercycler® Gradient machine. The 
relative activity of the enzymatic reactions was plotted against the temperature. 
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Metal ion study 
 
The cofactor study was performed by setting up the enzyme assay with 0.3 mM 
H-Asp-Ala-Pro-β-Napthylamide in 50 mM Tris-HCl buffer (pH 7.5) containing 1 
mM ZnSO4, MgCl2, MnCl2, or CaCl2. 
 
Inhibitor study 
 
The inhibitor study entailed setting up the enzyme assay with 0.3 mM H-Asp-Ala-
Pro-β-Napthylamide in 50 mM Tris-HCl buffer (pH 7.5) containing 1 mM 
Pefabloc SC, 10 mM EDTA, 1 mM PMSF, or 10 µM Bestatin (Sigma-Aldrich 
Corporation, St. Louis, USA). Samples were preincubated at 37 ºC for 10 minutes 
before the substrate was added. 
 
Maximum velocity and Michaelis constant determination 
 
The maximum velocity (Vmax) and Michaelis constant (Km) were determined from 
enzyme assays containing a range from 0.1-3 mM H-Asp-Ala-Pro-β-
Napthylamide in 50 mM Tris-HCl buffer (pH 7.5). The velocity of each reaction 
was calculated and plotted against the substrate amount used in each reaction and 
the graph used to read the values of Vmax and Km according to the Michaelis-
Menten equation: 
V0 = (Vmax x [S0]) / ([S0] + Km) 
where V0 = initial velocity and S0 = initial substrate concentration 
 
A Lineweaver-Burk plot was constructed by plotting the 1/V readings against the 
1/[S] values and Km and Vmax read from the x- and y-intercepts respectively.  
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4.3 Results 
4.3.1 PfM18AAP 
 
PfM18AAP is an exopeptidase classified with the enzyme commission (E.C.) 
number 3.4.11.21: where ‘3’ represents a hydrolase; ‘4’ indicates that the enzyme 
acts on a peptide bond; ‘11’ indicates that the enzyme cleaves at the amino 
terminus of the peptide and ‘21’ that the enzyme is an aspartyl aminopeptidase 
(International Union of Biochemistry, 1992). This enzyme is also classified in a 
separate system, available in the MEROPS database, that describes only 
peptidases (Rawlings and Barrett, 1993, Rawlings et al., 2006). The system 
applies a hierarchical, structure-based approach to assign each peptidase to a 
family on the basis of statistically significant similarities in amino acid sequence. 
Furthermore, families that are thought to be homologous are grouped into a clan. 
In this system PfM18AAP belongs to the MH clan of metallopeptidases and is 
part of the M18 family which currently contains 253 aminopeptidases (Rawlings 
et al., 2006). Yokoyama et al. (2006) suggested that the M18 family be further 
divided into two groups based on their substrate specificity. The first group, for 
example, contains aminopeptidase I from Saccharomyces cerevisiae (E.C. 
3.4.11.22) (Chang and Smith, 1989), which cleaves N-terminal hydrophobic 
amino acids from a peptide substrate. An example of an enzyme in the second 
group is the human aspartyl aminopeptidase (DAP) (E.C. 3.4.11.21) (Wilk et al., 
2002), which cleaves N-terminal aspartates or glutamates from a peptide substrate. 
PfM18AAP was initially categorised in the second group of M18 aminopeptidases, 
but recently this enzyme and the other Plasmodium M18 aspartyl aminopeptidase 
homologues, as well as the M18 aminopeptidases from Theileria and 
Cryptosporidium, were regrouped into a third group based on the amino acid 
sequence of PfM18AAP. 
 
4.3.2 M18 aminopeptidase family primary sequence features 
 
A search of the crystal structure Protein Data Bank with the PfM18AAP amino 
acid sequence revealed a similarity to four aminopeptidase protein structures, 
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namely Clostridium acetobutylicum, Thermotoga maritima, Borrelia burgdorferi 
and Pseudomonas aeruginosa. These four proteins, as well as the H. sapiens 
aspartyl aminopeptidase and PfM18AAP are found in the M18 peptidase family in 
the MEROPS database (Rawlings et al., 2006). C. acetobutylicum, T. maritima, 
and B. burgdorferi are listed in the first group of M18 aminopeptidases, which 
also contains aminopeptidase I from Saccharomyces cerevisiae, and P. aeruginosa 
is categorised in the second group of M18 aminopeptidases, which also contains 
the H. sapiens aspartyl aminopeptidase and another aspartyl aminopeptidase from 
S. cerevisiae (Yokoyama et al., 2006). As mentioned above, PfM18AAP and the 
other Plasmodium aspartyl aminopeptidase homologues are grouped into the third 
group. In addition, a search of the PlasmoDB database showed that PfM18AAP is 
the only M18 protease in P. falciparum. 
 
According to the PlasmoDB database, PfM18AAP has a 30.7 % sequence identity 
to the H. sapiens aspartyl aminopeptidase. This is lower than that obtained from a 
ClustalW alignment of PfM18AAP and the H. sapiens aspartyl aminopeptidase 
(Table 16). The highest identities are found amongst the Plasmodium species 
(rows 8-11), while other Apicomplexa (rows 12-16) showed only low identities. 
 
Table 16: Sequence comparison of M18 aminopeptidases to PfM18AAP. 
Organism Percentage sequence identity 
Saccharomyces cerevisiae (1) 22 
Clostridium acetobutylicum 18 
Borrelia burgdorferi 18 
Thermotoga maritima 16 
Homo sapiens 33 
Saccharomyces cerevisiae (2) 30 
Pseudomonas aeruginosa 30 
Plasmodium chabaudi chabaudi 74 
Plasmodium yoelii yoelii 73 
Plasmodium knowlesi 64 
Plasmodium vivax 64 
Cryptosporidium parvum 33 
Cryptosporidium hominis 33 
Theileria annulata 33 
Theileria parva 33 
Babesia bovis 34 
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The MEROPS sequence alignment of the two S. cerevisiae, C. acetobutylicum, B. 
burgdorferi, T. maritima, H. sapiens, P. aeruginosa and PfM18AAP is given in 
Figure 44. According to the MEROPS database, seven conserved amino acids are 
involved in the active site, namely two histidines, three aspartates and two 
glutamates (for clarification purposes the conserved amino acids are numbered 
according to the human aspartyl aminopeptidase (Wilk et al., 2002) and the amino 
acid numbers of PfM18AAP are given in brackets). Amongst the conserved amino 
acids, the two histidines, HsH94 and HsH440 (PfH86 and PfH534), the two 
aspartates, HsD264 and HsD346 (PfD324 and PfD434), and one glutamate, 
HsE302 (PfE380), are involved with cofactor or metal ligand binding (all labelled 
in red in Figure 44). The two remaining amino acids, one glutamate, HsE301 
(PfE379), and one aspartate, HsD96 (PfD88), are directly and indirectly involved 
in substrate cleavage (labelled in pink in Figure 44). A third histidine, HsH170 
(PfH160) (labelled in light blue in Figure 44), is conserved amongst all the 
sequences, and enzyme activity is abolished when it is replaced with 
phenylalanine in the H. sapiens aspartyl aminopeptidase (Wilk et al., 2002). In 
addition, Wilk et al. (2002) showed that substitution of another histidine, HsH352 
(PfH440) (labelled in dark blue in Figure 44), causes the subunits of the native H. 
sapiens aspartyl aminopeptidase to dissociate. This histidine is not found in the 
first group of M18 aminopeptidases and is therefore only present in H. sapiens, P. 
aeruginosa, PfM18AAP and the other Plasmodium homologues (Figure 44 and 
Figure 45). 
 
A motif scan revealed a putative protein kinase C (Pf535-537; light blue box) and 
a casein kinase II (Pf535-538; dark blue box) phosphorylation site located near the 
C-terminus of all the proteins (Figure 44 and Figure 45). The SOSUI 
transmembrane domain scan gave two transmembrane domains in the PfM18AAP 
sequence (Pf504-526 and Pf538-560) (labelled in green in Figure 44 and Figure 
45), suggesting that this protein is able to associate with membranes. None of the 
other aminopeptidases contained a transmembrane domain and were thus 
classified as soluble proteins. 
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Sc(1) EHNYEDIAQEFIDFIYKNPTTYHVVSFFAELLDKHNFKYLSEKSNWQDSIGEDGGK 101 
Ca -KEVFALGDRFKNFISNCKTERECVTELIKTAEKSGYRNIEDILAK-GETLKEGDK  75 
Bb    KNQILNFSESYKKFISKFKTEREVTAYALDKAKKLGFINAEEK-----KNLMPGDK  65 
Tm    ----EAFSKEYMEFMSKAKTERMTVKEIKRILDESGFVPLEDF-----AGDPMNMT  64 
Hs    KEAVQTAAKELLKFVNRSPSPFHAVAECRNRLLQAGFSELKETEKW---NIKPESK  63 
Sc(2) KTCKSDYPKEFVSFLNSSHSPYHTVHNIKKHLVSNGFKELSERDSW-AGHVAQKGK  66 
Pa    MRAEL--NQGLIDFLKASPTPFHATASLARRLEAAGYRRLDERDAW---HTETGGR  51 
Pf    DKKAREYAQDALKFIQRSGSNFLACKNLKERLENNGFINLSEGETW---NLNKNEG  54 
 
Sc(1) FYTIRNGTNLSAFILGKNWRAEK-GVGVIGSHVDALTVKLKPVSFKDTAEGYGRIA 156  
Ca    VYANNRGKGLIMFLIGKEPL-YT-GFKILGAHIDSPRLDLKQNPLYED-TDLAMLE 128 
Bb    IFYTCREKSVAFAIIGKNPI-ED-GMNFIVSHTDSPRLDAKPSPISEE-NELTFIK 118 
Tm    VYAVNRGKAIAAFRVVDDL--KR-GLNLVVAHIDSPRLDFKPNPLIED-EQIALFK 116 
Hs    YFMTRNSSTIIAFAVGGQYVPGN-GFSLIGAHTDSPCLRVKRRSRRSQ-VGFQQVG 117 
Sc(2) YFVTRNGSSIIAFAVGGKWEPGN-PIAITGAHTDSPALRIKPISKRVS-EKYLQVG 120 
Pa    YYVTRNDSSLIAIRLGRRSPLES-GFRLVGAHTDSPCLRVKPNPEIAR-NGFLQLG 105 
Pf    YVLCKENRNICGFFVGKNFNIDTGSILISIGHIDSCALKISPNNNVIK-KKIHQIN 109 
 
Sc(1) VAPYGGTLNELWLDRDLGIGGRLLYKKKGTNEIKSALVDSTPLPVCRIPSLAPHF- 211 
Ca    THYYGGIKKYQWVTLPLAIHGVIVKKDGT--IVNVCVGEDDNDPVFGVSDILVHLA 182  
Bb    TNYYGGIKKYQWLSTPLSIRGVVFLKNGE--KVEINIGDNENDPVFVIPDILPHLD 172 
Tm    THYYGGIKKYHWLSIPLEIHGVLFKNDGT--EIEIHIGDKPEDPVFTIPDLLPHLD 170  
Hs    VETYGGGIWSTWFDRDLTLAGRVIVKCPTSGRLEQQLVH-VERPILRIPHLAIHL- 171  
Sc(2) VETYGGAIWHSWFDKDLGVAGRVFVKDAKTGKSIARLVD-LNRPLLKIPTLAIHL- 174 
Pa    VEVYGGALFAPWFDRDLSLAGRVTFRA-N-GKLESRLVD-FRKAIAVIPNLAIHL- 157 
Pf    VECYGSGLWHTWFDRSLGLSGQVLYKKGN--KLVEKLIQ-INKSVLFLPSLAIHL- 161 
 
Sc(1) -GKPAEG---PFDKEDQTIPVIGFPTPDEEGN------------------------ 239 
Ca    SE-QLEKKASKVIEGEDLNILIGSIPL----------------------------- 208 
Bb    RKIQRNKKSDEIVEGENLKILIGSLPI----------------------------- 199 
Tm    KE---DAKISEKFKGENLMLIAGTIPL----------------------------- 194 
Hs    -QRNINE-NFGPNTEMHLVPILATAIQEELEK------------------------ 201 
Sc(2) -DRDVNQ-KFEFNRETQLLPIGGLQEDKTEAK------------------------ 204 
Pa    -NRAANE-GWPINAQNELPPIIAQLAPGEAAD------------------------ 187 
Pf    QNRTRYDFSVKINYENHIKPIISTTLFNQLNKCKRNNVHHDTILTTDTKFSHKENS 217 
 
Sc(1) -------------------------------------------EPPTDDEKKSPLF 252 
Ca    --------------------------------------------------KDGEEK 214 
Bb    ---------------------------------------------------ETKEK 204 
Tm    ---------------------------------------------------SGEEK 199 
Hs    --------------------------------------------GTPEPGPLNAVD 213 
Sc(2) ---------------------------------------TEKEINNGEFTSIKTIV 221 
Pa    -------------------------------------------------------- 187 
Pf    QNKRDDQMCHSFNDKDVSNHNLDKNTIEHLTNQQNEEKNKHTKDNPNSKDIVEHIN 273 
 
Sc(1) GKHCIHLLRYVAKLAGVE-VSELIQMDLDLFDVQKGTIGGIGKHFLFAPRLDDRLC 307 
Ca    QKVKHNIMKILNEKYDIS-EEDFVSAELEIVPAGKARDYGFDRSMVMGYGQDDRIC 269 
Bb    NKVKLATLQLIKEKYKIE-EEDFVSSEIEIVPAGTAKDVGFDKALIGAYGQDDKIC 259 
Tm    EAVKTNVLKILNEMYGIT-EEDFVSGEIEVVPAFSPREVGMDRSLIGAYGQDDRIC 254 
Hs    ERHHSVLMSLLCAHLGLS-PKDIVEMELCLADTQPAVLGGAYDEFIFAPRLDNLHS 268 
Sc(2) QRHHAELLGLIAKELAIDTIEDIEDFELILYDHNASTLGGFNDEFVFSGRLDNLTS 277 
Pa    --FRLLLDEQLLREHGIT-ADVVLDYELSFYDTQSAAVVGLNDEFIAGARLDNLLS 240 
Pf    TDNSYPLLYLLSKELNCK-EEDILDFELCLMDTQEPCFTGVYEEFIEGARFDNLLG 328 
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Sc(1) SFAAMIALICYAKDVN---------------------TEESDLFSTVTLYDNEEIG 342 
Ca    AYTSFEAMLEM-K------------------------NAKK--TCITILVDKEEVG 298 
Bb    VFTSLESIFDLEE------------------------TPNK--TAICFLVDKEEIG 289 
Tm    AYTALRALLSA--------------------------NPEK--SIGVIFFDKEEIG 282 
Hs    CFCALQALIDSCAGPGSLA------------------TEPH--VRMVTLYDNEEVG 304 
Sc(2) CFTSMHGLTLAADTEID--------------------RESG--IRLMACFDHEEIG 311 
Pa    CHAGLEALLNA--------------------------EGDE--NCILVCTDHEEVG 268 
Pf    SFCVFEGFIELVNSIKNHTSNENTNHTNNITNDINDNIHNN--LYISIGYDHEEIG 382 
 
Sc(1) SLTRQGAKGGLLESVVERSS-SAFTKKP---------VDLHTVWANSIILSADVNH 388 
Ca    SIGATGMQSKFFENTVADIM-SLCG-DYDE-------LKLRKALYNSEMLSSDVSA 345 
Bb    STGSTGLDSRYLEYFVSDMIFKIKKSEYNN-------LHVQKALWNSKSISADVCA 338 
Tm    SDGNTGAKARFYLKALRQIL-KMQGAKDSE-------FVLDEVLENTSVISGDVCA 330 
Hs    SESAQGAQSLLTELVLRRIS-ASCQHP----------TAFEEAIPKSFMISADMAH 349 
Sc(2) SSSAQGADSNFLPNILERLS-ILKGDGSDQTKPLFH-SAILETSAKSFFLSSDVAH 365 
Pa    SCSHCGADGPFLEQVLRRLL-PE------G-------DAFSRAIQRSLLVSADNAH 310 
Pf    SLSEVGARSYCTKNFIDRII-SSVFKKEIHEKNLSVQEIYGNLVNRSFILNVDMAH 437 
 
Sc(1) LYNPNFPEVYLKNHFPVPNVGITLS--LDPNGHMATDVVGTALVEEL------ARR 436 
Ca    AFDPNYPNVMEKRNSAYLGKGIVFNKYTGSRGKSGCNDANPEYIAELRRI---LSK 398 
Bb    AINPLFSSVHDEQNAPQLGYGIPIMKYTGHGGKSMASDADAELVSYIRQL---LNK 391 
Tm    AVNPPYKDVHDLHNAPKLGYGVALVKYTGARGKYSTNDAHAEFVARVRKV---LNE 383 
Hs    AVHPNYLDKHEENHRPLFHKGPVIK--VNSKQRYASNAVSEALIREV------ANK 397 
Sc(2) AVHPNYANKYESQHKPLLGGGPVIK--INANQRYMTNSPGLVLVKRL------AEA 413 
Pa    GVHPNYADRHDANHGPALNGGPVIK--INSNQRYATNSETAGFFRHL------CQD 358 
Pf    CSHPNYPETVQDNHQLFFHEGIAIK--YNTNKNYVTSPLHASLIKRTFELYYNKYK 491 
 
Sc(1) NGDKVQ-YFQIKNNSRSGGTIGPSLASQTGARTIDLGIAQLSMHSIRAATGSKDVG 491  
Ca    ESVNWQTAELGKVDQGGGGTIAYILA-EYGMQVIDCGVALLNMHAPWEISSKADIY 453 
Bb    NNIAWQVATLGKVEEGGGGTVAKFLA-GYGIRTIDMGPAVISMHSPMEITSKFDLY 446 
Tm    QGVIWQVATLGKVDQGGGGTIAKFFA-ERGSDVIDMGPALLGMHSPFEISSKADLF 438 
Hs    VKVPLQ-DLMVRNDTPCGTTIGPILASRLGLRVLDLGSPQLAMHSIREMACTTGVL 452 
Sc(2) AKVPLQ-LFVVANDSPCGSTIGPILASKTGIRTLDLGNPVLSMHSIRETGGSADLE 468 
Pa    SEVPVQ-SFVTRSDMGCGSTIGPITASQVGVRTVDIGLPTFAMHSIRELAGSHDLA 413 
Pf    QQIKYQ-NFMVKNDTPCGSTVGSMVAANLSMPGIDIGIPQLAMHSIREIAAVHDVF 546 
 
Sc(1) LGVKFFNGFFKHWRSVYDEFG 512  
Ca    ETKNGYSAFLNN--------- 465 
Bb    NAYLAYKAFYRE--------- 458 
Tm    ETYVAYRSLMEKL-------- 451 
Hs    QTLTLFKGFFELFPSLSHNLL 473 
Sc(2) FQIKLFKEFFERYTSIESEIV 489 
Pa    HLVKVLGAFYASSELP----- 429 
Pf    FLIKGVFAFYTYYNQVLSTCV 567 
Figure 44: MEROPS database sequence alignment of M18 aminopeptidases.  
Amino acid sequence alignments of S. cerevisiae (Sc 1 & 2), C. acetobutylicum 
(Ca), B. burgdorferi (Bb), T. maritima (Tm), H. sapiens (Hs), P. aeruginosa (Pa), 
and PfM18AAP (Pf). The N- and C-terminal amino acids of most of the 
sequences have been omitted by the creators of this alignment and therefore the 
first and last three amino acids are missing from the PfM18AAP sequence. Amino 
acid colours: red = metal binding sites; pink and light blue = active site residues; 
dark blue = quaternary structure residue; green = putative transmembrane 
domains; and underlined yellow = spectrin-binding region. Box colours: light blue 
= putative protein kinase C phosphorylation site; and dark blue = putative casein 
kinase II phosphorylation site. 
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Pc    ----------MDKKAREYAQEAIKFIQRSGSSFMACKNLREKLESHGLIHIKEGDQ  46 
Py    FVSVVILFKQMDKKAREYAQEALKFIQRSGSNFMACKNLREKLESHGLIHIKEGDQ  57 
Pk    ---MQPTDDTMEKKVRDYAQGAVKFIKKSGSNFLACKNLREKLEEKGFKRIQEGEK  53 
Pv    ----------MEKKAREYAQGAVRFIQKSGSNFLACKNLREKLEERGFKRIHEGEK  46 
Pf    ----------MDKKAREYAQDALKFIQRSGSNFLACKNLKERLENNGFINLSEGET  46 
                *:**.*:*** *::**::***.*:*****:*:**..*: .: **: 
 
Pc    WKLQKNQGYVLCKENRNICSFFVGKNFNINNGSILISIGHIDSCALKISPNNKVTK 102 
Py    WKLQKNQGYVLCKENRNICSFFIGKNFNINNGSILISIGHIDSCTLKISPNNKVTK 113 
Pk    WDLRKNEGYVFSKQNRNICGFFIGKDFNMEKGSILISIGHVDTCCLKISPNNNTVK 109 
Pv    WELRKNEGYVLSKQSRNICGFFIGKDFTIEKGSILISIGHIDSCCLKVSPNNNVVK 102 
Pf    WNLNKNEGYVLCKENRNICGFFVGKNFNIDTGSILISIGHIDSCALKISPNNNVIK 102 
      *.*.**:***:.*:.****.**:**:*.::.*********:*:* **:****:. * 
 
Pc    DQISQLNVECYGSGLWHTWFDRSLGLSGQVVYKKDNKLVEKIIQINKSVLFLPSLA 158 
Py    DQISQLNVECYGSGLWHTWFDRGLGLSGQVVYKKDNKLIEKIIQINKSVLFLPSLA 169 
Pk    SKVNQLNVECYGSGLWHTWFDRSLGLSGQVVYKKDDKLVEKLIQINRSIIFLPSLA 165 
Pv    SKLHQLNVECYGSGLWHTWFDRSLGLSGQVLYKKEGKLVERLIQINKSLLFLPSLA 158 
Pf    KKIHQINVECYGSGLWHTWFDRSLGLSGQVLYKKGNKLVEKLIQINKSVLFLPSLA 158 
      .:: *:****************.*******:*** .**:*::****:*::****** 
 
Pc    IHLQNRTRYDFSVKVNYENHLKPILSTVLYEKLIKG-------------------- 194 
Py    IHLQNRTRYDFSVKVNYENHLKPIISTLLYEKLIKG-------------------- 205 
Pk    IHLQNRTRFEFSVKVNFENHLKPIISTVLYDQLIKGK------------------- 202 
Pv    IHLQNRTRFEFSVKINYEAHLKPILSTLLYEHLVKG-------------------- 194 
Pf    IHLQNRTRYDFSVKINYENHIKPIISTTLFNQLNKCKRNNVHHDTILTTDTKFSHK 214 
      ********::****:*:* *:***:** *:::*  * 
 
Pc    ---------------------NENISEKNNS-----STDDEDKNSKN--------- 215 
Py    ---------------------NENILEKNISNIDDNNNDDDDMNSKN--------- 231 
Pk    --------------------EKQNTDAFTEDTLHAEKIQDKCLNGDD--ASPSCLS 236 
Pv    --------------------GKPGAASPTEDATDADNAQEKRLDAED--HSPSCHS 228 
Pf    ENSQNKRDDQMCHSFNDKDVSNHNLDKNTIEHLTNQQNEEKNKHTKDNPNSKDIVE 270 
                           : .    . .     . ::.  . .:          
 
Pc    ----INSSPLLYLLANELKCKEDDILDFELCLMDTNQPCFTGVYEEFIEGARFDNL 267 
Py    ----LNSSPLLYLLANELKCKEEDILDFELCLMDTNKPCFTGVYEEFIEGARFDNL 283 
Pk    HQENPNSSPLLYTLAKELQCEEKDILDFELCLMDVNEPCFTGAYEEFIEGARFDNL 292 
Pv    HQENPNSSPLLYTLAKELQCQEKDILDFELCLMDVNQPCFTGAYEEFIEGARFDNL 284 
Pf    HINTDNSYPLLYLLSKELNCKEEDILDFELCLMDTQEPCFTGVYEEFIEGARFDNL 326 
           ** **** *::**:*:*.***********.::*****.************* 
 
Pc    LGTFSVFEAYIELIKMIKSE--------------------------NNKNEPLENN 297 
Py    LGTFGVFEAYVELIKNLKNE--------------------------DNEN--LGNN 311 
Pk    LGSYCVFEAFAEMIDMLKG--------------------KTPPSDGAVLPPEAHAN 328 
Pv    LGSFCVFEAFAEMVDMLRGGAEAAAGAAAAAEGEASAAGAASAGAAAAPPPGAHAN 340 
Pf    LGSFCVFEGFIELVNSIKNHT-------------SNENTNHTNNITNDINDNIHNN 369 
      **:: ***.: *::. ::.                                    * 
 
Pc    LYICIGYDHEEIGSLSEIGAQSYFTKSFIERIIGNIFKNELKN------------- 340 
Py    LYICIGYDHEEIGSLSEIGAQSYFTKNFIERILGNIFKNELKN------------- 354 
Pk    LYICIGYDHEEIGSLSEVGAQSYFTQNFIKRILTAISSSQVGQNTHP--------S 376 
Pv    LYICIGYDHEEIGSLSEVGAQSYFTQNFIKRILAAVCSSHACDAASATTSSAATAS 396 
Pf    LYISIGYDHEEIGSLSEVGARSYCTKNFIDRIISSVFKKEIHE------------- 412 
      ***.*************:**:** *:.**.**:  : ...  : 
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Pc    NETTVDEIYGSLSSRSLILNVDMAHCGHPNYPETIQQSHHLRFHDGIAIKYNTNKN 396 
Py    NDITIDEIYGSLSNRSLILNVDMAHCGHPNYPETIQQNHHLRFHEGIAIKYNTNKN 410 
Pk    SPTSIDELYGSLMSRSLILNVDMAHCSHPNYPETVQANHQLFFHEGIAIKYNTNRN 432 
Pv    APPSIDELYGSLMSRSLLLNVDMAHCSHPNYPETVQASHQLFFHEGIAIKYNTNKN 452 
Pf    KNLSVQEIYGNLVNRSFILNVDMAHCSHPNYPETVQDNHQLFFHEGIAIKYNTNKN 468 
         :::*:**.* .**::********.*******:* .*:* **:*********:* 
 
Pc    YVTSPYYACLLKRTFELYQNQYNQKIKYQNFMIKNDTPCGSTVGSMVASNLSMPGM 452 
Py    YVTSPYYACLLKRTFELYQNQNNQKIKYQNFMIKNDTPCGSTVGSMVAANLSMPGM 466 
Pk    YATSPYYTCLLKRTFELFTSKFNEKIKYQNFMVKNDTPCGSTVGSMVASNLSMPGV 488 
Pv    YVTSPYYTCLLKRTFELFASNFNEKIKYQNFMVKNDTPCGSTVGSMVAANLSMPGI 508 
Pf    YVTSPLHASLIKRTFELYYNKYKQQIKYQNFMVKNDTPCGSTVGSMVAANLSMPGI 524 
      *.*** ::.*:******: .: :::*******:***************:******: 
 
Pc    DIGISQLAMHSIREIAAIHDIYYLIKGVFAFYAYYNQVLSTCVHDA 498 
Py    DIGIPQLAMHSIRELAAIHDIYYLVKGIFAFYAYYNQVLSSCVHDS 512 
Pk    DIGIPQLAMHSIREIAAVRDIYYLVKGILAFYTYYSHVHASCVPDE 534 
Pv    DIGIPQLAMHSIREIAAVRDVYYLVKGVLAFYAYYSHVLASCVPDA 554 
Pf    DIGIPQLAMHSIREIAAVHDVFFLIKGVFAFYTYYNQVLSTCVHDK 570 
      ****.*********:**::*:::*:**::***:**.:* ::** * 
Figure 45: Sequence alignment of the Plasmodium PfM18AAP homologues. 
ClustalW alignment of the P. chabaudi chabaudi (Pc), P. yoelii yoelii (Py), P. 
knowlesi (Pk), P. vivax (Pv) and PfM18AAP amino acid sequences. Amino acid 
colours: red = metal binding sites; pink and light blue = active site residues; dark 
blue = quaternary structure residue; green = putative transmembrane domains; and 
underlined yellow = spectrin-binding region. Box colours: light blue = putative 
protein kinase C phosphorylation site; and dark blue = putative casein kinase II 
phosphorylation site. Alignment annotation: ‘*’ = residues that are identical in all 
sequences; ‘:’ = conserved substitutions; and ‘.’ = semi-conserved substitutions. 
 
The spectrin-binding region (Pf216-257; labelled yellow in Figure 44 and Figure 
45) is located within an amino acid stretch that is not found in any of the other 
aminopeptidases and represents a unique sequence insertion in PfM18AAP. 
Despite this P. falciparum-specific insert (Pf195-234) and the larger size of the P. 
falciparum protein (16-72 amino acids longer), there is still a 64-74 % sequence 
identity (Table 16) between PfM18AAP and the Plasmodium homologues. 
 
4.3.3 PfM18AAP secondary structure 
 
The secondary structure of PfM18AAP was analysed to determine what structural 
elements are found in the unique spectrin-binding region. These data were 
obtained from the PlasmoDB database or by sequence analysis with the SOSUI or 
Jpred programme. The PlasmoDB secondary structure prediction for the 
PfM18AAP-specific spectrin-binding region (Pf216-257; orange box in Figure 
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46) showed that this region contains two alpha helices. This contrasts with the 
Jpred secondary structure prediction (labelled orange in Figure 47), which only 
revealed one alpha helix corresponding to the second peak in the PlasmoDB 
prediction. The SOSUI program predicted two transmembrane domains (Pf504-
526 and Pf538-560; labelled in green in Figure 47), but this was not substantiated 
by the Kyte-Doolittle hydropathy plot provided by PlasmoDB (green boxes in 
Figure 46). 
 
 
Figure 46: PlasmoDB hydropathy plot, secondary structure and low 
complexity regions for PFI1570c (PfM18AAP). 
Diagram showing the Kyte-Doolittle hydropathy plot, secondary structure and low 
complexity region prediction for the PfM18AAP amino acid sequence. Secondary 
structures: red = alpha helix; and blue = beta strand. Box colours: orange = 
spectrin-binding region (Pf216-257); and green = putative transmembrane 
domains (Pf504-526 and Pf538-560). 
 
Secondary structure predictions for the whole enzyme were performed with Jpred 
to ascertain if the different M18 aminopeptidases had a similar alpha helix, beta 
sheet and random coil pattern. Figure 47 shows the secondary structure alignment 
of the M18-family aminopeptidase 1 from T. maritima, the M18-family 
aminopeptidase 2 from P. aeruginosa and PfM18AAP. A similar helix and sheet 
pattern was predicted for all the M18 aminopeptidases, indicating that PfM18AAP 
could fold in a similar way to the other M18 aminopeptidases. 
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Tm    ----EAFSKEYMEFMSKAKTERMTVKEIKRILDESGFVPLEDF---AGDPMNMTVY  66 
Pa    MRAEL--NQGLIDFLKASPTPFHATASLARRLEAAGYRRLDERDAW-HTETGGRYY  53 
Pf    DKKAREYAQDALKFIQRSGSNFLACKNLKERLENNGFINLSEGETW-NLNKNEGYV  56 
 
Tm    ----HHHHHHHHHHH------HHHHHHHHHHHHH--------------------EE  66 
Pa    --HHH--HHHHHHHH------HHHHHHHHHHHHH----E--------------EEE  53 
Pf    ---HHHHHHHHHHHH------HHHHHHHHHHHHH----HHH------------EEE  56 
 
 
Tm    AVNRGKAIAAFRVVDDL--KR-GLNLVVAHIDSPRLDFKPNPLIEDEQIALFKTHY 119 
Pa    VTRNDSSLIAIRLGRRSPLES-GFRLVGAHTDSPCLRVKPNPEIARNGFLQLGVEV 108 
Pf    LCKENRNICGFFVGKNFNIDTGSILISIGHIDSCALKISPNNNVIKKKIHQINVEC 112 
 
Tm    EEE---EEEEEEE----------EEEEEE-------------------EEEEEEEE 119 
Pa    EEE---EEEEEEE----------EEEEEE-------E-----------EEEEEEEE 108 
Pf    EEE---EEEEEEE----------EEEEEE-------E-----------EEEEEEEE 112 
 
 
Tm    YGGIKKYHWLSIPLEIHGVLFKNDGT-EIEIHIGDKPEDPVFTIPDLLPHLDKE-- 172 
Pa    YGGALFAPWFDRDLSLAGRVTFRA-NGKLESRLVD-FRKAIAVIPNLAIHL--NRA 160 
Pf    YGSGLWHTWFDRSLGLSGQVLYKKGN-KLVEKLIQ-INKSVLFLPSLAIHL-QNRT 165 
 
Tm    ------------------EEEEE-----EEEEEEE------EE---HHHH------ 172 
Pa    ------------------EEEEE-----EEEEEE-------EE------------- 160 
Pf    -----EEEE---------EEEEE-----EEEEEEE--------------------- 165 
 
 
Tm    -DAKISEKFKGENLMLIAGTIPL--------------------------------- 194 
Pa    ANE-GWPINAQNELPPIIAQLAPGEAAD---------------------------- 187 
Pf    RYDFSVKINYENHIKPIISTTLFNQLNKCKRNNVHHDTILTTDTKFSHKENSQNKR 221 
 
Tm    ----------------EEE------------------------------------- 194 
Pa    --------------EEEE-------------------------------------- 187 
Pf    -----EEEEEEE----EEEEE---------EEEEE------EEEE----------- 221 
 
 
Tm    -----------------------------------------------SGEEKEAVK 203 
Pa    ------------------------------------------------------FR 189 
Pf    DDQMCHSFNDKDVSNHNLDKNTIEHLTNQQNEEKNKHTKDNPNSKDIVEHINTDNS 277 
 
Tm    -------------------------------------------------------H 203 
Pa    -------------------------------------------------------H 189 
Pf    ----------------------HHHHHHHHHHH----------------------- 277 
 
 
Tm    TNVLKILNEMYGITEEDFVSGEIEVVPAFSPREVGMDRSLIGAYGQDDRICAYTAL 259 
Pa    LLLDEQLLREHGITADVVLDYELSFYDTQSAAVVGLNDEFIAGARLDNLLSCHAGL 245 
Pf    YPLLYLLSKELNCKEEDILDFELCLMDTQEPCFTGVYEEFIEGARFDNLLGSFCVF 333 
 
Tm    HHHHHHHHHH------HHHHHEEEEE-----------HHHHH------HHHHHHHH 259 
Pa    HHHHHHHHHHH-----------EEE--------------HHH------HHHHHHHH 245 
Pf    HHHHHHHHHH---------EEEEEEE------------HHHH------HHHHHHHH 333 
 
 
Tm    RALLSA--------------------------NPEKSIGVIFFDKEEIGSDGNTGA 289 
Pa    EALLNA--------------------------EGDENCILVCTDHEEVGSCSHCGA 275 
Pf    EGFIELVNSIKNHTSNENTNHTNNITNDINDNIHNNLYISIGYDHEEIGSLSEVGA 389 
 
Tm    HHHH---------------------------------EEEEEE------------- 289 
Pa    HHHHH--------------------------------EEEEEE--EEE-------- 275 
Pf    HHHHH-------------------------------EEEEEE-------------- 389 
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Tm    KARFYLKALRQILKMQGAKDSE-------FVLDEVLENTSVISGDVCAAVNPPYKD 338 
Pa    DGPFLEQVLRRLLPE------G-------DAFSRAIQRSLLVSADNAHGVHPNYAD 318 
Pf    RSYCTKNFIDRIISSVFKKEIHEKNLSVQEIYGNLVNRSFILNVDMAHCSHPNYPE 445 
 
Tm    ---HHHHHHHHHHHH------H-------HHHHHHHHH-EEE-------------- 338 
Pa    ----HHHHHHHHHH-------H-------HHHHHHHH--HHHH------------- 318 
Pf    ---HHHHHHHHHHH--------------HHHHHHHHH---EEE------------- 445 
 
 
Tm    VHDLHNAPKLGYGVALVKYTGARGKYSTNDAHAEFVARVRKV---LNEQGVIWQVA 391 
Pa    RHDANHGPALNGGPVIK--INSNQRYATNSETAGFFRHL------CQDSEVPVQ-S 365 
Pf    TVQDNHQLFFHEGIAIK--YNTNKNYVTSPLHASLIKRTFELYYNKYKQQIKYQ-N 498 
 
Tm    -------------EEEEEE-----------HHHHHHHHHHHH---HH-----EEEE 391 
Pa    -------------EEEE--E---------HHHHHHHHHH------HHH----EE-E 365 
Pf    -------------EEEE--E----------HHHHHHHHHHHHHH--------EE-E 498 
 
 
Tm    TLGKVDQGGGGTIAKFFA-ERGSDVIDMGPALLGMHSPFEISSKADLFETYVAYRS 446 
Pa    FVTRSDMGCGSTIGPITASQVGVRTVDIGLPTFAMHSIRELAGSHDLAHLVKVLGA 421 
Pf    FMVKNDTPCGSTVGSMVAANLSMPGIDIGIPQLAMHSIREIAAVHDVFFLIKGVFA 554 
 
Tm    EEEE--------E-HHHH------EEE----------HHHH----HHHHHHHHHHH 446 
Pa    EEE---------HHHHHHHH----EEEE----E-----EEE---HHHHHHHHHHHH 421 
Pf    EEEE-----------HHH------EEE----------HHHH-----HHHHHHHHHH 554 
 
 
Tm    LMEKL-------- 451 
Pa    FYASSELP----- 429 
Pf    FYTYYNQVLSTCV 567 
 
Tm    HH----------- 451 
Pa    HHH---------- 429 
Pf    HHH-------EEE 567 
Figure 47: Jpred secondary structure prediction of PfM18AAP and its 
aminopeptidase homologues. 
Jpred secondary structure predictions and MEROPS sequence alignments of the T. 
maritima (Tm), P. aeruginosa (Pa), and PfM18AAP (Pf) aminopeptidases. Amino 
acid colours: red = metal binding sites; pink and light blue = active site residues; 
dark blue = quaternary structure residue; green = putative transmembrane 
domains; and underlined yellow = spectrin-binding region. Secondary structure 
predictions: H = alpha helix; E = beta-sheet or strand; ‘-‘ = random coil; and 
orange letters = predicted alpha-helix in spectrin-binding region. 
 
4.3.4 Molecular weight and isoelectric point of the rPfM18AAP 
monomer 
 
To determine some of the chemical characteristics of the PfM18AAP monomer, 
the molecular weight and the pI of the denatured enzyme was analysed by SDS-
polyacrylamide gel and two-dimensional polyacrylamide gel electrophoresis. 
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The rPfM18AAP monomer separated on a 12 % Laemmli SDS-polyacrylamide 
gel with a molecular weight of approximately 67 kDa. This value correlates well 
with the calculated molecular weight for rPfM18AAP of 66.919 kDa. Removal of 
the histidine-tag resulted in a molecular weight of ~65 kDa for the rPfM18AAP 
monomer (Figure 48). 
 
The histidine-tag was removed from rPfM18AAP by thrombin cleavage, so that it 
would not alter the pI of the aminopeptidase. Figure 48 shows that the His-tag was 
successfully removed from rPfM18AAP after 4 hours of thrombin cleavage at 
room temperature (Lane T) and that there was no significant degradation of the 
protein throughout the procedure. A loss of protein was however observed during 
the cleavage procedure, because double the volume of protein (Lane T and Tu) 
had to be electrophoresed through the gel to be visible after Coomassie staining. 
This was probably due to some of the protein-containing supernatant remaining 
on the agarose beads at the end of the cleavage procedure, because it was very 
difficult to remove all the supernatant from the beads.  
 
 
Figure 48: Thrombin cleavage of rPfM18AAP. 
Laemmli gel (left) and immunoblot with the Penta•His™ HRP Conjugate 
antibody (right) showing the purification and thrombin-cleavage of rPfM18AAP. 
Lane M = 3 µg erythrocyte membrane proteins; W = 10 µl of the 8 ml induced E. 
coli whole cell extract; S = 10 µl of the 8 ml soluble protein fraction after 
sonication; Ub = 10 µl of the 8 ml protein fraction that did not bind to the HIS-
Select™ Magnetic Agarose Beads; 1-5 = 20 µl of each 1.2 ml 20 mM imidazole 
wash; E = 1 µl of the 750 µl 200 mM imidazole elution; DE = 1 µl of 750 µl 
dialysed rPfM18AAP; T = 2 µl of 875 µl thrombin-cleaved rPfM18AAP; Tu = 2 
µl of 875 µl unbound thrombin-cleaved rPfM18AAP; P = 1 µl of precipitated 
rPfM18AAP resuspended in 100 µl IEF buffer after thrombin cleavage. 
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The isoelectric point of rPfM18AAP was determined by two-dimensional gel 
electrophoresis (Figure 49), where carrier ampholytes were used to set up the pH 
gradient. Rabbit muscle GAPDH (36 kDa), which has a pI of 8.3 and 8.5, was 
right at the edge of the gel, indicating that the pH gradient did not go up to pH 10. 
rPfM18AAP had been resuspended in IEF buffer that contained pH 5/8 
ampholytes, causing this segment of the pH gradient to spread over a greater 
distance of the gel and possibly causing the lower and higher pH ranges to be 
compacted at the gel ends. The spread of the pH gradient could also have been 
caused by a phenomenon called cathodic drift, in which the ampholytes 
responsible for the higher end of the pH gradient, are drawn out of the gel matrix 
into the upper chamber buffer (Westermeier, 1997). 
 
The approximate pI values of the three charge isomers of rPfM18AAP were 
estimated from the position of the standards and were found to be ~6.6, ~6.7, and 
~6.9. Apart from the standards, additional protein spots can be seen (not circled in 
Figure 49). These contaminants were also seen during purification (Figure 48) and 
when performing the purification procedure from E. coli cells that only contained 
the pET-15b plasmid (results not shown). A large amount of rPfM18AAP can also 
be seen at the edge of the pH gradient (at pH 8.5), indicating that some of the 
protein did not electrophorese into the IEF gel. This was surprising because 
rPfM18AAP was resuspended in IEF buffer that contained 9.5 M urea. Protein 
aggregation could have been due to the rPfM18AAP high protein concentration 
required for the IEF procedure. 
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Figure 49: Two-dimensional gel electrophoresis of rPfM18AAP. 
Second dimension silver stained Laemmli gel showing the Bio-Rad 2-D SDS-
PAGE Standards and rPfM18AAP after they had been separated by IEF. The three 
charge isomers (circled in white) of rPfM18AAP have a pI of ~6.6, ~6.7 and ~6.9 
respectively. Bio-Rad 2-D SDS-PAGE Standards (circled in yellow): Hen egg 
white conalbumin type 1 (MW = 76 kDa; pI = 6.0, 6.3, 6.6); BSA (MW = 66.2 
kDa; pI = 5.4 & 5.6); Bovine muscle actin (MW = 43 kDa; pI = 5.0 & 5.1); Rabbit 
muscle GAPDH (MW = 36 kDa; pI = 8.3 & 8.5); Bovine carbonic anhydrase 
(MW = 31 kDa; pI = 5.9 & 6.0); Soybean trypsin Inhibitor (MW = 21.5 kDa; pI = 
4.5); Equine myoglobin (MW = 17.5 kDa, pI = 7.0). Laemmli gel marker (M) = 
15 µl erythrocyte membrane proteins. 
 
4.3.5 The oligomeric state of native rPfM18AAP 
 
The four M18 aminopeptidase crystal structures show that these enzymes occur as 
multimers in their native state. rPfM18AAP was therefore electrophoresed 
through non-denaturing gels to determine the approximate molecular size and 
hence the number of subunits of the native protein. 
 
Figure 50 shows that several oligomeric forms of rPfM18AAP were separated on 
the native gels. As the percentage acrylamide increases, protein bands are 
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separated, which comigrate on the 2 and 3 % polyacrylamide native gels. The first 
and third band can be seen clearly on the gels and the second band is very faint. A 
large amount of protein can also be seen at the top of the gels. 
 
 
Figure 50: Non-denaturing gel electrophoresis of rPfM18AAP. 
Photograph of 2-10 % native tube gels showing the protein bands of rPfM18AAP. 
Twenty-five micrograms of recombinant rPfM18AAP was electrophoresed 
through each native gel and stained with Coomassie Blue stain. 
 
The Ferguson plot linear regression lines (Figure 51), which were calculated from 
the Rm values of each rPfM18AAP band, intersect between 3 and 4 % gel 
concentration, indicating that these bands are oligomers of rPfM18AAP (Hedrick 
and Smith, 1968, Rodbard et al., 1974). 
 
The approximate molecular weights of the rPfM18AAP subunits that were 
estimated from the standard curve (Figure 52) are listed in Table 17. The second 
band is approximately double the size of the rPfM18AAP monomer (band 1) and 
is therefore a dimer, and the third band is four times the size of the monomer and 
is therefore a tetramer of rPfM18AAP (Table 17). 
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Figure 51: Ferguson plot of the rPfM18AAP protein bands. 
Graph showing the log Rm of the rPfM18AAP monomer, dimer and tetramer at 
different polyacrylamide percentages. These proteins are oligomers of each other 
because the lines intersect above 3 % gel concentration (Hedrick and Smith, 1968, 
Rodbard et al., 1974). Squares = first rPfM18AAP band; triangles = second 
rPfM18AAP band; and crosses = third rPfM18AAP band 3. 
 
 
Figure 52: Non-denaturing gel electrophoresis standard curve. 
Double-log graph of the negative slopes (obtained from Ferguson plots) versus the 
molecular weight of each standard. The molecular weight of the three 
rPfM18AAP bands was read from this graph and found to be ~70, ~155, and ~290 
kDa respectively. Yellow crosses = BSA (66 and 132 kDa); blue crosses = 
spectrin (460, 920, and 1380 kDa); red crosses and numbers = rPfM18AAP. 
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Table 17: Approximate molecular weights of the rPfM18AAP subunits. 
Band Molecular weight from standard curve (kDa) Subunit 
1 ~70 monomer 
2 ~155 dimer 
3 ~290 tetramer 
 
The native gel protein bands were transferred onto nitrocellulose membrane and 
the presence of the histidine-tag in rPfM18AAP detected by chemiluminescence. 
The rPfM18AAP monomer was seen as a distinct band and the tetramer is part of 
the smear above the monomer (Figure 53). Several other protein bands were not 
visualised on the immunoblot indicating that these proteins are contaminants 
isolated during the purification procedure. 
 
The smear extends to the top of the gels indicating that even higher oligomeric 
forms of rPfM18AAP are present. These higher oligomers could include an 
octamer, which is the rPfM18AAP subunit composition that Teuscher et al. 
(2007) determined by assaying HPLC fractions for enzymatic activity. Octamers 
were also observed for the H. sapiens and S. cerevisiae aspartyl aminopeptidases 
(Wilk et al., 2002, Yokoyama et al., 2006). However, the smear could also 
include a dodecamer, which is the native subunit composition of the crystal 
structures of the T. maritima, C. acetobutylicum and P. aeruginosa M18 
aminopeptidases (Min and Shapiro, 2006). 
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Figure 53: Detection of rPfM18AAP in non-denaturing gels. 
Photograph of 5-8 % native tube gels (left) and immunoblot with the Penta•His™ 
HRP Conjugate antibody (right) showing the monomer and oligomers of 
rPfM18AAP. Fifteen to twenty-five micrograms of recombinant rPfM18AAP was 
electrophoresed through each native gel. The tetramer is seen as an intense protein 
band in the Coomassie Blue stained gels, but a large amount of rPfM18AAP 
remained at the top of each gel, indicating that higher oligomeric forms of 
rPfM18AAP are present. This is confirmed by the immunoblot, where the higher 
oligomeric forms are part of the smears. 
 
4.3.6 PfM18AAP tertiary structure 
 
The tertiary structures of four M18 aminopeptidases were studied to gain insight 
on the structure of PfM18AAP and to study the location and conformation of the 
active site and the spectrin-binding region. 
 
The monomers of the C. acetobutylicum, T. maritima, B. burgdorferi and P. 
aeruginosa M18 aminopeptidase crystal structures (Min and Shapiro, 2006) were 
compared with each other using the Swiss-PdbViewer and showed similar tertiary 
structures. The monomer of T. maritima was the most complete structure (i.e. no 
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gaps were present in the amino acid sequence) and was therefore used for the 
structure analysis and comparisons with PfM18AAP. 
 
                   
                   
a) b) 
c) d) 
Figure 54: Crystal structures of the monomers of the M18 aminopeptidases. 
Diagram showing similar ribbon structures for the Pseudomonas aeruginosa (2ijz) 
(a), Clostridium acetobutylicum (2glj) (b), Borrelia burgdorferi (1y7e) (c) and 
Thermotoga maritima (2glf) (d) M18 aminopeptidases. Ribbon structures were 
created with DeepView Swiss-PdbViewer, version 3.7 (SP5). The PDB codes of 
the different proteins are listed in brackets. Blue = domain I and green = domain 
II. 
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The T. maritima aminopeptidase monomer contains two distinct structural regions 
that will be termed domain I and II (Figure 55a). Domain I is not contiguous and 
is formed by the N- and C-terminal amino acids of the enzyme. The active site lies 
at the edge of domain I, in close proximity to domain II, and forms a pocket in 
which the cofactor-binding amino acids, TmH93, TmD250, TmE280, TmD327 and 
TmH426 (PfH86, PfD324, PfE380, PfD434 and PfH534) and the two cofactors 
are located (Figure 55b inset). The two amino acids, TmE279 (PfE379) and 
TmD95 (PfD88), which are directly and indirectly involved in substrate cleavage 
are positioned at the edge of the active site. Domain II is formed by T. maritima 
amino acids Tm97-232 and is thus an internal section of the protein. The histidine, 
TmH168 (PfH160), that Wilk et al. (2002) found to be essential for enzyme 
activity in the H. sapiens aspartyl aminopeptidase, is located in an unstructured 
loop of domain II and faces in the opposite direction to the active site in domain I. 
When two monomers (A and B in Figure 55b) associate according to the 
parameters listed in the crystal structure file (Min and Shapiro, 2006), TmH168 of 
monomer B completes the active site in monomer A (Figure 55b inset) and vice 
versa. The histidine, HsH352 (PfH440), speculated to be involved in quaternary 
structure stabilisation in the H. sapiens aspartyl aminopeptidase (Wilk et al., 
2002), is not present in T. maritima and is therefore not shown in the crystal 
structure.  However, if this residue were present, it would be located on domain I 
of one monomer and could interact with domain II of the other monomer, thereby 
stabilising the quaternary structure. The putative protein kinase C and casein 
kinase II phosphorylation sites are located next to a histidine, TmH426 (PfH534), 
which forms part of the active site in domain I and therefore these two 
phosphorylation sites could be used to regulate enzymatic activity. The active 
sites are however located inside the native enzyme (Figure 56) and access to the 
phosphorylation sites by kinases could be limited. However, phosphorylation 
could also occur before the monomers are assembled into the quaternary structure. 
 
The T. maritima M18 aminopeptidase occurs as dodecamer in its native state and 
has the symmetry of a tetrahedron. Because the dimers lie along the edge of the 
triangles (Figure 56a), three domain Is, each containing an active site, form a 
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single vertex and three domain IIs form the flat surface of each triangle in the 
tetrahedron. Franzetti et al. (2002) described the crystal structure of a tetrahedral 
M42 aminopeptidase, which is also classified in the MH clan in the MEROPS 
database. In this enzyme, substrate access to the active sites located within the 
tetrahedron occurs via pores on the faces (21 Å) and in the vertices (17 Å) of the 
active enzyme. 
 
Secondary structure prediction showed that the T. maritima aminopeptidase is 
similar to rPfM18AAP (Figure 47), and therefore the quaternary structure of these 
two enzymes could be similar. If this is the case, then the amino acids, which form 
the spectrin-binding region in the PfM18AAP structure, would be located in 
domain II on the opposite side to domain I (asterisk in Figure 55a). When the 
transformation parameters of the T. maritima crystal structure file (Min and 
Shapiro, 2006) are applied to build a dimer and a dodecamer, the spectrin-binding 
region remains on the surface of these two structures (asterisks in Figure 55b and 
black amino acids on the surface of the ribbon structure in Figure 56a). If 
PfM18AAP is a dodecamer, then each triangle face of the tetrahedron would have 
three spectrin-binding regions extending as loops from its surface (white loops in 
Figure 56b) and the three active sites would be located on the inside of each 
vertex of the tetrahedron (red circles in the inset of Figure 56a). 
 
Finally, the putative transmembrane domains of PfM18AAP are found near the C-
terminus of the protein. Since the C-terminus of the T. maritima aminopeptidase is 
embedded in domain I (Figure 55) and contributes towards the tertiary structure of 
the domain (Min and Shapiro, 2006), it is unlikely that the putative 
transmembrane domains of PfM18AAP function as membrane anchors. 
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Figure 55: The T. maritima M18 aminopeptidase monomer and dimer. 
Diagram showing the ribbon structure of a monomer (a) and dimer (b) of T. 
maritima M18-family aminopeptidase 1 (PDB code: 2glf) (Min and Shapiro, 
2006). Domain I of monomer A and B are shown in blue and light blue 
respectively. Domain II of both monomers are depicted in green and light green 
respectively. The asterisk marks the predicted location of the PfM18AAP 
spectrin-binding region in the structure. The inset shows the active site with the 
two manganese atoms (black dots) surrounded by the metal binding amino acids 
(red residues: TmH93, TmD250, TmE280, TmD327 and TmH426) and the 
additional histidine involved in enzyme activity (lavender residue: TmH168). The 
two amino acids that are directly and indirectly involved in substrate cleavage are 
located at the edge of the active site (pink residues: TmE279 and TmD95). 
Structures were created with DeepView Swiss-PdbViewer, version 3.7 (SP5). 
b) 
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Figure 56: The M18 aminopeptidase dodecamer. 
Ribbon structure and diagram showing the quaternary structure of T. maritima 
M18-family aminopeptidase 1 (PDB code: 2glf) (a) (Min and Shapiro, 2006) and 
diagram of a possible structure outline of PfM18AAP (b). Dimers (yellow, green 
and blue) form the edges of the tetrahedron and each triangle face contains three 
domain IIs (dark blue ribbons in (a) and dark blue circles in (b)), on which the 
spectrin-binding region of PfM18AAP would be located (black amino acids in (a) 
or white loops in (b)). Three active sites (red amino acids in (a) and red circles in 
inset) lie within the vertices of the tetrahedron and the substrate can access these 
sites via pores located in the faces and vertices of the enzyme. The ribbon 
structure was created with DeepView Swiss-PdbViewer, version 3.7 (SP5). 
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4.3.7 rPfM18AAP enzyme activity 
 
PfM18AAP is described in the PlasmoDB database as an aminopeptidase that has 
homology to the human aspartyl aminopeptidase. The coupled enzyme assay 
designed to assay the human aminopeptidase was thus used to test if PfM18AAP 
is an active aminopeptidase and to establish the optimal cleavage conditions. 
 
rPfM18AAP was active as shown in Figure 57. The middle test tube shows the 
colour development after rPfM18AAP was allowed to cleave the substrate, in 
contrast to the blank reaction (left test tube) and one of the standard curve samples 
(right test tube). 
 
Figure 57: Colour reaction of the rPfM18AAP enzyme activity assay. 
Photograph of test tubes after completion of the substrate cleavage reaction and 
azo dye development. Left = blank; middle = rPfM18AAP incubated with 0.3 mM 
Asp-Ala-Pro-β-Napthylamide and dipeptidyl peptidase IV; right = 0.8 mM β-
Napthylamide (3rd highest standard). 
 
After it was established that rPfM18AAP cleaved Asp-Ala-Pro-β-Napthylamide, 
enzyme assay conditions were optimised (results not shown) so that product 
formation was linear with time and the substrate concentration exceeded enzyme 
concentration. These experimental conditions were used to determine the optimal 
pH, temperature and ionic strength for the enzyme reaction. Figure 58 shows that 
rPfM18AAP was most active at pH 7.5 and at 37 ºC and that the enzyme retained 
most of its enzymatic activity between pH 7-8.5 and 33-39 ºC. Varying the ionic 
strength of the 50 mM Tris buffer (50 or 150 mM NaCl) had no effect on 
enzymatic activity (results not shown). Even though overnight storage with 20 % 
glycerol at 4 ºC only decreased the enzymatic activity of rPfM18AAP by 2 %, all 
studies were performed directly after purification. 
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The enzymatic activity of rPfM18AAP was studied in the presence of metal ions 
(Table 18) and showed that none of the tested metal ions increased the activity of 
rPfM18AAP. Magnesium and manganese had no effect on substrate cleavage, 
indicating that these metal ions could be the actual or substitute cofactors of the 
enzyme. In contrast, zinc and calcium had a strong (>90 %) and moderate (~20 %) 
inhibitory effect on enzymatic activity, suggesting that these metal ions are not the 
cofactors of the enzyme. Cobalt was not tested, but Teuscher et al. (2007) showed 
that it increased the activity. 
 
 
Figure 58: pH and temperature optima of rPfM18AAP. 
Graphs showing the relative activity (%) of rPfM18AAP over a pH and 
temperature range. Left graph = 2.5 µg rPfM18AAP was incubated with 0.3 mM 
Asp-Ala-Pro-β-Napthylamide and 0.125 U dipeptidyl peptidase IV for 15 minutes 
at 37 ºC in different buffers. For pH 6.8, 7.5, 8, 8.5, and 9, 50 mM Tris-HCl buffer 
was used. For pH 5.3 and 6, 0.1 M sodium citrate buffer was used. Right graph = 
2.5 µg rPfM18AAP was incubated with 0.3 mM Asp-Ala-Pro-β-Napthylamide 
and 0.125 U dipeptidyl peptidase IV in 50 mM Tris-HCl buffer (pH 7.5) for 15 
minutes at 25, 30, 33, 37, and 39 ºC. The curves represent two independent 
experiments. 
 
Table 18: rPfM18AAP relative activity in the presence of metal ions. 
Cofactor Relative activity (%) ± SEM* 
no cofactor 100 
1 mM Zn2+ 7 ± 3 
1 mM Mg2+ 89 ± 6 
1 mM Mn2+ 89 ± 9 
1 mM Ca2+ 78 ± 8 
* sample size = 4 
SEM = standard error of the mean 
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Enzymatic assays in the presence of enzyme inhibitors (Table 19) showed that 
EDTA, which is a metal chelator and therefore affects metalloproteases, had the 
strongest effect on rPfM18AAP (46 % loss of activity). This effect was increased 
to 57 % when the enzyme was preincubated with EDTA for 10 minutes at 37 ºC. 
Bestatin, which specifically inhibits aminopeptidases, only inhibited rPfM18AAP 
by 20 %, but this effect was enhanced to 39 % when rPfM18AAP was 
preincubated with this competitive inhibitor for 10 minutes at 37 ºC. Presumably 
this allowed the dipeptide analogue, which cannot be processed by 
aminopeptidases, to bind in the rPfM18AAP active site.  
 
The serine protease inhibitor, Pefabloc SC, inhibited enzymatic activity, but 
another serine protease inhibitor, PMSF, showed only a slight inhibition. The 
difference could be attributed to the instability of PMSF at elevated temperatures 
and the insolubility of PMSF in aqueous solutions. PMSF stock solutions are 
prepared in DMSO and addition of this stock solution to the reaction buffer may 
cause precipitation of the inhibitor, resulting in a decreased amount of available 
inhibitor. The active site of rPfM18AAP has serine residues adjacent to two of the 
amino acids that are involved in cofactor binding and substrate cleavage (PfH534 
and PfD88). The serine protease inhibitors could have bound to these serine 
molecules and prevented the substrate from entering the active site, thereby 
reducing enzymatic activity. 
 
Table 19: rPfM18AAP relative activity in the presence of protease inhibitors. 
Inhibitor Relative activity (%) ± SEM* with no preincubation at 37 ºC 
no inhibitor 100 
10 mM EDTA 54 ± 13 
1mM Pefabloc SC 61 ± 8 
1 mM PMSF 90 ± 7 
10 µM Bestatin 79 ± 5 
* sample size = 4 
SEM = standard error of the mean 
 
It was problematic to determine a reliable value for Km and Vmax from all the 
experiments because a fresh enzyme preparation was used each time, with 
variable activity. In addition, slight substrate inhibition was observed at high 
 
 
156
concentrations (>1.5 mM). Figure 59 shows velocity versus substrate curves for 
three experiments with a high, medium and low enzyme activity of rPfM18AAP 
and due to the inconsistent behaviour of the enzyme, Km and Vmax values were 
only determined from experiments showing medium and high enzymatic activity. 
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a) b)
c) 
Figure 59: Variation in rPfM18AAP enzymatic activity. 
Plots of velocity (V) against substrate (S) according to the Michaelis-Menten 
equation showing a high (a), medium (b) and low (c) enzymatic activity for 
different preparations of rPfM18AAP. 
 
The Michaelis-Menten calculation does not take substrate inhibition into 
consideration (Figure 60a) and therefore a Lineweaver-Burk plot (Figure 60b) was 
used to determine the following approximate Km and Vmax values for 
rPfM18AAP: 
Km = ~0.8 mM 
Vmax = ~2 nmol/min 
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Figure 60: Michaelis-Menten and Lineweaver-Burk plots for rPfM18AAP. 
Plot of velocity (V) against substrate (S) according to the Michaelis-Menten 
equation (a) and double-reciprocal plot of 1/V against 1/S (b) for rPfM18AAP. 
Substrate inhibition occurs at ~1.5 mM Asp-Ala-Pro-β-Napthylamide in the 
Michaelis-Menten graph and therefore the mean velocity of 1.5, 2, and 3 mM 
Asp-Ala-Pro-β-Napthylamide was not used for the Lineweaver-Burk plot. 
Michaelis-Menten plot: N = 3; error bars represent standard error of the mean. 
Lineweaver-Burk plot: Km = 0.83 mM; Vmax = 2.02 nmol/min. Graphs and 
transformation data were generated with GraphPad Prism® (Version 4.0.3). 
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4.3.8 Binding studies 
 
The interaction of the PfM18AAP fragment with spectrin, which was identified by 
phage display, was confirmed by overlaying full length rPfM18AAP on a dot and 
slot blot containing spectrin dimers and tetramers (Figure 61). rPfM18AAP binds 
to both spectrin dimers and spectrin tetramers. 
 
 
Figure 61: Spectrin dimers and tetramers overlaid with rPfM18AAP. 
Photographs of dot (a) and slot (b) blots containing spectrin dimers and tetramers 
overlaid with 5 µg rPfM18AAP (+) and 50 mM Tris buffer (pH 7.5) (-). 
rPfM18AAP was detected with the Penta•His™ HRP Conjugate antibody. Dot 
blots: A1 = 100 ng rPfM18AAP; A2-4 = 2, 1.4 and 0.5 µg spectrin dimers; B1 = 
100 ng BSA; B2-4 = 2, 1.4 and 0.5 µg spectrin tetramers. Slot blots: A1 = 100 ng 
rPfM18AAP; A2 = 100 ng BSA; B1 = 1 µg spectrin dimers; B2 = 1 µg spectrin 
tetramers. 
 
The blot overlays were also used to determine if rPfM18AAP bound to other 
erythrocyte membrane proteins. Membrane proteins separated on Laemmli or 
Fairbanks SDS-polyacrylamide gels, transferred to nitrocellulose and overlaid 
with rPfM18AAP, showed that the enzyme interacted strongly with β-spectrin, 
protein 4.1, protein 4.2, actin and G3PD (Figure 62a and b). A weak interaction 
with band 3 (Laemmli blot) and α-spectrin (Fairbanks blot) was also observed. 
The transfer of large molecules such as α- and β-spectrin onto the nitrocellulose 
membrane from the low percentage Fairbanks gel was better than from the high 
percentage Laemmli gel, accounting for the signals on the Fairbanks blot overlay.  
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Figure 62: Erythrocyte membrane proteins overlaid with rPfM18AAP. 
Laemmli (a) and Fairbanks gel (b) (left) and the corresponding immunoblots with 
the Penta•His™ HRP Conjugate antibody (right) showing the erythrocyte 
membrane proteins bound by rPfM18AAP. The enzyme binds strongly to β-
spectrin, protein 4.1, protein 4.2, actin, and glyceraldehyde-3-phosphate 
dehydrogenase and weakly to α-spectrin and band 3. Lane 1 = 500 ng (gel) and 
100 ng (immunoblot) rPfM18AAP; Lane 2 = 500 ng (gel) and 100 ng 
(immunoblot) BSA; Lane 3 = 20 µg erythrocyte membrane proteins. 
 
A blot overlay was subsequently performed on trypsin-digested spectrin to 
determine which spectrin domains rPfM18AAP binds and to see if the enzyme 
interacts with the N-terminal α- and β-spectrin domains. The experiment (Figure 
63) did however not give clear results because of several factors. Firstly, the 
trypsin-digested α- and β-spectrin domains often comigrate (Figure 63 α- and β-
antibody immunoblot) making it difficult to delineate the domains. Secondly, α- 
and β-spectrin are composed of homologous repeats that could all bind 
rPfM18AAP. Thirdly, the tryptic digest could expose glutamates and aspartates at 
the N-termini of the spectrin protein fragments, because trypsin cleaves proteins 
on the C-terminal side of arginine and lysine residues. This results, for example, 
in the exposure of a glutamate and an aspartate on the 80 and 52 kDa α-spectrin 
domains respectively (Speicher and Marchesi, 1984), which could subsequently 
serve as substrates for rPfM18AAP. Fourthly, only a limited tryptic digest was 
performed with a low trypsin to spectrin ratio and digestion at 4 ºC, to prevent the 
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spectrin domains from being digested into smaller peptides. This however resulted 
in the presence of some incompletely digested spectrin molecules containing 
several domains, which are larger than the 80 kDa N-terminal α-spectrin domain 
(Figure 63) that still bound rPfM18AAP, thereby obscuring the results. Finally, 
the 74 kDa N-terminal domain of β-spectrin is often broken down into smaller 52, 
41 and 30 kDa protein fragments during the tryptic digest (Figure 63 α- and β-
antibody immunoblot), which could comigrate with the α-spectrin fragments and 
thereby making it impossible to distinguish between the α- and β-spectrin binding 
profile. The generation of the different spectrin domains as separate peptides with 
recombinant protein expression systems and subsequently allowing these peptides 
to interact with rPfM18AAP, could resolve the issues with mentioned above. 
 
 
Figure 63: Spectrin tryptic digest overlaid with rPfM18AAP. 
Immunoblot with the anti-α- and anti-β-spectrin antibodies (left) showing the α- 
and β-spectrin tryptic digest peptides, two exposures of the same immunoblot with 
the Penta•His™ HRP Conjugate antibody (middle) showing the spectrin tryptic 
digest peptides bound by rPfM18AAP, and Laemmli gel (right) showing the 
spectrin tryptic digest peptides. Alpha and beta-spectrin immunoblot: 40 µg 
trypsin digested with 0.4 µg trypsin for 18 hours at 4 ºC. Blot overlay 
immunoblots and gel: Lane 1 = 100 ng (immunoblot) and 500 ng (gel) BSA; Lane 
2 = 100 ng (immunoblot) and 500 ng (gel) rPfM18AAP; Lane 3 = 40 µg spectrin 
tryptic digest, Lane M = 20 µg erythrocyte membrane proteins. Red arrowheads = 
α-spectrin peptide domains; blue arrowheads = β-spectrin peptide domains. 
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4.4 Discussion 
4.4.1 The PfM18AAP active site 
 
Teuscher et al. (2007) showed that rPfM18AAP was activated by cobalt, which 
suggests that the active site contains cobalt as cofactors. It was therefore possible 
to draw a diagram of the inferred PfM18AAP active site based on the crystal 
structures of the other aspartyl aminopeptidases (Stamper et al., 2001, Schürer et 
al., 2004). The two Co2+ ions are each coordinated with one histidine (PfH86 and 
PfH534) and an aspartate or a glutamate (PfD434 or PfE380), while another 
aspartate (PfD324) and a water molecule bridge the two metal ions (Figure 64). A 
second glutamate residue (PfE379) is located near the active site and is hydrogen 
bonded to the bridging water molecule and another aspartate (PfD88) decreases 
the Lewis acidity of the second metal ion by binding to PfH86. 
 
 
Figure 64: The putative metal binding site of PfM18AAP. 
Diagram showing how the two metal ions of PfM18AAP could be bound in the 
active site of the enzyme. The metal ions, possibly cobalt, are bound by two 
histidines (PfH86 and PfH534), two aspartates (PfD434 and PfD324) and a 
glutamate (PfE380). A water molecule, or hydroxide ion, is hydrogen bonded to a 
second glutamate (PfE379) and bridges both cobalt ions. A third aspartate 
(PfD88) decreases the Lewis acidity of the second metal ion by binding to PfH86. 
The final histidine (PfH170), which is involved in enzymatic activity, is located 
between PfH534 and PfD324, but is too far away from these residues and the 
metal ions to form bonds with them (not shown).  
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Aminopeptidases that contain a co-catalytic active site, use a common reaction 
mechanism to cleave a substrate (Schürer et al., 2004), regardless of the type of 
metal ions present in the enzyme. The Aeromonas proteolytica aminopeptidase 
active site contains the same metal-binding amino acids as PfM18AAP to bind 
two zinc ions and therefore the reaction mechanism that is employed by this 
enzyme may be used to explain the substrate cleavage mechanism of PfM18AAP 
(Figure 65) (Stamper et al., 2001, Schürer et al., 2004). 
 
The enzymatic reaction is initiated when the substrate (a dipeptide with an N-
terminal aspartate) binds with its N-terminal amino group to the second Co2+ ion 
and with the carbonyl oxygen of the scissile peptide bond to the first Co2+ ion. 
The N-terminus (NH2) of the substrate also interacts with Asp434, which is bound 
to the second Co2+ ion. After substrate-binding, the bridging water molecule loses 
its coordination to the second Co2+ ion, leaving it bound to only the first Co2+ ion. 
This loss of coordination is enhanced by the hydrogen bond between His86 and 
Asp88, which reduces the Lewis acidity of the second Co2+ ion and therefore 
reduces the metal ion’s affinity for the water molecule. Substrate cleavage occurs 
after the water molecule is deprotonated by Glu379 (base catalysis), resulting in a 
nucleophilic hydroxide ion that acts on the substrate’s peptide bond. Finally, 
Glu379 may donate two protons to the peptide nitrogen to complete the separation 
of the substrate into two molecules (acid catalysis). 
 
Wilk et al. (2002) showed that an additional histidine (PfH170), which is not part 
of the conserved metal-binding amino acids, is also required for substrate 
cleavage. Histidines are generally used by metalloenzymes to coordinate the 
catalytic metal ion (Auld, 2001), but by analogy to the human enzyme, histidine 
PfH170 might be acting directly on the substrate as a nucleophile or base (Bugg, 
2004), or it may be involved in substrate-binding because it is located on the side 
of the active site where the substrate enters the pocket. 
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Figure 65: The putative substrate cleavage mechanism of PfM18AAP. 
Diagram showing the cleavage of a dipeptide substrate by PfM18AAP. The 
dipeptide, which has an N-terminal aspartate, binds to both cobalt ions, followed 
by deprotonation of the water molecule by the glutamate (PfE379). The 
nucleophilic hydroxide ion attacks the peptide bond in the substrate resulting in 
the release of two amino acids. The exact function of PfH170 in the cleavage 
mechanism is not known. PfH86, PfD88, PfH170, PfE380, and PfH534 have been 
omitted to simplify the diagram (adapted from Schürer et al., 2004, and Stamper 
et al., 2001). 
 
4.4.2 The PfM18AAP spectrin-binding site 
 
The spectrin-binding region (Pf216-257) is only found in PfM18AAP and could 
therefore represent a special evolutionary adaptation of P. falciparum. Secondary 
structure prediction and a comparison to the quaternary structures of the other 
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aspartyl aminopeptidases showed that the spectrin-binding region contains an 
alpha helix and occurs on the outer surface of the native enzyme. This alpha-
helical region (Pf243-254) lies within an unstructured region of amino acids on 
the outer surface of the enzyme and can therefore provide an anchoring point for 
PfM18AAP to the erythrocyte membrane skeleton, without interfering with the 
enzymatic function. The enzyme could, for example, bind to one of the proteins it 
interacts with and cleave any of the proteins of the erythrocyte membrane skeleton, 
since all these proteins are interlinked. The binding region could also guide 
spectrin, which has a diameter of 20 Å (Yan et al., 1993), or any of the other 
erythrocyte membrane proteins that PfM18AAP interacts with, into the pores 
towards the internal active sites of the enzyme. 
 
4.4.3 rPfM18AAP protein and enzyme characteristics 
 
Non-denaturing gel electrophoresis of rPfM18AAP indicated that the native 
enzyme consisted mainly of a tetramer and higher order oligomers, possibly 
octamers and dodecamers. Teuscher et al. (2007) showed that PfM18AAP 
occurred as an octamer in its active native state by assaying HPLC fractions for 
enzymatic activity. This is the same number of subunits as predicted for the H. 
sapiens and S. cerevisiae aspartyl aminopeptidases (Wilk et al., 2002, Yokoyama 
et al., 2006). However, the unpublished crystal structures of the P. aeruginosa, C. 
acetobutylicum, T. maritima and B. burgdorferi M18 aminopeptidases showed 
that these enzymes occurred as dodecamers. Crystallisation or velocity 
sedimentation of PfM18AAP could be performed to determine the exact number 
of monomers that are necessary to form the native enzyme. 
 
Enzyme activity assays showed that rPfM18AAP cleaved the N-terminal aspartate 
from the tripeptide Asp-Ala-Pro-β-Napthylamide. Teuscher et al. (2007) showed 
that rPfM18AAP also cleaved the N-terminal amino acids from the fluorogenic 
dipeptide substrates H-Asp-4-methyl-7-coumarinylamide (NHMec) and H-Glu-
NHMec and that rPfM18AAP was more active on N-terminal glutamates in 
comparison to N-terminal aspartates. Both these amino acids are acidic, indicating 
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that PfM18AAP only cleaves peptides and proteins that have an acidic N-terminus. 
This was confirmed by Teuscher et al. (2007), who also tested substrates 
containing hydrophobic, basic or neutral N-terminal amino acids and found no 
enzymatic activity. 
 
A pH study showed that rPfM18AAP was active from pH 7-8.5, with the highest 
activity at the physiological pH of 7.5. The enzyme had no activity at pH 5.3, 
which is close to the pH of the food vacuole (5.0-5.2 (Yayon et al., 1984)), 
indicating that it does not participate in the initial breakdown of host haemoglobin 
into 2-10 amino acid peptides (Klemba et al., 2004). These small peptides are 
subsequently exported from the food vacuole into the parasite cytosol where they 
are converted into amino acids by PfM18AAP and other aminopeptidases 
(Teuscher et al., 2007, Dalal and Klemba, 2007). This correlates well with the 
fluorescence microscopy findings of Dalal et al. (Dalal and Klemba, 2007) that 
PfM18AAP (PfDAP in their nomenclature) was excluded from the food vacuole. 
The parasite cytosol has a pH of 7.3-7.4, allowing PfM18AAP to be active in this 
parasite compartment. Even though PfM18AAP has no export signals, it has also 
been localised to the parasitophorous vacuole by immunoblot analysis (Teuscher 
et al., 2007) and the erythrocyte membrane by mass spectroscopy (Florens et al., 
2004), as well as by phage display interactions in this study. The enzyme could 
therefore also be active in the erythrocyte cytosol which has a neutral pH of 7.2-
7.3 (Funder and Wieth, 1966). 
 
The temperature study revealed that rPfM18AAP was active from 33-39 ºC with 
maximum activity at 37 ºC, which indicates that the enzyme is active when the 
parasite resides in the human host. rPfM18AAP had 90 % activity at 39 ºC, 
implying that the enzyme is still functional when the human host experiences 
fever (maximum temperature 42 ºC), which occurs after the erythrocytes rupture 
(Sinden and Gilles, 2002). PfM18AAP could therefore be active during the initial 
growth phase in new erythrocytes. The enzyme only had ~35 % activity at 25 ºC, 
which is the ambient body temperature of the mosquito (Oaks et al., 1991), 
suggesting that the enzyme is not fully functional during this stage of its lifecycle.  
 
 
166
Studies utilising metal ions and protease inhibitors revealed some interesting 
features of rPfM18AAP. EDTA inhibited enzymatic activity confirming that 
rPfM18AAP is a metalloprotease and that the metal ions remained bound in the 
enzyme during the purification procedure. Bestatin, an aminopeptidase inhibitor, 
also inhibited the enzyme, but the effect was not as pronounced as it was with the 
metal chelator, EDTA. Teuscher et al. (2007) observed an 86 % inhibition of 
enzymatic activity when rPfM18AAP was preincubated with EDTA for 30 
minutes. This is higher than the 39 % inhibitory effect observed in this study, 
presumably because the enzyme was preincubated for 10 minutes only. The metal 
ion study revealed that zinc inhibited enzymatic activity and that calcium, 
magnesium and manganese had only a slight effect. The zinc ions could have 
displaced the natural cofactor of rPfM18AAP in the active site and therefore 
obliterated the enzymatic activity. The in vitro study performed by Teuscher et al. 
(2007) with pure enzyme and parasite extracts, showed that cobalt was the only 
metal ion that enhanced PfM18AAP enzymatic activity. They also confirmed the 
inhibitory effect of zinc. 
 
The substrate concentration versus velocity curve for rPfM18AAP showed that 
substrate inhibition occurred at ≥1.5 mM Asp-Ala-Pro-β-Napthylamide. Substrate 
inhibition is a form of uncompetitive inhibition, where two substrate molecules 
simultaneously bind in the active site, at the positions where only one substrate 
molecule would normally bind during enzymatic cleavage, thereby forming a 
dead-end complex. The second substrate molecule therefore becomes an inhibitor. 
In the case of rPfM18AAP, a second substrate molecule could for example bind to 
the cobalt ion that normally binds the carbonyl oxygen of the scissile peptide bond 
of the first substrate molecule, thereby preventing the nucleophilic attack on the 
peptide bond.  The presence of substrate inhibition made it difficult to determine 
accurate Km and Vmax values for rPfM18AAP using the non-linear least squares 
procedure based on the Michaelis-Menten equation and therefore Km and Vmax 
values were estimated from the Lineweaver-Burk plot. 
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Enzyme activity was very variable amongst different enzyme preparations. This 
could be due to numerous factors. Firstly, the proportion of contaminating 
proteins varied in the different purifications, which would decrease the amount of 
rPfM18AAP in the assay and yield lower activity. Secondly, folding of the protein 
could be different each time the protein is expressed in E. coli and this could 
compromise activity. Thirdly, manipulation of the enzyme during purification 
could inactivate some of the enzyme and the degree of inactivation could vary 
between preparations. Finally, the variable length of time from purification to 
assay could have caused a decrease in enzyme activity. 
 
4.4.4 rPfM18AAP-erythrocyte membrane protein interactions 
 
In the phage display studies (Chapter 2) an interaction between spectrin and a P. 
falciparum-specific 42 amino acid stretch of PfM18AAP was identified. To verify 
this association with the full length protein, blot overlays were performed. These 
demonstrated strong specific binding to spectrin dimers, spectrin tetramers and in 
the case of the spectrin monomers, marked preferential binding to β-spectrin 
compared to α-spectrin. In addition, rPfM18AAP interacted with protein 4.1, 
protein 4.2 and actin. All these erythrocyte membrane proteins contain one or 
more aspartates or glutamates within the first 10 N-terminal residues (Figure 66), 
making them putative substrates for rPfM18AAP. However, the host glycolytic 
enzyme, G3PD, which associates with the cytoplasmic domain of band 3, also 
showed a strong binding of rPfM18AAP on the blot overlays. The significance of 
this interaction between the parasite and the human enzyme is unclear, since 
G3PD does not have any aspartates or glutamates in the first 10 N-terminal 
residues (Figure 66).  
 
Actin or α-spectrin could be prime targets for PfM18AAP, because they have 
three aspartates (actin) and one glutamate (α-spectrin) after the N-terminal 
methionine (Figure 66), which would be cleaved from newly synthesised proteins 
by human methionine aminopeptidases (reviewed in Bradshaw et al., 1998). There 
is however a possibility that PfM18AAP does not cleave actin because it is 
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acetylated (Figure 66). Yeast aspartyl aminopeptidase, for example, cannot 
remove an N-acetylated aspartate from a N-terminally blocked substrate 
(Yokoyama et al., 2006). 
 
α-spectrin     MEQFPKETVV 
β-spectrin     MTSATEFENV 
protein 4.1     MTTEKSLVTE 
protein 4.2     MGQGEPSQRS 
actin      MDDDIAALVV 
G3PD      MGKVKVGVNG 
Figure 66: The first 10 amino acids of the rPfM18AAP-binding erythrocyte 
membrane proteins. 
Diagram showing the first ten N-terminal amino acids of α-spectrin, β-spectrin, 
protein 4.1, protein 4.2, actin, and glyceraldehyde-3-phosphate dehydrogenase 
(G3PD). Aspartates and glutamates are labelled in red. Post-translationally 
modified amino acids are boxed in blue: actin and β-spectrin = acetylated; and 
protein 4.2 = myristoylated. 
 
The N-termini of β-spectrin molecules are linked to actin and protein 4.1 in the 
junctional complex (Ungewickell et al., 1979) and protein 4.2 is part of the band 3 
complex of the erythrocyte membrane (Korsgren and Cohen, 1988). Cleavage of 
any of these proteins could therefore destabilise and disrupt the junctional 
complexes and the band 3 complexes. The N-termini of α-spectrin are located at 
the self-association sites of spectrin tetramers (Morrow et al., 1980) and since 
PfM18AAP shows a marked preferential binding to β-spectrin compared to α-
spectrin, the enzyme could bind to β-spectrin near the self-association site and 
cleave the N-termini of α-spectrin, thereby disrupting the spectrin tetramers. 
 
4.4.5 The function of PfM18AAP in the infected erythrocyte 
 
The primary function of PfM18AAP in P. falciparum is to cleave aspartates or 
glutamates from the oligopeptides that are exported from the food vacuole into the 
parasite cytosol after haemoglobin digestion (Teuscher et al., 2007, Dalal and 
Klemba, 2007). These and other free amino acids are utilised by the parasite for 
protein synthesis. In addition, 84 % of the amino acids derived from haemoglobin 
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digestion, are released from the cell and this regulates the colloid-osmotic 
pressure within the infected erythrocyte to prevent premature cell lysis and to 
establish a concentration gradient that facilitates the entry of rare amino acids into 
the infected erythrocyte (Lew et al., 2003). PfM18AAP is therefore indirectly 
involved in regulating the volume of the host cell to accommodate the increasing 
size of the growing parasite. 
 
Results from this study, as well as PfM18AAP mRNA and protein data from other 
laboratories, indicate that the enzyme could also perform additional functions in 
the parasitophorous vacuole, the erythrocyte cytosol and particularly at the 
infected erythrocyte membrane skeleton. Microarray data showed that PfM18AAP 
mRNA is expressed throughout the erythrocytic stages, with the highest 
expression levels in early and late trophozoites and in gametocytes (Le Roch et al., 
2003, Bozdech et al., 2003), whilst Northern blot analysis revealed predominant 
expression in rings (Teuscher et al., 2007). Protein data localised PfM18AAP in 
merozoites, trophozoites and schizonts (Florens et al., 2002) and at the infected 
erythrocyte membrane in trophozoite/schizont stage parasites (Florens et al., 
2004). Western blot analysis and immunolocalisation experiments, utilising anti-
PfM18AAP antiserum, also revealed the enzyme in rings, the parasite cytosol and 
the parasitophorous vacuole (Teuscher et al., 2007). PfM18AAP mRNA is 
therefore translated into the enzyme at several stages in the erythrocytic life cycle 
and the PfM18AAP protein is located in several compartments within the parasite-
infected erythrocyte. These data imply that PfM18AAP could play a role in 
parasite invasion, growth and/or exit from the host cell, since parasite proteins 
interact with the erythrocyte membrane and the underlying erythrocyte membrane 
skeleton during all phases of the erythrocytic stage of the parasite. Transfection of 
parasite-infected erythrocytes with a plasmid containing PfM18AAP fused to 
green fluorescent protein could shed more light on the location of the enzyme 
during the different stages of the parasite life cycle. 
 
Merozoites are the invasive form in erythrocytic schizogony and utilise proteases 
to gain entry into the new host cell. Inhibition studies with 1,10-phenanthroline 
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have shown that metalloproteases are involved in parasite invasion (Kitjaroentham 
et al., 2006) and hence PfM18AAP could be involved in this process. During 
invasion the red cell membrane and membrane skeleton are rearranged in 
localised areas to facilitate entry of the parasite (Bannister and Mitchell, 2003). 
PfM18AAP could weaken the spectrin skeleton and thus assist in invasion. 
 
The host experiences febrile paroxysms triggered by the release of toxins during 
parasitised erythrocyte rupture (Sinden and Gilles, 2002). Since PfM18AAP is 
functional at elevated temperatures, it could thus be responsible for regulating, 
processing and/or activating other parasite proteins within the early ring stage by 
removing their N-termini. 
 
During further growth the parasite introduces NPPs into the erythrocyte 
membrane to facilitate the import and export of nutrients and waste products from 
the red cell. PfM18AAP could aid in the insertion of these NPPs in the 
erythrocyte membrane by disrupting the membrane skeleton. The enzyme could 
also be responsible for altering the activity of erythrocyte membrane channels and 
transporters. Maturation of the parasite in the erythrocyte is also concomitant with 
the formation of knobs on the erythrocyte surface. Knobs are anchored in the 
erythrocyte membrane skeleton (Cooke et al., 2004) and therefore PfM18AAP 
could be responsible for weakening and disrupting the erythrocyte membrane 
skeleton to facilitate the insertion of these structures.  
 
Several parasite proteases, such as plasmepsin-II (Le Bonniec et al., 1999) and 
falcipain-2 (Dua et al., 2001), which are primarily involved in haemoglobin 
digestion inside the food vacuole, also facilitate the release of the parasite from its 
erythrocytic host by cleaving membrane skeleton proteins such as spectrin, protein 
4.1 and ankyrin. Studies with inhibitors have proven that parasite proteases first 
weaken the parasitophorous vacuole membrane and then the erythrocyte 
membrane prior to parasite release (Wickham et al., 2003), which is caused by an 
osmotic pressure build-up within the erythrocyte (Glushakova et al., 2005). 
Weakening of the erythrocyte membrane would involve disruption of the spectrin-
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junctional complex network below the plasma membrane and therefore 
PfM18AAP could also play a role in the release of the parasite from its 
erythrocyte host. 
 
4.4.6 PfM18AAP as a novel drug target 
 
A knockout experiment utilising a single-crossover strategy to integrate an 
episome into the PFI1570c open reading frame, was used by Dalal and Klemba 
(2007) to express PfM18AAP, which lacked 236 amino acids from its C-terminus. 
Parasites expressing the truncated enzyme showed less than 10 % enzymatic 
activity when compared to wild-type parasites, indicating that enzymatic activity 
was nearly completely abolished. Alteration of the PFI1570c gene did however 
not have deleterious effects on parasite replication, possibly because the small 
amount of active enzyme was enough to perform all the necessary PfM18AAP 
enzymatic reactions in the parasite. This interpretation may explain the contrasting 
findings from Teuscher et al. (2007), who performed knockdown experiments 
utilising a plasmid containing an antisense copy of the PFI1570c gene. They 
showed an 80-fold decrease in PfM18AAP enzyme activity in parasite extracts 
that resulted in a lethal phenotype due to significant morphological damage, 
which included rupture of the food vacuole and the accumulation of haemoglobin 
and lipid droplets in the parasite. The same group tested phosphorus-containing 
inhibitors on PfM18AAP and found that these compounds were only moderately 
effective in vitro and had no inhibitory effect on the growth of the parasite in 
culture (Teuscher et al., 2007).   
 
These experiments show that PfM18AAP is required for parasite survival and 
therefore further studies on the function of the enzyme and its reaction mechanism 
could lead to the development of new drugs that can be employed to fight malaria 
infections. 
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Chapter 5: Conclusion 
 
The malaria parasite depends on parasite-host protein interactions during invasion 
of, development in and exit from the human erythrocyte and interactions with 
human erythrocyte membrane proteins are of particular importance. The aim of 
this study was therefore to identify and characterise P. falciparum proteins that 
interact with human spectrin, which is the main structural component of the 
erythrocyte membrane skeleton. To achieve this goal, a novel approach based on 
the construction of a P. falciparum phage display library and subsequent 
biopanning of this library against immobilised spectrin, was applied to identify 
five spectrin-binding P. falciparum peptides. These results show that phage 
display is a very powerful tool to probe host-parasite interactions. In addition, this 
species-specific library can be used to identify other protein-protein interactions, 
provided a target protein can be purified and immobilised for the panning 
procedure. 
 
PfM18AAP is an aminopeptidase, which contains a P. falciparum-specific insert 
that interacts with spectrin, as evidenced by phage display studies. The full length 
protein was expressed as a 6His-recombinant protein in E. coli and characterised. 
The enzyme cleaves an N-terminal aspartate from a peptide substrate and 
participates in the final stages of haemoglobin digestion. Results from this study 
suggest that PfM18AAP performs additional functions in the parasite and infected 
erythrocyte, by acting on spectrin and other erythrocyte membrane proteins. 
Cleavage of spectrin could for example destabilise the erythrocyte membrane 
skeleton and facilitate parasite entry or exit, or it could allow for the insertion of 
NPPs into the erythrocyte membrane during parasite development. Further 
characterisation of this multifunctional enzyme could identify additional 
substrates of PfM18AAP in the parasite and the human host and could ultimately 
lead to the development of new therapeutics for malaria treatment. 
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APPENDICES 
 
A1: METHODS 
 
0.4 mM PMSF stock preparation and addition to erythrocyte lysis buffer 
(Section 2.2.2) 
A 0.4 mM PMSF stock solution was prepared in DMSO and slowly added to the 
erythrocyte lysis buffer with rapid stirring. PMSF is a serine and cysteine protease 
inhibitor that has a half-life of 110 minutes when incubated in phosphate buffer, 
pH 7 at 25 ºC. The hydrolysis of PMSF is accelerated with an increase in pH and 
temperature. 
 
PCR for radioactively labelled size markers 
Size markers were amplified using TaKaRa Taq™ (Takara Bio Inc., Otsu, Japan). 
The 347 bp fragment was amplified using the P2 and P3 primers (Inqaba 
Biotechnical Industries, Pretoria, South Africa), which are specific for human 
erythrocyte α-spectrin (exon 2). The 722 bp fragment was amplified with the P86 
and P87 primers (Inqaba Biotechnical Industries, Pretoria, South Africa) which 
are specific for human erythrocyte band 3 (exon 18 and 19). Approximately 250 
ng human DNA was amplified with 300 nM of each primer, 2.5 µl 10 x PCR 
Buffer, 2 µl dNTP Mixture (2.5 mM of each nucleotide), 2.5 µCi [α-32P]dATP 
(specific activity = 3000 Ci/mmol), and 0.625 U enzyme (reaction volume = 25 
µl) under the following conditions using the Eppendorf Mastercycler® Gradient 
machine: 
Hot start:  95 ºC for 1 min 
30 cycles:  94 ºC for 1 min 
    55 ºC (P2/P3) or 63 ºC (P86/P87) for 1 min 
    72 ºC for 1 min 
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A2: VECTOR MAPS 
 
 
Figure A1: pET-15b vector map (a) and multiple cloning cassette (b) 
(adapted from Novagen, 1999b). 
 
 
175
 
Figure A2: pGEX-4T-2 vector map (a) and multiple cloning cassette (b) 
(adapted from GE Healthcare, 2007).  
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Figure A3: T7 bacteriophage vector map (a) and multiple cloning cassette (b) 
(adapted from Novagen, 2000a). 
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A3: CODON USAGE TABLES 
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A4: AUTOMATED SEQUENCING RESULTS OF PFI1570c 
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Automated sequencing results of pET-15b-PFI1570c. 
The PlasmoDB PFI1570c DNA and protein sequence is given above the automated sequencing DNA and protein sequence. The position of 
the A to G silent mutation, which translates into a lysine residue, is marked with a red arrow. Blue nucleotides = C; black nucleotides = G; 
red nucleotides = T; and green nucleotides = A. 
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